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INTRODUCTION
Internet-based prescribing and dispensing are poised to become major
components of healthcare delivery in the United States: In 2003, eighteen
percent of online U.S. households purchased prescription drugs online, a
number expected to grow to twenty-seven percent in 2004.' Together, this
infusion of technology and the broader trend toward increased
prescribing2 are changing the landscape of American healthcare, and the
manner in which the legal system interacts with these controversial
millennial delivery models will shape the future of healthcare.
This Article explores the policy issues and legal or regulatory
structures currently applied to prescribing and dispensing. Much of the
controversy surrounding Internet prescribing and dispensing can be
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1. Eric G. Brown with BradfordJ. Homes et al., Forrester's Top 10 Healthcare Predictions
for 2004 (Dec. 15, 2003), at
http://www.forrester.com/ER/Research/Brief/0,1317,33444,00.html.
2. See, e.g., Press Release, Health Affairs, Doctors Prescribing More Drugs? (July 9,
2002), http://www.healthaffairs.org/press/InTheNews_070902.htm.
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attributed to the unsavory origins of these initiatives: Many of the early
providers have been illegal or marginally legal businesses.3 This Article
argues that the threat posed by rogue prescribing and dispensing does not
justify the level, style, and mechanics of current regulation. The Article
further argues that current and emerging regulation may chill the
development of lawful, efficient, necessary, and patient-friendly services
and recommends alternate approaches.
Part I of the Article sets out the key distinguishing features of the
aforementioned initiatives and suggests that simple confusion between
different and emergent models seem to be misleading legislators and
regulators and imperiling patient choice. Part II discusses current
regulation of Internet prescribing and dispensing and addresses the areas
that most concern regulators. In the process, it examines the regulation of
Internet prescribing by state licensing boards and the controversy
surrounding transnational prescription dispensing.
Parts III and IV of the Article then look beyond the current forms of
Internet prescribing and dispensing to identify the stakeholders and
critically analyze the regulatory themes that populate the landscape. These
themes, including those labeled as uneasy federalism, under-regulation,
and over-regulation, help us better understand the ways our legal and
regulatory systems create disincentives to the adoption of new technologies
or business models. Part V of the Article describes the steps necessary to
maintain rigorous control over healthcare quality while avoiding
disincentives to the provision of the next generation of effective and
efficient healthcare. More importantly, it suggests positive steps (both legal
and structural) necessary to create a prescribing and dispensing
environment that is lawful, patient-friendly, and progressive in integrating
e-health solutions into standard care practices.
I. BACKGROUND: ISSUES AND TERMINOLOGY
To better understand the impact of regulation on Internet prescribing
and dispensing, it is important to appreciate the broader and highly varied
landscape of technologically-mediated healthcare. It is also critical to
distinguish between the overlapping and frequently confusing labels
applied in the relatively immature e-health domain.
In the early twentieth-century there were recorded attempts at what we
now call remote imaging or PACS (Picture Archiving and Communications
3. See discussion infra notes 18-20, 27-29 and accompanying text.
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Systems) . However, the first successful iterations of telemedicine were
primarily audio educational teleconferences in the 1950s." By the 1960s,
rudimentary telemedicine networks had added video, leading to the first
remote consultations.7 As POTS (Plain Old Telephone System) gave way to
faster ISDN (Integrated Services Digital Networks) and subsequent high-
speed networks, increasingly sophisticated data, such as charts and x-rays,
were added to the telemedical consultation mix."
Telemedicine began as a narrow construct-a consultation-based
model of diagnosis and occasionally treatment. 9 In the traditional
telemedicine model a primary (or originating) physician uses technology
(be it phone, e-mail, or interactive video) to connect to a consulting (or
remote) physician; the primary physician may provide the consulting
physician with access to a patient's chart, x-ray, or other medical
information.
Technological developments have allowed telemedicine to move
beyond its early intrastate models to interstate and international projects.'
4. Travis Wheeler, In the Beginning... Telemedicine and Telepsychiatry, 2 TELEMEDICINE
TODAY 2 (1994).
5. In this Part, I describe telemedicine's original meaning-i.e., the consultative
interaction between a patient, an on-site health professional, and a distant physician. See
infra text accompany note 9. In recent years, telemedicine has increasingly been used as an
umbrella term, encompassing a broad range of technologically-mediated interactions. See
infra note 10 and text accompanying note 12. I posit that continued use of a narrow
definition of telemedicine is preferable for its specificity, and other terms, such as
telehealth, are more appropriate as broadly inclusive references. See infra text
accompanying note 13.
6. Wheeler, supra note 4, at 2. Audio educational teleconferences were first used in
psychiatry. See Tracy D. Gunter et al., Misinformed Regulation of Electronic Medicine Unfair to
Responsible Telepsychiatby, 31 J. AcAD. PSYCHIATRY L. 10 (2003).
7. Wheeler, supra note 4, at 4.
8. See TELEMEDICINE: A GUIDE TO ASSESSING TELECOMMUNICATIONS FOR HEALTH CARE 34-
38 (MarilynJ. Field ed., 1996) [hereinafter TELEMEDICINE GUIDE].
9. Id. at 44-46.
10. Much of the technological innovation in telemedical services, particularly in the use
of microwave and satellite technologies, has been driven by the military and NASA. Id. at 39.
Increasingly, traditional bricks-and-mortar healthcare entities have invested heavily in
imaging technologies which enable store-and-forward type applications. See, e.g.,
Teleradiology FAQ Hospital for Special Surgery, at http://www.imaginghss.org/patient/dri-
pat-faq-telerradio.htm (last visited Apr. 15, 2004); The Apollo Telepathology System, Apollo
Telemedicine, at http://www.apollotelemedicine.com/solutions/telepathology (last visited
Apr. 15, 2004). These applications provide their physicians and consultants with widespread
remote access to patient data. See, e.g., Scott A. Edelstein, Careful Telemedicine Planning Limits
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Once it became possible for the remote physician to observe and
communicate directly with the patient, telemedicine practice began to
deemphasize the importance and role of the "local" physician; in many
instances, nurses, nurse practitioners, and IT technicians may now
substitute for the local physician.11
More recently, the "telemedicine" label has been applied to fully
disintermediated models-that is, where there is no on-site health
professional and technology alone links patients to distant healthcare
providers. For example,
in telehome medicine (technologically-mediate home care) patients
interact with monitoring or diagnostic appliances that transmit results to
healthcare professionals. 12 Rather than stretching the scope of
"telemedicine" to include the full range of remote diagnosis and
treatment, store-and-forward technologies, telehome medicine and other
disintermediated models, "telehealth"'13 is a broader term that more easily
captures all of this. However, the fact that telehealth is an appropriate term
to describe these related technologies should not suggest that they
necessarily merit collective regulatory treatment.
Extending well beyond the scope of terms like telemedicine or even
telehealth, "e-health" is now the accepted reference for the many varied
modes of technologically-mediated healthcare. 14 E-health includes
telehealth and also encompasses Internet-based prescribing and
dispensing, e-prescribing, 5 health advice websites, online continuing
medical education and health care procurement. 16 E-health stretches
beyond Internet-based commercial activities (commonly referred to as "e-
commerce") to include technologically-mediated healthcare more
generally. It includes the accelerating incorporation of technology into
traditional bricks-and-mortar healthcare-from reimbursement and
Costly Liability Exposure, HEALTHCARE FIN. MGMT., Dec. 1999,
http://articles.findarticles.com/p/articles/mim3257/is 12_53/ai58185760.
11. TELEMEDICINE GUIDE, supra note 8, at 44-46.
12. Id.
13. According to Nebraska law, "Telehealth means the use of telecommunications
technology by a healthcare practitioner to deliver healthcare services within his or her
scope of practice at a site other than the site where the patient is located .. " NEB. REV.
STAT. § 71-8503 (2002).
14. See Nicolas P. Terry, Structural and Legal Implications of e-Health, 33J. HEALTH L. 606
n.1 (2000); see also G. Eysenbach, Editorial, What Is e-Health?, 3J. MED. INTERNET RES. e20
(2001), http://www.jmir.org/2O01/2/e20/.
15. Infra note 17 discusses the definition of e-prescribing.
16. See Terry, supra note 14.
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insurance transactions, to longitudinal electronic medical records, to
computerized physician order entry (CPOE) systems, to surgery robots-to
improve the quality or efficiency of healthcare. Ironically, e-health is
unlikely to remain a meaningful label: The rapid deployment of
technologies in the health arena, fuelled by the need to reduce medical
and medication adverse events and the urgent imperative to remove
administrative costs, will rapidly blur the distinction between traditional
healthcare delivery and e-health.
Internet prescribing is a particularly important subset of e-health. It is
the practice of providing access to prescription drugs when the primary
contact between patient and prescriber is Internet or email-based. 7 Many
of the businesses involved in such practices are completely disconnected
from any model of responsible medical practice.18 They frequently dabble
in controlled substances or maintain a "side business" to perform credit
17. Care must be taken to distinguish the term "e-prescribing" (electronic prescribing)
from Internet prescribing which may result in electronic prescriptions. In its simplest forms,
e-prescribing consists of handheld devices that improve prescription writing or dispensing;
they are frequently used by physicians in hospitals. (Admittedly, given e-prescribing's
narrow definition, its use of the prefix "e-" is anomalous; elsewhere the prefix "e-" indicates
reliance on internet functionality, as in "e-commerce," or technological-mediation more
generally, as in "e-health.")
There are direct cost-savings associated with e-prescribing's use of electronic
interfaces, and the use of such interfaces will expand exponentially as the full HIPAA
electronic data interchange (EDI) and longitudinal patient records come online. See
Nicolas P. Terry, An eHealth Diptych: The Impact of Privacy Regulation on Medical Error and
Malpractice Litigation, 27 AM.J. L. & MED. 361, 365-66, 370 (2001). At present, however, the
dominant reason for adopting such technologies lies in their potential for reducing medical
error. See generally CAL. HEALTH CARE FOUND., E-PRESCRIBING (2001),
http://www.chcf.org/documents/hospitals/EPrescribing.pdf; CAL. HEALTH CARE FOUND.,
IMPROVING DRUG PRESCRIBING PRACTICES IN THE OUTPATIENT SETTING: A MARKET ANALYSIS
(2002), http://www.chcf.org/documents/ihealth/ImprovingDrugPrescribing.pdf.
Electronic prescription refers to the movement away from requiring a conventional
written prescription provided to a patient by a physician that is then manually transmitted
to a pharmacy. State laws increasingly allow for a purely electronic prescription and
resultant transmittal. See, e.g., MASS. GEN. LAws ch. 94C, § 23 (Supp. 2004) ("A prescription
may be transmitted electronically with the electronic signature and electronic instructions
of the prescriber, and shall be transmitted directly from the prescriber to the pharmacy
designated by the patient without alteration of the prescription information, except that
third-party intermediaries may act as conduits to route the prescription from the prescriber
to the pharmacy.").
18. See, e.g., Gilbert M. Gaul & Mary Pat Flaherty, Doctors Medicate Strangers on Web; Some
Physicians Face Own Troubles, WASH. POST, Oct. 21, 2003, at Al.
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card fraud or other scars.'9 Others are far greyer and make for the most
difficult policy and regulatory choices. These superficially professional sites
involve online "diagnosis" prior to prescribing. Subsequently, they
generate a prescription that they dispense or, more likely, is dispensed
through an Internet-based fulfillment partner. ° What they have in
common is best described as an opportunistic physician-patient
"relationship" that is entered into for a single purpose (and often a solitary
transaction) -the purchase of a specific drug.
Internet dispensing is a potentially far larger business than Internet
prescribing, and much of the existing traffic is facially lawful, premised on
a valid U.S. prescription that is far more likely to have been written by a
patient's primary care provider than by a Perl script 2' on a website. In 2001,
legal Internet and mail-order dispensing accounted for only $28 billion of
the $164 billion in drug sales, but it is the fastest growing segment of the
pharmacy industry and is predicted to double each year in the near term.
These legal Internet-based pharmacies and prescription fulfillment
businesses, such as Drugstore.com, (often referred to in the press as "e-
pharmacies") are desperate to differentiate themselves from their less
reputable brethren 23 and to recapture the business they are losing to
Canadian pharmacies.2 4 They possess multiple state pharmacy licenses and,
frequently, Verified Internet Pharmacy Practice Sites (VIPPS)
accreditation. Formalism aside, these legal Internet-based pharmacies are
distinguishable by reference to their business model; they do not offer
prescribing services but fill prescriptions that, while frequently
electronically transmitted, are written by a traditional healthcare provider.
Overlapping conceptually with these legal Internet-based pharmacies
are Pharmacy Benefits Managers (PBMs), prescription fulfillment services
that increasingly are part of the managed care bundle. A growing number
of health plans and employers seek to control pharmaceutical costs by
contracting with a PBM, such as Medco Health or ExpressScripts, to
19. Mary Pat Flaherty & Gilbert M. Gaul, Lax System Allows Criminals To Invade the Supply
Chain, WASH. POST, Oct. 22, 2003, at Al.
20. See infra text accompanying notes 408-415.
21. For examples of the use of Perl scripts generally, see The CGI Resource Index, at
http://cgi.resourceindex.com/Programs-and-Scripts/Perl/ (last visitedJuly 29, 2004).
22. See Bob Tedeschi, As Baby Boomers Grow Older, Online Prescription Drug Sales Are
Showing Steady Growth, N.Y. TIMES, Dec. 16, 2002, at C16.
23. See Gilbert M. Gaul & Mary Pat Flaherty, Warnings Target Rogue Drug Sites, WASH.
POST, Oct. 24, 2003, at A7.
24. See Bob Tedeschi, As the Debate Continues, Opinions Are Divided over the Merits of
Allowing Online Drug Purchases from Canada, N.Y. TIMES, Mar. 8, 2004, at C4.
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manage the fulfillment side of the patient benefits package. 5 The larger
PBMs have their own online pharmacies or have contracted with Internet-
based pharmacies for prescription fulfillment, threatening the heretofore
dominant role of bricks-and-mortar pharmacies. 6
In contrast to the legal Internet-based pharmacies, illegal pharmacies
generally employ a composite model in which prescribing and dispensing
businesses overlap. For example, it is not uncommon to see a portal-style
advice site that drives users first to an online diagnosis and then on to
Internet dispensing.27 Some Internet addresses that seem to be cohesive,
one-stop diagnosis and prescribing businesses in fact have outsourced to
28separate fulfillment businesses. Even though the domain names for these
businesses may "look" American (i.e., dot.com), it is likely that a large
percentage are based offshore.
II. REGULATING INTERNET PRESCRIBING AND DISPENSING
It is not disputed that Internet prescribing and dispensing require
close regulation and that some market participants may merit criminal
prosecution. Unfortunately, to date, the regulatory routes chosen tend to
be conceptually awkward and operationally flawed; so, too, have been the
medical community's efforts to self-regulate. An unfortunate byproduct of
25. In some cases, HMOs have opted to develop their own in-house Internet
prescription fulfillment services, instead of contracting with a PBM. For a summary of HMO
activity and models, see Health Plan Strategies for Pharmacy Benefit Management, MANAGED CARE
WK., Jan. 13, 2003, at http://www.aishealth.com/DrugCosts/HMOstrategies.html. For the
technological structure and other details of Medco, a major PBM, see Alan Cohen, Online
Prescriptions, PC MAG., Aug. 19, 2003, at 68,
http://www.pcmag.com/article2/0,4149,1204843,00.asp.
26. See The Internet's Drug Lords, INDUSTRY STANDARD, Apr. 10, 2000,
http://www.thestandard.com/article/0,1902,13407,00.html; Associated Press, Retail
Pharmacies Fight for Share in Medicare Bill (Oct. 21, 2003), available at
http://www.foxnews.com/ story/0,2933,100595,00.html.
27. Indeed, Internet businesses may register multiple domain names, feeding their
single business from multiple or transient storefronts.
28. See, e.g., Anelia K. Dimitrova & Tony Leys, Government Closes Dubuque Pharmacy over
Internet Orders, DES MOINES REG., Sept. 13, 2003, at IA (describing how federal and state
agents shut down a neighborhood pharmacy suspected of fulfilling orders for a Virgin
Islands-based Internet company).
29. For example, Buymeds.com is based in the Virgin Islands but fulfills its orders
through U.S. bricks-and-mortar pharmacies. See Pharmacy Linked to Internet Sales Ordered
Closed, USA TODAY, Sept. 12, 2003, available at
http://www.usatoday.com/tech/news/techpolicy/2003-09-12-pharmacy-x.htm?csp=15.
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this imperfect regulation may be the chilling of responsible practices.
A. Traditional Licensure
The monopoly granted to physicians to prescribe and pharmacists to
dispense vests the regulation of pharmaceutical distribution in the hands
of state licensure systems .3 The modern legal history of medical practice
acts, licensure, and discipline began in the 1870s with the enactment of
state statutes governing the licensing of physicians' and pharmacies. The
role of the state was sanctioned in 1889, when the Supreme Court denied a
due process challenge to a West Virginia medical practice act which
required state licensure of physicians.3 From this point onward, the state
police power has been widely recognized as the source of licensure
regulation-since then only states have licensed physicians.4 Pharmacy
licensure also remains resolutely state-based, although the reciprocity
process and standardized examinations administered by the National
Association of Boards of Pharmacies (NABP) have pushed the profession
closer to national standards.
5
Physician mobility in the early part of the twentieth century led to
30. See, e.g., Az. STAT. § 32-1961 (A) (2000).
31. Medical licensure statutes enforced by state medical boards have existed for over
two hundred years, and historical antecedents aimed at quackery and overcharging date
back almost four hundred years. However, after the Civil War, licensure went into decline
in the hands of local medical societies and inferior medical schools. Thus, the modern
history of practice acts and licensure statutes did not truly begin until Texas enacted such
legislation in 1873. ROBERT C. DERBYSHIRE, MEDICAL LICENSURE AND DISCIPLINE IN THE UNITED
STATES 3-12 (1969); see Texas State Bd. of Med. Examiners, Board of Medical Examiners'
History, at http://www.tsbme.state.tx.us/boards/mbhis.htm (last visited Apr. 12, 2004).
32. CARL T. MARCOS, PHARMACY AND THE LAw 42 (1984). Licensure statutes began to
appear in the 1870s; they continue to focus on drug preparation and premises. Id.
33. Dent v. Virginia, 129 U.S. 114 (1889) (upholding 1882 W. Va. Act 93, §§ 9, 15). The
Court explained:
The power of the State to provide for the general welfare of its people authorizes
it to prescribe all such regulations as, in its judgment, will secure or tend to
secure them against the consequences of ignorance and incapacity as well as of
deception and fraud.... The nature and extent of the qualifications required
must depend primarily upon the judgment of the State as to their necessity.
Id. at 122.
34. See Kevin Outterson, Health Care, Technology and Federalism, 103 W. VA. L. REV. 503,
505-09 (2001).
35. MARcos, supra note 32, at 27.
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discussions of reciprocity and national (or uniform) licensure-issues that
the Federation of State Medical Boards has nurtured, albeit inconclusively,
since its founding in 1912. "" Today, a modern rationale for state as opposed
to national licensure seems difficult to identify. The supposed premise for
state licensure is the desirability of regulatory heterogeneity based on
geographically distinct economic, religious, or other social policies.
37Malpractice law, national health quality regulators, accreditation systems,
and even state boards themselves" have recognized that medical practice:
as well as its training, testing, and literature, is national in scope.39
Healthcare workers and consumers are highly mobile and large integrated
healthcare providers have more in common with national or multinational
corporations than the local hospitals of an earlier age. Protection of the
public is a laudable goal, but not one that requires the Balkanization of the
medical profession. °  Contemporary state licensure justifies local
professional fiefdoms, perpetuates parochialism, and encourages anti-
competitive protectionism. 4
The current state medical board systems and analogous pharmacy
systems have two key functions: gate-keeping via licensure and quality
36. DERBYSHIRE, supra note 31, at 8-9. Some progress was made, however, with the
establishment of the Federation Credentials Verification Service in 1996. See Federation
Credentials Verification Service, at http://www.fsmb.org/fcvs-program/cvrhome.htm. See
also FED'N OF STATE MED. BDS., REPORT OF THE SPECIAL COMMITTEE ON LICENSE PORTABILITY
(2002),
http://www.fsmb.org/Policy%20Documents%20and%2OWhite%2OPapers/license%20-por
tability.htm (last visited Apr. 19, 2004); infra text accompanying note 464.
37. See, e.g., Sheeley v. Memorial Hosp., 710 A.2d 161 (R.I. 1998); Hall v. Hilbun, 466
So. 2d 856 (Miss. 1985); Morrison v. MacNamara, 407 A.2d 555 (D.C. 1979).
38. See, e.g., Gabri v. Rhode Island Bd. of Med. Licensure & Discipline, No. 974344,
1998 R.I. Super. LEXIS 36 (approving use of expert testimony to determine a national
standard in sexual misconduct hearing).
39. On the role of the federal government in healthcare delivery, see Outterson, supra
note 34, at 515-20.
40. There is even less contemporary rational for making the licensure of physicians
state-based than there is for having state bar requirements for lawyers. State laws, customary
practices, and client expectations do in fact vary across state lines. The same cannot be said
for human physiology. See, e.g., Supreme Court of Virginia v. Friedman, 487 U.S. 59, 68
(1988) (holding that state bar residency requirement violated privileges and immunities
clause, but apparently approving of state requirements designed to demonstrate familiarity
with state law).
41. See DERBYSHIRE, supra note 31, at 13-31; STANLEYJ. GROSS, OFFOXES AND HEN HOUSES:
LICENSING AND THE HEALTH PROFESSIONS 9 (1984).
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control via standard-setting and discipline.2 Arguably, medical licensure
alone reveals more about qualifications than quality. The pace of quality
assurance is instead set by federal and accreditation-based reporting and
institutional peer review, as well as managed care contracting, which
identifies pools of approved providers for patients. 43 Although, for
example, state medical boards have followed state malpractice law by
adopting national standards for quality and ethics," the requirement of
licensure and the concept of disciplinary jurisdiction continue to be
interpreted, implicitly or explicitly, as fundamentally intrastate concepts. 45
Thus, the presence of the physician and patient in separate states
(interstate practice)-as is frequently the case with technologically-
mediated care-implicates discrete and frequently asymmetrical regulatory
46systems.
State medical boards are not only hostile to interstate practice, but also
47
tend to be skeptical of non-traditional forms of practice, putting even
intrastate practice that is technologically-mediated at disciplinary risk. Such
disciplinary scrutiny likely has its roots in customary standards, professional
conservatism, or even softly articulated protectionism. Nonetheless, state
licensure statutes have been able to accommodate two modest technology-
induced changes in the practice of medicine. First, when patients travel
out of state and then realize they have left their medications behind, they
may phone or email their physician for a replacement prescription. 48
42. See, e.g., Sugarman v. Bd. of Registration in Med., 662 N.E.2d 1020, 1023 (Mass.
1996) (noting the broad authority of medical boards "to sanction physicians for conduct
which undermines public confidence in the integrity of the medical profession").
43. See GRoss, supra note 41, at 16-21. See generally Nicolas P. Terry, Wen the "Machine
That Goes 'Ping'" Causes Harm: Default Torts Rules and Technologically-Mediated Health Care
Injuries, 46 ST. LOUIS U. L.J. 37 (2002).
44. See supra note 37 and accompanying text.
45. The conceptual and operational basis of state licensure and disciplinary jurisdiction
is the idea of the "practice of medicine"-a term of art referring to legally permitted
provisions of allopathic medicine. Implicitly or explicitly, that foundational concept is
interpreted to mean the practice of medicine in a given state. See, e.g., KY. REV. STAT. ANN.
§311.560(1) (Michie 2001); CAL. Bus. & PROF. CODE § 2052(a) (West 2003).
46. This dynamic becomes even more complicated once the location of web or mail
servers in additional states is considered. See, e.g., United States v. Kammersell, 7 F. Supp. 2d
1196 (C.D. Utah 1998), aff'd 196 F.3d 1137 (10th Cir. 1999) (allowing indictment for
interstate transmission of a threat between intrastate actors because of the routing of
threatening email through server in remote state).
47. See infra notes 434-442 and accompanying text.
48. See, e.g., ALA. CODE § 34-24-505(a) (1975) (emergencies); id. § 34-24-505(b)
IV:2 (2004)
PRESCRIPTIONS SANS FRONTIERES
Second, inherent to all professions is the practice of consultation-the
formal or informal (that is, remunerated or unremunerated) discussion of
a case between professionals. It is now accepted that this will occur among
physicians across technological media.4'
B. Telemedicine Regulation
Traditional telemedicine-the use of communication technology to
facilitate long-distance consultation-was readily accepted under state
regulatory systems. There are several possible explanations for the absence
of controversy. First, it may be that most telemedicine consults have
historically been intrastate in nature. Second, cost factors have constrained
the number of such consults because of the limited reimbursement offered
by private payers, Medicaid, or Medicare.5 0 Third, where there is no
relationship between the patient in one state and a consulting physician in
another state because the consulting physician has a relationship only with
the originating physician, then such a consultation-potentially interstate
and telemedical-arguably does not qualify as the "practice of medicine"
and therefore does not require regulation.5' Furthermore, many state
licensing statutes included narrow exceptions to the requirement of
licensure tailored to some geographically indeterminate physician-patient
interactions.52 Fourth (and related to the general lack of reimbursement),
it may be that the majority of telemedicine initiatives have been state-
funded and carried out by state actors-hardly politically feasible targets
for even the most regulatory active or technophobic state medical boards.
Although traditional telemedicine was readily accepted without
provoking change in existing state regulatory systems, more recent
developments-particularly Internet-based changes-have resulted in
(infrequent consultations).
49. See, e.g., AMA President Talks to IBD About Guidelines for Information Technology Use,
June 3, 2002, http://www.ama-assn.org/ama/pub/article/ 1 615-6309.html (reporting AMA
President statement that "[t] here's going to be cautious adoption of freestanding, online
consultations. What's clearly going to happen is an extension of telemedicine, where
doctors are messaging between themselves.").
50. See Edelstein, supra note 10.
51. See Irvin v. Smith, 31 P.3d 934 (Kan. 2001) (holding that a physician who gives an
informal opinion at the request of a treating physician does not owe a duty to the patient).
52. See, e.g., Ky. REv. STAT. ANN. § 311.560(2) (b) (1) (Michie 2003) (exempting from the
state licensure requirement physicians who are licensed and reside in another state and
whose only practice in Kentucky is infrequent consultation on medicine or osteopathy); see
also 225 ILL. COMP. STAT. ANN. 60/49.5 (West 2003).
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legislative reforms, changes in regulatory attitudes, and shifts in
enforcement practices. There are several possible explanations for these
changes. First, there is an atmosphere of distrust of all things Internet
among medicine's professional leadership. Notwithstanding the patient
safety movement's focus on technological solutions to medical and
medication errors and patient demand for email contact with physicians,
the Internet and related technologies are a source of frustration for most
physicians. For example, patient access to under-regulated 5 direct-to-
consumer (DTC) information provided by pharmaceutical company
websites is viewed as suspect and adversely affecting physician-patient
dialogue.54 Further, many physicians deeply resent the federal e-health
flagship initiative-the privacy regulations promulgated under the Health
Insurance Portability and Accountability Act55-and view it as an expensive
example of overreaching regulation. 6
Second, technological innovations have allowed us to move past the
paradigmatic telemedicine consult to more advanced direct telemedical
examinations of the patient by the remote physician.57 An IT technician or
nurse may be the only "local" professional 58 sharing physical space with the
patient. Moreover, on the near horizon is the increased deployment of
telehome appliances that enable the patient to communicate directly with
53. See Christopher Rowland, Lawmakers Assail FDA, Say Agency Fails To Get Tougher on
Drug-ad Claims, BOSTON GLOBE,Jan. 30, 2004,
http://www.boston.com/business/globe/articles/2004/O1 /30/lawmakersassail-fda/.
54. Physicians, many of whom feel that visits are already overly compressed and
burdened by the requirements of managed care, complain that DTC advertising makes
patients more difficult to deal with and make visits even more time-consuming. See
SUSANNAH Fox & DEBORAH FALLOws, PEW INTERNET & AMERICAN LIFE PROJECT, INTERNET
HEALTH RESOURCES (2003) [hereinafter Fox & FALLOWS],
http://207.21.232.103/pdfs/PIPHealthReport-July-2003.pdf; Paul R. Helft et al.,
American Oncologists' Views of Internet Use by Cancer Patients: A Mail Survey of American Society of
Clinical Oncology Members, 21 J. CLINICAL ONCOLOGY 942 (2003).
55. Standards for Privacy of Individually Identifiable Health Information, 45 C.F.R. §§
160, 164 (2003).
56. See, e.g., South Carolina Med. Ass'n v. Thompson, 327 F.3d 346 (4th Cir. 2003)
(upholding HIPAA against impermissible delegation and vagueness challenges brought by
medical associations and physicians); see also infra text accompanying note 253.
57. Some specialties, such as psychiatry, used these techniques earlier than other
specialties and continue to utilize them more frequently. Similarly, certain sub-populations,
such as those in correctional facilities, have been particularly likely to receive direct
telemedical services. See, e.g., Kate Murphy, Telemedicine Getting a Test in Efforts To Cut Costs of
Treating Prisoners, N.Y. TIMES, June 8, 1998, at D1.
58. See infra text accompanying note 496.
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health providers through consumer-friendly interfaces; such appliances
have no need for a "local" professional other than an IT technician to
hook the device into the patient's broadband connection or nursing home
network. Such medical practices cannot be characterized as "consultations"
and thus cannot gain cover from the established exceptions in the medical
practice acts; from the perspective of state regulators, these telehealth
innovations must be addressed in a more direct (and generally disfavored)
manner.
Third, telemedicine has been caught in the crossfire between
regulators and Internet prescribers. Just as the regulation of cloning and
harvesting of fetal and embryo tissue influences responsible stem cell
research, °  the regulatory attack on Internet prescribing likely chills
telemedicine. A large number of states have rewritten their licensure rules
to bring Internet prescribing within the importing state's disciplinary
ambit and, in the process, have added new definitions of telemedicine
which impose state regulations on what heretofore were legally "safe"
consulting relationships. For example, several jurisdictions have amended
their licensing laws to specifically include "imported" electronic diagnosis
or treatment.6 1 Contemporary regulation of telemedicine, however, is
anything but uniform. For example, the updated definitions of
telemedicine in Arizona32 and California 63 capture both intrastate and
interstate consultations. In contrast, the Montana statute applies
telemedicine-specific regulation only to interstate exchanges between
physician and patient,64 and the West Virginia definition of the "practice of
59. Regulating the Internet certainly presents certain challenges: As I have argued
elsewhere, "[The] lack of physicality, the decoupling of physician from jurisdiction-
delimited practice, severely challenges state licensing systems that apply to healthcare
professionals." Terry, supra note 14, at 607. However, state regulators have responded in
different ways; some have increased the enforcement of physician practice requirements
and standards, while others have developed novel regulation of pharmacy practice. See
generally infra Section II.C.
60. See generally Timothy StoltzfusJost, Rights of Embryo and Foetus in Private Law, 50 AM.J.
COMP. L. 633, 644-45 (2002). However, California specifically distinguishes between
disapproved tissue transactions, CAL. HEALTH & SAFETY CODE § 125117 (West 2004), and
encouraged stem cell research, CAL. HEALTH & SAFETY CODE § 125115 (West 2004).
61. ALA. CODE § 34-24-501 (a) (1975). The same definition is used by Mississippi, MIss.
CODE ANN. § 73-25-34 (1998); Missouri, Mo. REv. STAT. § 334.010 (2001); New Mexico, N.M.
STAT. ANN. § 61-6-6 (Michie 2004); and Oregon, OR. REV. STAT. § 677.135 (2004).
62. ARIz. REV. STAT. § 36-3601 (2) (2003).
63. CAL. Bus. & PROF. CODE § 2290.5 (a) (1) (West 2003).
64. MONT. CODE ANN. § 37-3-342 (2003).
YALE JOURNAL OF HEALTH POLICY, LAW, AND ETHICS
telemedicine" is limited to diagnosis or treatment by out-of-state
65physicians.
The assumption that cross-border telemedical consultations are
exempt from regulation by an additional state board is also being
challenged. For example, while the Alabama statute purports to still
exclude consultations from regulation, this exemption is limited to
uncompensated, informal consultations where the remote physician has
not given a formal or written opinion.6 The same state exempts physicians
from the requirement of a telemedicine practice certificate ("special
purpose license") in emergency situations 7 or "on an irregular or
infrequent basis.,
68
The types of interactions the emerging telemedicine definitions seek
to regulate differ among states. While the Arizona law applies broadly to all
forms of technologically-mediated healthcare,69 the California statute is
limited to "real time (synchronous) or near real time (asynchronous) two-
way transfer of medical data and information. , 70 The statute explicitly
excludes telephone or email.71 It is not immediately clear why regulators
make distinctions based on the technologies employed or would disfavor
closed (and likely secure) systems such as teleradiology or
videoconferencing over open or public systems such as telephony. There is
reason to suspect technophobia; in practice, stringent regulation of
synchronous interactions disproportionately targets physicians employing
sophisticated and secure technologies that are professionally appropriate.
Not content with tightening up their existing controls and reducing
exemptions for telemedicine, states are targeting telemedicine and other
65. W. VA. CODE § 30-3-13 (Michie 2003).
66. According to Alabama law,
this definition is not intended to include an informal consultation between a
licensed physician located in this state and a physician located outside this state
provided that the consultation is conducted without compensation to or the
expectation of compensation to either physician and does not result in the
formal rendering of a written or otherwise documented medical opinion
concerning the diagnosis or treatment of a patient by the physician located
outside the state.
ALA. CODE§ 34-24-501 (a) (3) (1975).
67. Id. § 34-24-505(a).
68. The statute defines the latter as one that "occurs less than 10 times in a calendar
year or involves fewer than 10 patients in a calendar year or comprises less than one percent
of the physician's diagnostic or therapeutic practice." Id. § 34-24-505 (b).
69. ARIz. REv. STAT. § 36-3601 (2) (West 2003).
70. CAL. Bus. & PROF. CODE § 2290.5 (a) (2) (West 2003).
71. Id. § 2290.5(a) (1).
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models of technologically mediated care for additional regulation. For
example, several states, including Alabama,2 Minnesota,3 Montana,4 New
Mexico,75 and Ohio7 6 require an out-of-state physician to apply for a
specialty-specific telemedicine practice certificate. Another trend,
exemplified by regulatory changes in Arizona," California, 
7 Kentucky, 79
Nebraska,80  Oklahoma"' Puerto Rico, 2 and Texas,83 is to require
telemedicine-specific consent and correlated record-keeping. 4  For
example, California requires "verbal and written informed consent
[including a] description of the potential risks, consequences, and benefits
of telemedicine.' 's5 Kentucky, among other states, emphasizes compliance
with state and federal confidentiality and privacy laws.86
72. ALA. CODE § 34-24-502 (1975).
73. MINN. STAT. § 147.032 (West 2003).
74. Mont. CODE ANN. § 37-3-343 (2003).
75. N.M. STAT. ANN. § 61-6-11-1 (Michie 2004).
76. OHIO REv. CODE ANN. § 4731.296 (Anderson 2003).
77. ARIz. REv. STAT. § 36-3602 (West 2003).
78. CAL. Bus. & PROF. CODE § 2290.5 (West 2003).
79. Ky. REV. STAT. ANN. § 311.5975(1)(a) (Michie 2001) ("A treating physician who
provides or facilitates the use of telehealth shall ensure: ... [t] hat the informed consent of
the patient, or another appropriate person with authority to make the health care
treatment decision for the patient, is obtained before services are provided through
telehealth....").
80. NEB. REv. STAT. § 71-8505 (2002).
81. OKLA. STAT. ANN. TIT. 36, § 6804 (West 1999).
82. 20 P.R. LAWS ANN. § 6006 (2003).
83. Texas State Board of Medical Examiners, Rule 174.10,
http://www.tsbme.state.tx.us/rules/rules/174.htm.
84. See, e.g., ALA. CODE § 34-24-504 ,1975) ("Any licensee licensed under the provision
of this article shall comply with all laws, rules, and regulations governing the maintenance
of patient medical records, including patient confidentially requirements, regardless of the
state where the medical records of any patient within this state are maintained."). Not all
states, however, apply these requirements to intrastate relationships. See also 36 OKLA. STAT.
ANN. tit. 36, § 6804 (F)(G) (West 1999).
85. CAL. Bus. & PROF. CODE § 2290.5 (c) (West 2003); see also CAL HEALTH & SAFETY CODE
§ 123149.5 (West 2004).
86. KY. REv. STAT. ANN. § 311.5975(1) (b) (Michie 2001) ("A treating physician who
provides or facilitates the use of telehealth shall ensure .... [t] hat the confidentiality of the
patient's medical information is maintained as required by this chapter and other
applicable law. At a minimum, confidentiality shall be maintained through appropriate
processes, practices, and technology as designated by the board and that conform to
applicable federal law.").
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C. Emerging Regulation of Internet Prescribing
State legislatures or medical boards seem to favor three approaches to
controlling Internet prescribing. First, some states rely on the regulatory
changes that they have already made to accommodate telemedicine.
Second, other states concentrate on the specifics of the physician-patient
relationship, either by requiring a so-called "traditional" or "proper"
relationship, or more transparently, by requiring face-to-face contact or
prohibiting questionnaire-based prescribing. Third, some states have
shifted their focus from physician to pharmacy regulation by concentrating
on the product of an often out-of-state technologically-mediated
relationship (i.e., the prescription) and seeking to control its in-state
dispensing. Many states have adopted two or more of these approaches,
creating overlapping and frequently confusing regulatory regimes.
Some states impose explicit new controls on prescribing by requiring
an existing physician-patient relationship and a physical face-to-face
examination prior to prescribing.87 This requirement aims to eliminate
"one-shot" transactions between Internet prescribers and patients where
the interaction is the fulfillment of a single drug order (the previously
noted opportunistic physician-patient relationship); it is also supposed to
outlaw so-called questionnaire prescribing.88
Questionnaires are widely used by both illegal and marginally legal• 89
websites. Typically, the questionnaire is a web-based form that purports to
87. The California statute provides that "[p]rescribing, dispensing, or furnishing
dangerous drugs ... without a good faith prior examination and medical indication
therefor, constitutes unprofessional conduct." CAL. Bus. & PROF. CODE § 2242(a) (West
2003). Arizona extends its definition of"[u]nprofessional conduct," other than in
emergencies, to "[p] rescribing, dispensing or furnishing a prescription medication or a
prescription-only device to a person if the licensee has not conducted a physical
examination of that person or has not previously established a physician-patient
relationship." ARIZ. STAT. §32-1854(51) (West 2003).
88. See Sana Siwolop, Buying Your Pills Online May Save You Money, but Who's Selling
Them?, N.Y. TIMES, Sept. 29, 2002, at 3-10 ("According to the Federation of State Medical
Boards, a professional group, only one state, Kentucky, has passed legislation that
specifically prohibits prescriptions based only on online questionnaires, while 22 states,
including New York, have rules that essentially require a physical exam before an online
prescription can be filled.")
89. According to the National Center on Addiction and Substance Abuse (CASA), of
the sites selling controlled prescription drugs on the Internet forty-five percent required no
prescription or made no mention of it, forty-nine percent provided an online consultation
in lieu of a prescription, but only six percent required a preexisting prescription. NAT'L
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collect a health history and asks questions specific to the drug requested.
The drug-related questions are usually based on information taken from
the Physicians' Desk Reference. ° The completed questionnaire is then
transmitted for approval. This approval may well be placed in the hands of
a physician licensed to practice medicine in the patient's home state, and
the process that follows purports to be the functional equivalent of in-
office or telephone prescribing. The suspicion, however, is that in most
cases any "approval" is performed by contract ghost-writers of
indeterminate licensure who rubber-stamp hundreds of such prescriptions
per week. In some cases, the "approval" seems to be omitted or
automated, and the order is merely forwarded for fulfillment.
States are increasingly tightening their scrutiny of these practices.
Some have chosen a statutory route that adds a gloss to its requirement of
a "proper physician-patient relationship," taking the position that "an
electronic, on-line, or telephonic evaluation by questionnaire is inadequate
for the initial evaluation of the patient or for any follow-up evaluation.' ' 2 At
least one state seems to be relying on its medical board to issue rules93 or
guidance 94 that have a similar effect.
Regulatory amendments to control the prescribing practices of out-of-
state physicians or automated pill-mills are ineffective without strong cross-
CTR. ON ADDICTION AND SUBSTANCE ABUSE AT COLUMBIA, You'vr GOT DRUGS! PRESCRIPTION
DRUG PUSHERS ON THE INTERNET 5 (2004),
http://209.208.151.183:8080/pdshopprov/files/you-ve-got-drugs.pdf.
90. Physicians'Desk Reference, now in its fifty-eighth edition, is the standard prescription
drug reference manual.
91. See, e.g., United States v. Nelson, 72 Fed. Appx. 837 (10th Cir. 2003). One doctor
contacted by congressional investigators has admitted to writing 100,000 prescriptions for
several Internet pharmacies over a two-year period. Typically he received $2.50 to $5 per
prescription. He approved ninety-five percent of the drug applications sent to him,
although the online pharmacy pre-screened out some applications. NI:. Doctor's Rx on the
Web Draws Scrutiny, THE RECORD (Bergen County, NJ),Jan. 21, 2004, at A01; see also Gilbert
M. Gaul, Crossing Lines To Prescribe Online, Internet Pathologist Outmaneuvers State Medical
Boards, WASH. POST, Dec. 18, 2003, at Al (discussing prescribing practices of Dr. MilesJ.
Jones and noting "Jones said he has written online prescriptions for more than 35,000
patients for netdr.com and its affiliatemaleclinic.com. Nearly eight of every 10 customers
have requested Viagra, the popular drug for treating erectile dysfunction. All but about 100
of the requests have been approved.").
92. Ky. REv. STAT. STAT. §311.597(1) (e) (Michie 2003).
93. ALA. ADMIN. CODE §540-X-9-.11 (1975).
94. See, e.g., Texas State Board of Medical Examiners, Internet PrescribingPolicy (Dec. 8-
11, 1999), http://www.tsbme.state.tx.us/guidelines/ipp.htm (last visited Apr. 16, 2004).
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border enforcement mechanisms. Recognizing the practical difficulties of
curtailing the activities of those outside their borders, several states have
introduced a more indirect form of regulation that requires in-state
pharmacists to verify that the prescriptions presented to them are written
after physical (and hence for all practical purposes in-state) examinations.95
Thus, some state rules now prohibit a pharmacist from dispensing a
prescription drug if he "knows or should have known that the prescription
was issued on the basis of an Internet-based or telephonic consultation
without a valid patient-practitioner relationship."9
Regulation is sure to escalate as illegal pill-mills learn to hide in
cyberspace and, like pornographers and online casinos, move their
physical businesses offshore. Regulators will be forced to "follow the
money" as they have in pornography and gambling cases and hope for the
cooperation of credit card companies, 7 other financial intermediaries, 9
and shipping companies9 while legitimate businesses bring pressure on
infomediaries such as search engines to de-list illegal operations. °
95. See, e.g., CAL. Bus. & PROF. CODE § 4067; see also id. § 2242.1 (b); VA. CODE ANN. §
54.1-3303(A) (B) (Michie 2004).
96. TEX. ADMIN. CODE §§ 291.34, 291.36 (West 2004). California imposes a similar rule
and backs it with fines up to $25,000 per occurrence. CAL. Bus. & PROF. CODE § 4067; see also
id. § 2242.1 (b); VA. CODE ANN. § 54.1-3303 (A) (B) (Michie 2004).
97. See, e.g., Associated Press, MasterCard Sets Rules for Online Gambling To Settle Lawsuit
(July 14, 1999), http://standup.quiknet.com/news/1999/ap-1999-july-14.html; Press
Release, MasterCard Voices Support for Measures To Stop the Use of Payment Cards for
Illegal Internet Gambling (Mar. 17, 2003), http://www.mastercardintl.com/cgi-
bin/newsroom.cgi?id=708.
98. See, e.g., CNET News.com, PayPal Turns Off the Red Light (Apr. 30, 2003), at
http://news.com.com/2100-1017-999002.html (discussing decision by PayPal's revised
policy on processing payment for adult material). PayPal already places limits on payments
for prescription drugs, PayPal, at PayPal Prescription Drugs and Devices Policy,
http://www.paypal.com/cgibin/webscr?cmd=p/gen/ua/use/indexframe-
outside&ed=prescript._drugs (last visited July 29, 2004).
99. See, e.g., Gilbert M. Gaul & Mary Pat Flaherty, Google To Limit Some Drug Ads, Web
Giants Asked To Help Discourage Illicit Online Pharmacies, WASH. POST, Dec. 1, 2003, at Al
[hereinafter Gaul & Flaherty, Google To Limit]; Gilbert M. Gaul & Mary Pat Flaherty, Firms
Pressed on Internet Drugs; Senate Panel Writes to Credit Card Companies, Shippers, WASH. POST,
Dec. 10, 2003, at A04 [hereinafter Gaul & Flaherty, Firms Pressed]; Rick Brooks, FedEx and
UPS Say They Shun Parcels Containing Illicit Drugs, WALL ST.J., Jan. 9, 2004, at A8.
100. See, e.g., CNET News.com, Search Engines Face Drug Test (Nov. 10, 2003), at
http://rss.com.com/2100-1024-3-5105044.html?tag=prntfr. Google, Yahoo, and MSN have
announced plans to refuse advertising from unlicensed pharmacies. Google also will
prevent the names of certain controlled drugs from appearing in the results of keyword
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D. Regulating Online Dispensing
Illegal online dispensing is an extension of the previously discussed
Internet prescribing. Since few Internet prescribers have their own
distribution business, they pass the prescriptions they write onto a subset of
legally suspect fulfillment pharmacies usually based in the United States.
Much of domestic Internet prescribing is driven by patients seeking drugs,
including controlled substances, which their physicians will not prescribe
or that are "lifestyle" drugs that patients do not want to publicly request. In
most cases, patients are prepared to pay at least as much for the drugs as
they would at a local or legal Internet pharmacy. Simultaneously, a new
model of international fulfillment is flourishing that promises to deliver
considerable savings over U.S.-sourced drugs by importing "legend
drugs"'0 ' from non-U.S. sources such as Canada.
1. Domestic Drug Distribution
The Food and Drug Administration's (FDA) process for new drug
approval (NDA) and the Drug Enforcement Agency's (DEA) controlled
substances policies underpin domestic drug availability. Thereafter, the
core operational rules on domestic distribution are found in state
pharmacy statutes and regulations. The relationship between state and
federal regulators has generally been harmonious, 0 2 with the states usually
happy to rely on their better funded federal counterparts to provide
enforcement.
State regulation of drug distribution has both negative and positive
aspects. State law generally prohibits anyone in the chain of distribution
from purchasing or receiving prescription drugs from anyone other than a
licensed person. 0 3 Having reinforced the retail prescription drug
monopoly of pharmacies, state law then regulates the practice of pharmacy
through the traditional tools of licensure and discipline. Assuming
compliance with the FDA, DEA, and state licensing board regulations, the
searching. Gaul & Flaherty, Google To Limit, supra note 99.
101. 'Legend drugs" are those that, under Section 503(b) of the Federal Food, Drug,
and Cosmetic Act, cannot be dispensed without a prescription.
102. There are some exceptions to the general harmony, such as occasional differences
over issues such as medical marijuana. Cf Conant v. Walters, 309 F.3d 629 (9th Cir. 2002).
103. See, e.g., N.D. CENT. CODE § 43-15.1-02 (2001) ("No person may knowingly purchase
or receive any prescription drug from any source other than a wholesale drug distributor,
manufacturer, pharmacy distributor, pharmacy, or other person licensed pursuant to the
laws of this state except where otherwise provided.").
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growth of technology in prescription fulfillment affects a local pharmacy in
two situations. First, and beyond the reach of this Article, technology
facilitates the disintermediation of pharmacists through a combination of
technology and lower-paid pharmacy technicians and so sharpens an
emerging scope of practice issue. Second, local pharmacists increasingly
face regulation on their fulfillment of out-of-state prescriptions written by
Internet-based physicians. 1 4 However, it is worth mentioning that states
have successfully regulated pharmacy distribution located outside their
borders for several decades.
State pharmacy law addressed issues concerning out-of-state pharmacies
long before the growth of Internet prescribing. Mail-order dispensing is at
least a century old and involves hundreds of thousands of deliveries per
year.1°5 Mail-order pharmacies are frequently subject to regulations in
importing states, 10 6 and even though regulators track down the occasional
miscreants, mail-order fulfillment is relatively uncontroversial. Mail-order
pharmacies and national pharmacy chains are large-volume businesses and
so likely possess the resources to absorb multiple licensing costs. While the
primary concern of state pharmacy regulation is distribution to consumers,
some states regulate other participants in the distribution chain, including
out-of-state wholesalers and distributors.
0 7
The states have sought to extend their mail-order model of required
licensure to interstate Internet prescribing. As with mail-order models,
large e-pharmacies or click-and-brick operations can absorb the costs of
multiple licensure. States frequently prosecute or enjoin out-of-state pill-
mills, but they are often hindered by insufficient enforcement resources
and, frequently, by the inadequacy of their own regulations. Increasingly,
104. Some border states allow the "importation" of a prescription, allowing their
pharmacists to fill prescriptions written by, for example, Canadian or Mexican doctors. See,
e.g., ARIZ. REV. STAT. § 32-1969 (2003).
105. See Nat'l Pharms. v. De Melecio, 221 F.3d 235, 237 (1st Cir. 2000).
106. Nat'lPharms., 221 F.3d at 242; see also Pharm. Mfrs. Ass'n v. New Mexico Bd. of
Pharmacy, 525 P.2d 931 (N.M. Ct. App. 1974) (upholding state pharmacy board regulation
of out-of-state manufacturers and distributors). For example, the North Dakota statute
provides:
Any pharmacy operating outside the state which ships, mails, or delivers in any
manner a dispensed prescription drug or legend drug into North Dakota shall
obtain and hold a pharmacy permit issued by the North Dakota state board of
pharmacy and that part of the pharmacy operation dispensing the prescription
for a North Dakota resident shall abide by state law and rules of the board.
N.D. CENT. CODE § 43-15-34.1 (2001).
107. See, e.g., N.D. CENT. CODE, § 43-15.1-05 (2001).
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states are re-vamping their pharmacy rules to deal specifically with the
latest generation of Internet businesses.' 8 For example, the Arkansas
Internet Prescription Consumer Protection Act 2001,09 which updates the
traditional prohibitions on unlicensed dispensing to specifically include
Internet operations, ll° requires the disclosure of the identity of and contact
information for the business,"' and outlaws the disclaimers and waivers
commonly found on Internet prescribing and dispensing sites."12 The
Texas statute, perhaps conscious of VIPPS efforts to validate licensure,
l 3
requires that e-pharmacies link to the Texas Pharmacy Board website.1
4
2. Cross Border Drug Distribution
While some illegal prescribing operations are moving offshore, the
scenario of Internet prescribing remains a primarily domestic, interstate
paradigm. In contrast, Internet dispensing is increasingly an international
phenomenon involving many regulatory actors and a complex legal
landscape." Over the last few years, direct personal importation of
pharmaceuticals into the United States has shown explosive growth;
approximately ten million U.S. citizens per year transport drugs over land
borders,"" and approximately two million shipments of foreign-sourced
prescription drugs entered the United States in 2002, double the number
in 2001." 7
The importation of drugs into the United States is regulated by a
combination of federal laws and policies enforced by the DEA and FDA in
conjunction with state pharmacy and controlled substance laws. Federal
authorities have traditionally taken the enforcement lead, in part because
108. See, e.g., ILL. COMP. STAT. 85/16a (1998); IND. CODEANN. § 25-26-18-1 (Supp. 2003);
NEV. REV. STAT. ANN. §§ 453.3618, 453.3625, 453.3638, 453.3643, 453.3648, 639.00865,
639.012; 639.2328 (2000).
109. ARK. CODEANN. §17-92-1001 to -1007 (2002).
110. Id. § 17-92-1004.
111. Id. § 17-92-1005.
112. Id. § 17-92-1006.
113. See infra note 374 and accompanying text.
114. TEx. Occ. CODE ANN. § 562.1045 (Vernon 2004).
115. See, e.g., Customs Confiscates Viagra Ordered over the Internet: Hundreds of Finns Order
Prescription Drugs Unaware That It Is Illegal, HELSINGIN SANOMAT, Oct. 23, 2002,
http://www.helsinki-hs.net/news.asp?id=20021023IE4.
116. Mary Pat Flaherty & Gilbert M. Gaul, Millions of Americans Look Outside U.S. forDrugs,
WASH. POST, Oct. 23, 2003, at Al.
117. A New Source for Discount Prescriptions, N.Y. TIMES, Dec. 26, 2002, at A36.
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of their greater resources but also because suspect drugs are usually
discovered by the United States Customs Service, the agency charged with
enforcing the drug laws and policies of the DEA and FDA.
According to the Federal Food, Drug, and Cosmetic Act (FDCA),
"[n]o person shall introduce or deliver for introduction into interstate
commerce any new drug, unless an approval of an application ... is
effective with respect to such drug."18 Thus, the central plank of the FDA's
prohibition of non-U.S. sourced prescription drugs is that they lack
approval under the NDA process. The FDA's position is that this
prohibition extends beyond foreign versions to also include a grey market
version of an approved drug, because the latter is unlikely to comply with
all the technical information required for domestic approval, such as
source of ingredients, place of manufacture, labeling and packaging of
containers.'9
More controversially, regulators view reimported drugs as unapproved
on the basis that they will comply with their destination market's labeling
and packaging requirements rather than those necessary in the United
States.' ° In addition, the FDA takes the speculative position that grey
market or reimported drugs are likely to be mislabeled 21 or dispensed
without a prescription. 2 2 The agency may be on firmer ground in relying
on legislation that grants the sole right of reimportation to U.S.
manufacturers. 1123
Federal law prohibits breach of these FDCA provisions. 12 4 The
118. 21 U.S.C. § 355(a) (2000).
119. See 21 C.F.R. § 314.50 (2003) (listing drug application requirements).
120. See, e.g., id. § 314.50(c) (2) (i).
121. 21 U.S.C. § 353(b) (2) (2000).
122. See id. § 353(b) (1). Also note that the exception to § 352 is inapplicable to mail
order drugs. Id. § 353(b) (2).
123. Id. § 381 (d) (1) ("[Nbo drug subject to section 353(b) of this title.., which is
manufactured in a State and exported may be imported into the United States unless the
drug is imported by the manufacturer of the drug."); see also Warning Letter from DavidJ.
Horowitz, Director, Office of Compliance, Center for Drug Evaluation and Research, Food
and Drug Administration to Harry LeeJones, Store Manager, Rx Depot, Inc. (Mar. 21,
2003) [hereinafter Warning Letter from DavidJ. Horowitz],
http://www.fda.gov/foi/warning-letters/g3888d.htm; Letter from William K. Hubbard,
Associate Commissioner for Policy and Planning FDA to Robert P. Lombardi, The Kullman
Firm (Feb. 12, 2003) [hereinafter Letter from William K. Hubbard],
http://www.fda.gov/ora/import/kullman.htm.
124. 21 U.S.C. § 331(a), (d), (t) (2000).
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prohibition is applicable to both interstate and intrastate traffic.' 25 If the
drug is a controlled substance it is further subject to regulation by the DEA
under the Controlled Substances Act of 1970 (CSA).I12 Operationally, state
pharmacy and other drug laws enter the regulatory mix because they
frequently prohibit possession or trafficking of drugs without a U.S.
prescription, or of drugs that do not comply with the federal act.
127
There are sound policy reasons for allowing some level of personal
importation of pharmaceuticals into the United States. First, as a practical
matter, residents and visitors will enter the United States carrying drugs
prescribed outside the United States or even within the United States prior
to outbound travel. In addition to the dangers it would pose to a traveler's
health, policing a rigid non-possession rule would be as nonsensical as it
would be unenforceable. Second, there is a small but significant traffic in
persons leaving the United States for treatment not otherwise available in
the United States. It would be punitive to deny, upon the patient's return
to the United States, pharmaceuticals related to the treatment. Third, the
high expense of travel and the small amounts of prescription drugs that
people can physically bring with them imposes high transaction costs on
patients, thus minimizing risks of diversion. Fourth, many if not most of
the drugs personally presented at United States borders are approved for
sale in the United States in some form or another, thus minimizing safety-
related risks.
These policies are effectuated by federal rules and policies that allow a
limited level of cross-border pharmaceutical traffic. The CSA, for example,
has a limited personal importation exception that allows individuals to
bring a controlled substance with them if: 1) the substance is found in one
of the approved "schedules," 2) the substance is in its original container, 3)
a declaration is made to the United States Customs Service, and 4) use of
such substance is permitted by federal and state laws.1
2
Concerns about the introduction of large amounts of controlled
substances, particularly over the border with Mexico, led to the tightening
of this exception by the Controlled Substances Trafficking Prohibition Act
of 1998 (CSTPA). The act states that a U.S. resident may not enter the U.S.
through an international land border with more than fifty dosage units of
a controlled substance unless the individual possesses a valid prescription
125. See, e.g., White v. United States, 399 F.2d 813 (8th Cir. 1968).
126. Controlled Substances Act (CSA), 21 U.S.C. §§ 801-971 (2000).
127. See, e.g., ARIz. REV. STAT. § 32-1962(A) (2002).
128. 21 U.S.C. § 956(a) (2000).
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issued by a practitioner in accordance with federal and state law."'
The CSA exemption clearly assumes that the drugs are in the
possession of a traveler.'3° The FDCA Guidance implies personal possession
by excluding commercial and promotional shipments.13' To determine if a
shipment is commercial or promotional, the Guidance suggests looking at
"the type of product, accompanying literature, size, value, and/or
destination of the shipment.' ' 32 The Guidance also states that non-
commercial shipments generally include products that are: "personally
carried, shipped by a personal non-commercial representative of a co-
129. Id. § 956(a) (2). The CSTPA has been the source of much confusion, some of which
derives from the misrepresentation seeded by parallel importers. On its face, the legislation
does not exempt amounts below fifty dosage units but uses that quantity as a ceiling. Id.
Nonetheless, the statutory phrase "50 dosage units," is cited frequently by importers as
exempting all pharmaceutical imports up to that amount. See, e.g., Nancy A. Melville, U.S.
Health Experts Say Caveat Emptor on South-ofBorder Prescription Drugs, at
http://www.roadandtravel.com/health/prescriptiondrugs.htm (last visitedJuly 10, 2004).
The DEA, however, has frequently disputed this interpretation. See, e.g., Hearing Before the
House Comm. on Energy and Commerce Subcomm. on Oversight and Investigations, 107th Cong.
(2001) (statement of Laura M. Nagel, Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration),
http://www.usdoj.gov/dea/pubs/cngrtest/ct607Ol.htm ("This does not mean that any
U.S. resident may enter the United States with up to 50 dosage units of a particular
controlled substance 'no questions asked.' Rather, the resident must satisfy all the
requirements set forth in 21 C.F.R. 1301.26. States may impose additional requirements as
well."). There is no personal importation exception in the FDCA. The FDA, however, has
issued enforcement guidelines that create a de facto exemption and answers the issue (or at
least the federal issue) left hanging by the Controlled Substances regulations. See 21 C.F.R. §
1301.26 (2003) ("Any individual who has in his/her possession a controlled substance...
may enter or depart the United States with such substance.., providing... [t]he
importation of the controlled substance for personal medical use is authorized or permitted
under other Federal laws and state law."). Described as "guidance" to its own personnel, the
FDA applies this "exemption" when "the quantity and purpose are clearly for personal use,
and the product does not present an unreasonable risk to the user." FDA/ORA, Regulatory
Procedures Manual, http://www.fda.gov/ora/complianceref/rpm-new2/ch9pers.html
(discussing personal importations). The agency emphasizes that "[a]lthough FDA may use
discretion to allow admission of certain violative items, this should not be interpreted as a
license to individuals to bring in such shipments." Id.
130. 21 C.F.R. § 1301.26 (2003) ("Any individual who has in his/her possession a
controlled substance. . . may enter or depart the United States .... ").
131. Marvin A. Blumberg, Information on Importation of Drugs, Prepared by the Division of
Import Operations and Policy, FDA, U.S. Food & Drug Administration,








Because the guidance stresses that there is no particular magic in a
U.S. prescription or a foreign prescription, the apparent keys to FDA
approval (i.e., non-enforcement) are personal use of a drug otherwise not
available and evidence of medical supervision.'
34
Crucially, the FDA denies that its de facto exemption applies to grey
market or reimported drugs whether personally or commercially imported.
According to the FDA,
foreign-made chemical versions of drugs available in the U.S. are not
intended to be covered by the policy.... FDA cannot assure that such
products have been properly manufactured and are effective;
therefore.., their use would present an unreasonable risk.., unless the
person seeking importation could establish that the drugs were needed
to refill a prescription while traveling .... 35
Despite this relatively clear regulatory position, importation drug sites
routinely and inaccurately cite this Guidance (albeit usually without
specific identification) as permitting the commercial importation of a
ninety-day supply of drugs.
36
3. The Canada-United States Connection
The movement of grey market and reimported drugs over the
Canadian-U.S. border predates Internet dispensing. For example, there
are old press reports of U.S. retirees taking buses across the border and
stocking up on prescription drugs.'3 7 Current economic conditions
encourage the traffic: The Canadian government closely controls drug
prices, and the weakness of the Canadian dollar favors U.S. purchasers. Dr.




136. GetMeds Direct, at http://www.getmedsdirect.com (last visited May 29, 2003) ("Did
you know U.S. law permits you to order a 60-90 day personal supply of Medications from
International Pharmacies?").
137. See, e.g., Sarah Lueck, Senators Push Drug-Reimportation Bill, WALL ST.J., June 3, 2002,
at A4; see also Alexander Calhoun, Get on the Bus: Extreme Answers to Prescription Drug Costs,
CHRISTIAN SCIENCE MONITOR, Apr. 18, 2000, at
http://csmweb2.emcweb.com/durable/2O00/04/18/p3sl.htm; Randi Hunter Epstein,
Some Retirees Look Abroad for Prescription Drugs, N.Y. TIMES, Sept. 24, 2002, at F5.
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for U.S. prescription drugs would result in savings of $38.4 billion per
annum, a figure which underpins much of the debate over the Canadian
connection. 138 A congressional estimate is even more optimistic: "Allowing
open pharmaceutical markets could save American consumers at least
$635 billion of their own money each year.'
139
By early 2003, there were approximately one hundred and fifty
Canadian e-pharmacies exporting price controlled drugs to the United
States.14 Unlike the practices of the domestic Internet prescribing and
dispensing sites frequently pursued by regulators, potential customers of
Canadian e-pharmacies typically are required to furnish copies of a
prescription written by their U.S. physician. Some of these businesses claim
that licensed Canadian physicians will perform the prescribing, and the
prescriptions will be fulfilled by licensed Canadian pharmacies. 4' In fact,
that is generally the case, although not without some legal gymnastics
north of the border. For example, Manitoba, home to about one-third of
the e-pharmacies, requires that a Canadian licensed physician co-sign the
prescription but the pharmacies have to use out-of-province physicians
because Manitoba physicians have been threatened with disciplinary action
if they become involved.
42
True to the ideals of web-commerce, there has been a growth of
infomediaries that provide licensure information and price comparisons
for U.S. and Canadian sources of prescription drugs. 43 A relatively new
twist in the U.S.-Canada traffic has been the proliferation of U.S.-based
intermediaries. These small bricks-and-mortar stores, frequently
established in locations with a large elderly population, assist patients who
138. See, e.g., Markian Hawryluk, Drugs Without Borders: VWen Prescription Drugs Go over the
Line, AMNEwS, Oct. 22/29, 2001, at http://www.ama-assn.org/sci-
pubs/amnews/pick 01/gvsal022.htm (last visited Apr. 17, 2004).
139. Pharmaceutical Market Access Act of 2003, H.R. 2427, 108th Cong. § 2(5).
140. SeeJoel Baglole, Canada's Southern Drug, WALL ST.J., Mar. 31, 2003, at B3.
141. SeeJoel Baglole, Manitoba Fills Niche for Affordable Drugs, WALL ST.J., Oct. 10, 2002, at
B3.
142. Plug May Be Pulled on On-line Pharmacies, GLOBE & MAIL, Dec. 15, 2003, available at
http://www.globeandmail.com/servlet/ArticleNews/front/RTGAM/2002
1215/wpharml 2
15a/Front/homeBN/breakingnews (last visited Apr. 13, 2004).
143. See, e.g., Pharmacy Checker.com, at http://www.pharmacychecker.com (last visited
Apr. 13, 2004). United Health Alliance, a Vermont-based non-profit, is among the most
visible. It lobbies for lower prescription drug costs and through its "Medicine Assist"
program provides pricing and ordering information from Canadian e-pharmacies. See




are less likely to be Internet savvy and may have difficulty filing out the
forms. 144 The intermediaries take prescription requests from U.S. patients
and transmit them to Canadian drugstores for direct fulfillment. The drugs
are then supplied via mail to the patients in the United States, with the
intermediary collecting a referral fee or commission on the sale.' 45 A
number of web-based businesses offer similar services.
46
Although the amounts involved are modest, approximately $700
million in annual Canadian e-pharmacy sales to the United States'
47
compared to the overall $150 billion U.S. pharmaceuticals market, U.S.-
based pharmaceutical companies have become increasingly wary of this
developing distribution channel. 18 Their attention seems to have become
particularly focused after the United Health Group Inc., which insures
nearly 100,000 AARP members, agreed to reimburse clients for
prescriptions filled abroad. Pharmaceutical interests in the United States
have also lobbied against legislation permitting drug reimportation on the
basis that it would increase the likelihood of counterfeit, contaminated, or
illegal drugs coming into the United States.'
49
This "quality" theme has underpinned the FDA's reaction to the
Canadian connection. The alleged fear of the FDA is that the drugs are
coming from some other country and simply passing through Canada.'
50
144. Buying Drugs via Canada Gets Tougher, SEATI'LE TIMES, May 29, 2003, at Al.
145. A New Source for Discount Prescriptions, N.Y. TIMES, Dec. 26, 2002, at A36.
146. See, e.g., Canadian Meds USA, at http://www.canadianmedsusa.com (last visited Apr.
13, 2004); Denver-based Web Site Helps Consumers Buy Cheaper Medications, SiliconValley.com, at
http://www.siliconvalley.com/mld/siliconvalleynews/editorial/3541606.htm?template=
(June 25, 2002).
147. Tedeschi, supra note 24. Some estimates project the number at $800 million to $1
billion for 2003. See Once Just a Trickle, Canada's Rx Drugs Pouring into USA, USA TODAY, Oct.
7, 2003, at Al [hereinafter Once Just a Trickle]; U.S. Targets Internet Pharmacies, Health Canada
Co-operating with U.S. Authorities, NAT'L POST, Nov. 11, 2003, at
http://medical.marijuana.com/article.php?sid=7843.
148. SeeJoel Baglole, Getting the Gray Out: Canadian and U.S. Regulators Are Looking To
Impose Order on the Sale of Cheap Online Drugs, WALL ST.J., Feb. 11, 2003, at R6.
149. See, e.g., National Association of Chain Drug Stores News Release, National
Association of Chain Drug StoresJoins Pharmacists in Endorsing the Cross-Border
Communiqu6 Opposing Illegal Importation of Prescription Drugs (May 13, 2003),
http://www.nacds.org/wmspage.cfm?parml=3028; see also Lueck, supra note 137.
150. Michelle Meadows, Imported Drugs Raise Safety Concerns, FDA CONSUMER MAG., Sept.-
Oct. 2002, http://www.fda.gov/fdac/features/2002/502_import.html. The FDA currently
has a task force working on counterfeit drugs and their impact on the U.S. distribution
system. See FOOD & DRUG ADMIN., COUNTERFErr DRUG TASK FORCE INTERIM REPORT (2003),
http://www.fda.gov/oc/initiatives/counterfeit/report/interim_report.html.
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The sensitive question is whether U.S. (FDA) drug regulation is
significantly superior to that found north of the border. 15' Health Canada's
Therapeutic Products Directorate (TPD)152 performs drug approvals under
the Food and Drug Regulations made under the Canadian Food and
Drugs Act. 153 The fact that Canada has a drug approval regulatory system
that places a value on quality similar to that of the FDA continues to add its
share of embarrassment to the dispute. In May 2003, a published report
suggested that the quality argument would be preempted because the TPD
would take responsibility for the safety of drugs reimported into the
United States. 54 Further discussions between the governments led to a
clarification to the effect that the Canadian government made no such
guarantee; 5 subsequently, Health Canada offered to assist with
enforcement."'
There are other reasons why dealing with the Canadian connection is
considerably more difficult than typical regulatory policies and
enforcement actions aimed at unlawful or marginally lawful domestic
distributors. First, the traffic does not generally include controlled
substances, depriving regulators of their traditional moral imperative.
Second, the pharmaceuticals involved tend not to be lifestyle drugs, but
rather life-sustaining or long-term maintenance drugs favored by seniors.
Third, the practical difficulties of closing down the Canadian channel are
immense. Huge numbers of suspect packages are crossing the border daily,
rendering enforcement impractical. And, even if U.S.-based intermediary
storefronts were closed, the bus trips by seniors across borders would
151. According to William Hubbard, FDA associate commissioner, "My own 90-year-old
mother cannot afford her drugs .... I know that. But nobody made FDA the drug-price-and-
safety administration. They just made us the drug-safety guys. Our mission is not to establish
prices of drugs, only to make sure they are safe." U.S. Moves To Shut Companies Selling
Imported Drugs, HEALTH DAY, Sept. 11, 2003, at
http://www.healthcentral.com/news/NewsFullText.cfm?id=515064.
152. Health Canada, Therapeutic Products Directorate, at http://www.hc-sc.gc.ca/hpfb-
dgpsa/tpd-dpt/aboutus-e.html (last visited Apr. 19, 2004).
153. Food and Drgs Act, R.S.C., ch. F-27, § 1 (1985) (Can.).
154. Marc Kaufman, Canada To Guarantee Imported Medicine, WASH. POST, May 8, 2003, at
A6.
155. Marc Kaufman, Canadian Drug Position Misinterpreted, WASH. POST, May 26, 2003, at
All.
156. PDA Seeks Help To Enforce Drug Laws; Health Canada Pledges Co-operation, CANADIAN
PRESS, Oct. 21, 2003; U.S. Targets Internet Pharmacies, Health Canada Co-operating with U.S.
Authorities, NAT'L POST, Nov. 11, 2003, at Al.
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continue 5 7 and the storefronts likely would be replaced by less formal
channels, such as "Tupperware"-style parties.1
5 8
It is the politicization of the issue that creates particular challenges.
Decreasing the cost of prescription drugs is a broadly-held political goal.
The elderly population that tends to face the most difficulty in affording
their drugs is electorally-significant and well-represented by lobbyists.
While the media is happy to display its mock indignation at web-supplied
Viagra, coverage of the enforcement of the reimportation prohibition
against a U.S. senior and AARP member struggling to pay her escalating
drug bill for life-sustaining medications is far more negative. 15 9
In January 2003, the pharmaceutical multinational GlaxoSmithKline
(GSK) increased monitoring of Canadian sales and threatened to cut off
supplies to Canadian pharmacies that shipped to U.S. patients. 1' ° Canadian
pharmacies and U.S. patient groups responded by urging a boycott of GSK
products. 16' The Canadian Competition Bureau launched a brief
investigation, but found no evidence that GSK was breaching the country's
antitrust laws. 62 In August 2003, Pfizer joined the other major drug
manufacturers in requiring exporting Canadian pharmacies to buy
supplies dictated by Canadian demand direct from Pfizer rather than from
wholesalers. 163 Pfizer also requires its wholesale distributors to report orders
157. See Once Just a Trickle, supra note 147.
158. Gardiner Harris, Canada Fills U.S. Prescriptions Under the Counter, N.Y. TIMES, June 4,
2003, at Al.
159. The poster "children" of the drug reimportation fight are Ray and Gaylee Andrews
of Elk Grove Village, Illinois. The two seventy-four year-olds spend $800 to $1,000 a month
to buy prescriptions and have filed suit against HHS and the FDA mounting an equal
protection challenge on the FDCA. Robert Pear, U.S. To Study Importing Canada Drugs, N.Y.
TIMES, Feb. 26, 2004, at A16.
160. Press Release, GlaxoSmithKline Acts To Prevent Illegal, Potentially Unsafe Imports
of Prescription Drugs (Jan. 21, 2003), available at
http://www.gsk.com/press-archive/press-01212003.htm; Sarah Lueck &Joel Baglole,
Glaxo Warns Canadian Clients Against Drug Sales to the U.S., WALL ST.J., Jan. 13, 2003, at B4.
161. SeeJulie Appleby, Canadian Druggists Mobilize Against Glaxo, USA TODAY, Feb. 5, 2003,
at lB.
162. Press Release, Competition Bureau, Competition Bureau Responds to Complaints
Regarding Supply of Canadian-Based Internet Pharmacies (Mar. 21, 2003),
http://strategis.ic.gc.ca/ epic/internet/incb-bc.nsf/en/ct02528e.html.
163. Scott Hensley & Anna Wilde Mathews, Pfizer Warning May Curb Drugs from Canada,
WALL ST.J., Aug. 7, 2003, at A2. A company spokesman stated "The objective of us having
more customers as direct clients is for us to better enforce our terms of sale which are that
our products are only to be sold in Canada for Canadian patients and that they are not for
export." Jane Taber, Pfizer Takes Aim at Resale of Drugs, GLOBE & MAIL, Aug. 7, 2003, at
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from individual drugstores and requires them to seek approval before
selling large amounts to any pharmacy or any amounts to new customers.1
6
4
With the drug companies strangling the supply chain, Canadian
pharmacies are being forced to buy the surplus supplies of other Canadian
pharmacies or through intermediaries" and pass the increased costs onto
U.S. consumers. At the same time, both individual pharmaceutical
companies and their trade group increased their spending on lobbying
against reimportation and other congressional threats to their price
structures. 166
The FDA signaled its intention to crack down on U.S.-Canada
prescription drug traffic in February 2003.167 In March 2003, the FDA's
Office of Compliance sent out its first warning notice to a U.S.-based
storefront, apparently an Arkansas affiliate or agent of a Manitoba
pharmacy. 68 The FDA took the position that "almost every time an
individual or business ships a prescription drug from Canada to a U.S.
consumer, the individual or business shipping the drug violates the
[FDCA]. Moreover, individuals and businesses, such as Rx Depot... and
its responsible personnel, that cause those shipments also violate the
Act."" 9  The FDA reiterated its position in a letter to
CanadianDiscountDrugs, an Alabama-based intermediary. 70 Subsequently,
http://globeandmail.com/servlet/story/RTGAM.2OO30807.wxudrugnO807/BNstory/Busin
ess/; see also Tom Cohen, Canada's Internet Pharmacies Hurting from Industry Steps To Halt U.S.
Sales, MERCURY NEWS, Aug. 29, 2003, http://www.detnews/2003/health/0308/31/health-
258099.htm.
164. Bernard Simon, Pfizer Moves To Try To Stop Drugs from Canada, N.Y. TIMES,Jan. 14,
2004, at WI.
165. See Mark Heinzl & Tomsin Carlisle, Canadian Pharmacies vs. Big Drug Makers, WALL
ST.J., Aug. 12, 2003, at D4; see also Cohen, supra note 163.
166. Drug Group Spent $8.5 Million Lobbying Against Importation, PHILA. INQUIRER, Oct. 13,
2003.
167. See Thomas A. Burton, The FDA Begins Cracking Down on Cheaper Drugs from Canada,
WALL ST.J., Mar. 12, 2003, at Al; Letter from William K. Horowitz, supra note 123.
168. SeeWarning Letter from DavidJ. Horowitz, supra note 123; see alsoJeff Gottlieb,
Stores Selling Drugs from Canada Thrive, L.A. TIMES, Mar. 24, 2003, at 2-1.
169. Warning Letter from DavidJ. Horowitz, supra note 123; see also Press Release, Food
& Drug Admin., FDA Collaborates with Arkansas State Board of Pharmacy in Enforcement
Action Against Storefront Obtaining Unapproved Drugs from Canada (Mar. 21, 2003),
http://www.fda.gov/bbs/topics/NEWS/2003/NEW00882.html.
170. Letter from DavidJ. Horowitz, Director, Office of Compliance, Food & Drug





both federal 1' and state authorities'72 have moved against pharmacies and
leading intermediaries involved in reimportation of drugs from Canada
and, with rare exception, 73 have been successful in obtaining preliminary
injunctions."'
The most extraordinary development in the reimportation scenario
has been the interest of some state and municipal governments in
reducing their drug costs by obtaining drugs from Canada. The issue was
presaged by an exchange between the FDA and the State of California;
concerned about the growing cost to its own pension fund, the State of
California inquired about buying reimported drugs, but was rebuffed by
the FDA. 75  Nonetheless, Montgomery, Alabama and Springfield,
171. See, e.g., Press Release, Food & Drug Admin., FDA Takes Action Against Companies
That Are Importing Unapproved, Potentially Unsafe Drugs (Sept. 9, 2003),
http://www.fda.gov/bbs/topics/NEWS/2003/NEW00939.html.
172. Al. State Bd. of Pharm. v. Canadian Discount Drugs, No. CV03287M (Ala. Dale
County Crt.June 30, 2003) (granting temporary restraining order),
http://www.nacds.org/user-assets/PDF-files/ALTRO_CanadianDiscountDrugs.pdf;
Plaintiff's Complaint, Okla. State. Bd. of Pharmacy v. Rx Depot, 290 F. Supp. 2d 1238 (N.D.
Okla. 2003) (No. 2003-2643), http://www.nacds.org/user-
assets/PDF.files/OklahomaBOPComplaint.pdf; Jean P. Fisher, Board Sues Canadian
Medicine Connections, NEWS & OBSERVER, Oct. 17, 2003,
http://newsobserver.com/business/story/2953 6 7 2p-27 09 9 3 6 c.html; see also Letter from
Charles S. Campbell, Executive Director, Arkansas State Board of Pharmacy to HenryJones,
Rx Depot, http://www.nacds.org/user-assets/PDF files/ARBOPLetterMarch03.pdf
(Mar. 21, 2003); Letter from Rebecca H. Deschamps, Executive Director, Montana Board of
Pharmacy to Gary Moffitt, Club Medzrx, http://www.nacds.org/user-
assets/PDF files/ClubMedzCeaseDesistMT.pdf (Mar. 10, 2003).
173. The exception was a West Virginia circuit court that ruled against a state pharmacy
board in favor of an intermediary on the basis that there was no evidence to show that
anyone had been misled into confusing the intermediary with a pharmacy. Susan Bush, W
Va. Court Decision Approves Importing of Drugs from Canada, BERKSHIRE EAGLE,Jan. 2, 2004,
http://www.canadianpharmacytrust.com/media/news4.html.
174. United States v. Rx Depot, Inc., 290 F. Supp.2d 1238 (N.D. Okla. 2003); see alsoJulie
Appleby, Firms Told To Cease Canadian Drug Orders, USA TODAY, Sept. 9, 2003, at 3B;
Canadian Press, U.S. Judge Agrees to Government Request To Shut Down Canadian Drug Importer
(Nov. 7, 2003),
http://mediresource.sympatico.ca/health-news-detail.asp?channel-id= I 1&menu-item-id
=&newsid=2651. But see United States v. Rx Depot, Inc., 297 F. Supp. 2d 1306 (N.D. Okla.
2003) (motion for emergency stay denied).
175. Letter from William K. Hubbard, FDA Associate Commissioner for Policy and
Planning, to Gregory Gonot, Deputy Attorney General, State of California,
http://www.fda.gov/opacom/gonot.pdf (Aug. 24, 2003) (discussing Opinion No. 03-601).
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Massachusetts have announced plans to supply their employees with drugs
from Canada.17 In response, the FDA targeted Springfield with a sting
operation.17 Iowa, Illinois, Vermont, and Minnesota have all requested a
variance from federal law to set up importation programs. 7 8 New
Hampshire has created a website that links to Canadian pharmacies from
which prescription drugs can be ordered; the site requires original
packaging and a prescription from a physician licensed in New
Hampshire. 7 9  Minnesota has adopted a somewhat more cautious
approach, setting up websites linking to Canadian pharmacies that meet its
safety criteria."s  Meanwhile, the Governor of Illinois'8' and the
Massachusetts Attorney General 18 2 have publicly called for a liberalization
of the FDA position. Throughout, the FDA has been resolute in its
176. SeeJulie Appleby, More Cities, States Opt for Canadian Drugs, USA TODAY, Dec. 23,
2003, at 3B; Mathew Mosk, Montgomery Explores Medicines from Canada, WASH. POST, Nov. 2,
2003, at C7.
177. Christopher Rowland, FDA Drug Scrutiny Rapped as Uneven, BOSTON GLOBE, Nov. 16,
2003, at Al.
178. Tony Leys, Vilsack Offers Plan on Canadian Drugs, Iowa Would Be Testing Ground for
Purchase of Prescriptions, DES MOINES REG., Jan. 22, 2004, at
http://desmoinesregister.com/news/stories/c4780934/23326025.html (last visited May 1,
2004).
179. Prescription Drugsfor New Hampshire, New Hampshire, at
http://www.nh.gov/governor/prescription/prescription.html (last visitedJuly 29, 2004); see
also Anna Wilde Mathews, States To Help Citizens Import Canadian Drugs, WALL ST.J., Dec. 18,
2003, at BI.
180. Welcome to Minnesota RxConnect Online, Minnesota RxConnect Online, at
http://www.minnesotarxconnect.com (last visitedJuly 29, 2004); see Bruce Murphy, State
Plans Web Link to Canada Pharmacies, MILWAUKEEJ. SENTINEL, Dec. 23, 2003, at
http://www.jsonline.com/news/state/dec03/1 9 4984.asp. Wisconsin planned a similar site
but recanted; a message on the state website from Governor Doyle stated: "I would like to
provide you with the names of those Web sites, but I can't. The Bush administration refuses
to permit states to help people save money by purchasing medicine from Canada."
Wisconsin Prescription Drug Resource Center, at http://drugsavings.wi.gov (last visited
Feb. 8, 2004).
181. Press Release, Rod R. Blagojevich, Blagojevich Calls on FDA To Reverse Policy on
Importing Drugs from Canada (Sept. 19, 2003),
http://wwwlOO.state.il.us/PressReleases/ShowPressRelease.cfm?SubjectID=1 &RecNum=22
83; see also Monice Davey, Illinois To Seek Exemption To Buy Drugs from Canada, N.Y. TIMES,
Dec. 22, 2003, at A27.




opposition,'" has ramped up inspections on imported packages, I 4 and has
issued statements highly critical of some state actions.
85
Congress has reacted somewhat negatively to the efforts to block drugs
from Canada, viewing safety issues as exaggerated1 6 and the FDA as siding
with the pharmaceutical industry. 87 Ironically, legislation to permit
reimportation already existed. The Medicine Equity and Drug Safety Act of
2000 (MEDS Act) was signed into law by President Clinton on October 28,
2000. The MEDS Act granted U.S. patients broad access to reimported
drugs. Its implementation, however, was conditioned on the Department
of Health and Human Services (HHS) completing a study and
implementing regulations. Secretary Shalala""' and Secretary Thompson,
after the 2000 election, refused to implement the MEDS Act. 89 Secretary
Shalala presciently identified practical flaws in the legislation that would
have allowed pharmaceutical interests to nullify its intended effects.8 °
Secretary Thompson, however, voiced concern about moving the United
States from a "closed" distribution system, arguing that "opening our
borders as required under this program would increase the likelihood that
the shelves of pharmacies in towns and communities across the nation
would include counterfeit drugs, cheap foreign copies of FDA-approved
drugs, expired drugs, contaminated drugs, and drugs stored under
183. William M. Welch, FDA on Canada Drugs: 'No way, USA TODAY, Dec. 23, 2003, at IA
(quoting FDA Associate Commissioner Peter Pitts as saying "It's very clear it's absolutely
illegal.... There's no way importing drugs not FDA-approved can be legal in any way or
form").
184. Gardiner Harris & Monica Davey, U.S. Steps Up Effort Against Drug Imports, N.Y. TIMES,
Jan. 24, 2004, at Cl.
185. Minnesota's Canadian Drug Site Draws FDA Warning, USA TODAY, Feb. 24, 2004, at
http://usatoday.com/tech/webguide/internetlife/2004-02-24-fda-minn-warning-x.htm
(reporting a letter sent by the FDA to Governor Pawlenty of Minnesota that noted "you...
shine a bright light on a path used not only by profiteers masquerading as pharmacists, but
by outright criminals").
186. See, e.g., U.S. House Members Slam JDA for Blocking Imports from Canada, REUTERS
HEALTH, Apr. 3, 2003.
187. International Prescription Drug Parity, Hearing Before the House Gov't Reform Subcomm. on
Human Rights and Wellness, 108th Cong. 1-5 (2003); see also Rowland, supra note 177.
188. Robert Pear, In a Turnaround, White House Kills Drug-Import Plan, N.Y. TIMES, Dec. 27,
2000, at Al.
189. Tommy G. Thompson, Secretary, Department of Health and Human Services,
Response to SenatorJamesJeffords (July 9, 2001),
http://www.fda.gov/oc/po/thompson/medsact.html.
190. Pear, supra note 188.
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inappropriate and unsafe conditions."'1 9'
Reimportation became a cause ctlibre in the 10 8 'h Congress. 192 Several
bills were introduced that prohibited discrimination against parallel
importers by pharmaceutical companies, 193 essentially legalizing the
Canadian necon. Bi-partisan support in the House finally coalesced
behind the Pharmaceutical Market Access Act of 2003.195 This would have
required the FDA to design and implement a system to grant individuals,
pharmacists, and wholesalers in the United States access to FDA-approved
drugs from FDA-approved facilities in industrialized nations including the
European Union, Australia, and Canada, but not Mexico. 96 Senate and
White House opposition, however, was strong,197 and House action was
more a warning shot to the administration regarding ongoing negotiations
on prescription drug benefits and drug prices than a genuine commitment
to legalizing reimportation. As the Medicare bill negotiations dragged on
into the fall of 2003, there were signs that a robust reimportation provision
was unlikely. 19 Nevertheless, as the AARP noted when it endorsed the bill,
191. Thompson, supra note 189.
192. See, e.g., Preserving Prescription Drugs Discounts Act, S. 477, 108th Cong. (2003);
North American Prescription Price Equity Act of 2003, H.R. 354, 108th Cong. (2003);
Prescription Drug Affordability Act, H.R. 616; 108th Cong. (2003); Senior Bill of Rights Act
of 2003, H.R. 1733 108th Cong. (2003); Preserving Access to Safe, Affordable Canadian
Medicines Act of 2003, H.R. 847, 108th Cong. (2003); Medical Independence, Privacy, and
Innovation Act of 2003, H.R. 2196, 108th Cong. (2003); Prescription Drug Benefit and Cost
Containment Act of 2003, S. 7, 108th Cong. (2003); see also Prescription Drug Price
Reduction Act, H.R. 5534, 107th Cong. (2002); Drug Importation Act of 2002, H.R. 5186,
107th Cong. (2002); Personal Prescription Drug Import Fairness Act, H.R. 1229, 107th
Cong. (2002); Affordable Drugs Access Act, H.R. 5217, 107th Cong. (2002); H.R. 4614,
107th Cong. (2002); Prescription Drug Price Parity for Americans Act, H.R. 2244, 107th
Cong. (2002); Prescription Drug Affordability Act, H.R. 2801, 107th Cong. (2002);
Prescription Reimportation, Improvement, Correction, and Enhancement Act, H.R. 698,
107th Cong. (2002).
193. E.g., Preserving Access to Safe, Affordable Canadian Medicines Act, H.R. 847, 108th
Cong. (2003).
194. E.g., Prescription Drug Parity for Americans Act, H.R. 2497, 108th Cong. (2003).
195. H.R. 2427, 108th Cong. (2002); see also Robert Novak, Drug Company Backlash Hits
Fever Pitch in Congress, CHI. SUN-TIMES, July 17, 2003, at 33.
196. SeeJim VandeHei &Juliet Eilperin, House Approves Drug Reimports, WASH. POST, July
26, 2003, at Al.
197. Nick Anderson, In Senate, Stiff Resistance to a Drug-Import Bill, LA TIMES, July 26, 2003,
at 1-10.
198. See Amy Goldstein & Helen Dewar, Hill Negotiators Rethink Reimported Drugs, WASH.
POST, Nov. 6, 2003, at A2.
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"It is a national embarrassment that in a country with the most advanced
medical system in the world, so many of our citizens can obtain affordable
prescription drugs only by seeking them in foreign countries. Legalized
reimportation was dropped from the final Medicare legislation, replaced
by what is in essence an update of the MEDS Act.2°°  However, Congress
continues to consider legislation seeking to liberalize reimportation of
prescription drugs.0 '
IV. UNDERSTANDING THE STAKEHOLDERS
In 1999, President Clinton initiated the current war on Internet drug
sales, signaling "zero tolerance for prescription drug Internet sites that
ignore federal and state laws and harm patient safety and health. 20 2 In fact,
there is even more at stake. Simmering behind the layers of regulation,
parochial regulators, and patchy enforcement are crucial questions about
the future of U.S. healthcare delivery. Most aspects of e-health, Internet
prescribing and dispensing in particular, are disruptive technologies that
challenge the status quo.03 The stakeholders have frequently divergent
views on the specific issues and the role of technologically mediated care.
A. Federal and State Regulators
It should be clear from the discussion above that U.S. drug marketing,
prescribing, and fulfillment exists in an immensely complex regulatory
matrix involving state, federal, and professional bodies. The matrix affects
more than local professional regulations and national quality regulation,
199. Dan Balz, Edwards Seeks a Lift with TVAds, WASH. POST, Aug. 7, 2003, at A3
(discussing a letter from AARP to sponsoring House members Reps. Emanuel and
Gutknecht).
200. Medicare Prescription Drug, Improvement, and Modernization Act of 2003, Pub. L.
No. 108-173, 117 Stat. 2469 (replacing 21 U.S.C. § 384). The 2003 legislation calls for a
study of reimportation similar to that called for by the MEDS Act. FDA Commissioner (and
CMS Secretary designate) Mark McClellan has been appointed to head the study. McClellan
To Study Drug Imports, WALL ST.J., Feb. 26, 2004, at D4.
201. See, e.g., Pharmaceutical Market Access and Drug Safety Act of 2004, S. 2328, 108th
Cong. (2004).
202. PBS, Clinton Proposes Regulation of Internet Drug Sales, Public Broadcasting Service, at
http://www.pbs.org/newshour/updates/december99/internet-drugs_12-28.html (Dec. 28,
1999).
203. See generally PHILIP EvANS & THOMAS S. WURSTER, BLOWN TO BITS: HOW THE NEW
ECONOMICS OF INFORMATION TRANSFORMS STRATEGY 180-89 (2000).
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but also strong criminal enforcement (e.g., DEA) necessitated by the
distribution of illegal controlled substances and the diversion of legally
204prescribed drugs. The international connection adds more complexity as
stakeholders confront not only illegal and offshore20 5 sources but also the
more benign, yet politically charged, Canadian connection.
The shifts in healthcare delivery implicate even broader interests for
regulators in the United States. Some of these interests are consistent with
a more positive approach to technologically-mediated care, while others
are the product of conservatism, parochialism, protectionism, and even
technophobia.
The federal government is committed to leveraging health technology
to decrease costs and improve medical quality. 0 6 The Bush Administration
has tried to assuage industry concerns about the HIPAA privacy regulations
but has remained committed to the introduction of the foundational
health Electronic Data Interchange (EDI) system.2 0 7  The federal
government remains committed to inter-operability and technology-led
efficiency in interstate medical and insurance markets.2 0 8 Federal regulators
recognize that the cost-savings of technologically-mediated care will be
204. One example is the abuse of OxyContin. See OxyContin Diversion and Abuse, U.S.
D.O.J. INFORMATION BULLETIN,Jan. 2001, at 1, available at
http://www.usdoj.gov/ndic/pubs/651/651p.pdf.
205.. See Melissa K Cantrell, The Taming Of E-Health: Asserting U.S. Jurisdiction over Foreign
and Domestic Websites, 103 W. VA. L. REV. 573 (2001); Ivette P. Gomez, Note, Beyond the
Neighborhood Drugstore: U.S. Regulation of Online Prescription Drug Sales by Foreign Businesses, 28
RUTGERS COMPUTER & TECH. L.J. 431 (2000).
206. See, e.g., Press Release, United States Department of Health & Human Services,
Secretary Thompson Announces Steps To Reduce Medication Errors (Mar. 13, 2003),
http://www.hhs.gov/news/press/2003pres/2OO30313.html; Ceci Connolly, Bar Codes on
Drugs Proposed, Errors Could Be Cut by Matching Hospital Patient, Prescription, WASH. POST, Mar.
8, 2003, at A7.
207. HIPAA's "Administrative Simplification" Subtitle F, sets out the framework and
provided CMS with the regulatory authority "to improve ... the efficiency and effectiveness
of the health care system, by encouraging the development of a health information system
through the establishment of standards and requirements for the electronic transmission of
certain health information." Health Insurance Portability and Accountability Act of 1996,
Pub. L No. 104-191, § 261, 110 Stat. 2021 (1996). The pivotal "Administrative
Simplification" subtitle introduced by the HIPAA regulations was the establishment of an
Electronic Data Interchange (EDI) for the healthcare system. When fully implemented, this
EDI architecture will provide for a fully interoperable, standardized system for processing
all data exchanges between healthcare entities.
208. This commitment is evidenced by the introduction of the administrative
simplification system. See infra note 207.
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realized more rapidly if consumers have confidence in the new systems,
which requires that providers internalize many of the privacy and security
costs in the healthcare information domain.
The White House has subordinated concerns about medical error to
the more populist rhetoric of the "malpractice crisis,"""' although in the
2004 State of the Union address the expected populist oversimplification
of "we must eliminate wasteful and frivolous medical lawsuits" was followed
by a more technical and forward-thinking directive- "[b]y computerizing
health records, we can avoid dangerous medical mistakes, reduce costs,
and improve care., 210 Federal agencies continue to push initiatives, such as
211 212e-prescribing, that directly reduce error or indirectly decrease patient
information costs in choosing safe providers through increased reporting,
analysis and disclosure.
Other federal goals are less clearly stated. Federal regulators appear
desperate to cut health costs by encouraging states to use technology to
increase the efficiency of federally-funded intrastate services and are thus
re-thinking reimbursement and subsidy programs. Although there are
articulated federal goals to prevent distortions in market conditions
between states,2 ' 4 these have not been applied in the e-health domain.
Finally, the principle of comity215 suggests a conservative approach to
dealing with international traffic in drugs; the United States needs to
209. "Because of excessive litigation, everybody pays more for healthcare, and many parts
of America are losing fine doctors. No one has ever been healed by a frivolous lawsuit; I
urge the Congress to pass medical liability reform." George W. Bush, State of the Union
Address, http://www.whitehouse.gov/news/releases/2003/01/20030128-19.html (Jan. 28,
2003); see alsoJeanne Cummings, Doctors' Activism Revives Malpractice Bill; Inspired By Bush,
Physicians Are Pressuring Congress 7o Cap Damage Awards, WALL ST.J., Jan. 13, 2003, at A4.
210. George W. Bush, State of the Union Address,
http://www.whitehouse.gov/news/releases/2004/01/20040120-7.html (Jan. 20, 2004).
211. See supra note 17.
212. One example is the work of the Agency for Healthcare Research and Quality
(AHRQ).
213. See infra notes 475-477.
214. Cf infra text accompanying note 311 (discussing FTC report on the interstate wine
market).
215. "Comity, in the legal sense, is neither a matter of absolute obligation, on the one
hand, nor of mere courtesy and good will, upon the other. But it is the recognition which
one nation allows within its territory to the legislative, executive, or judicial acts of another
nation, having due regard both to international duty and convenience, and to the rights of
its own citizens, or of other persons who are under the protection of its laws." Hilton v.
Guyot, 159 U.S. 113, 163-64 (1895).
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respect borders in order to gain international cooperation in curtailing
illegal traffic in a wide array of Internet enabled goods and services,
whether child pornography, gambling, or pharmaceuticals.
Today, improvements in health quality and safety primarily flow from
federal initiatives (e.g., the FDA and the Agency for Healthcare Research
and Quality), Medicare/Medicaid standards, and other national initiatives
such as those emanating from the Joint Commission on Accreditation of
Healthcare Organizations (JCAHO), the Leapfrog Group, 6 and the
,,117Markle Foundation's "Connecting for Health Collaborative. The blunter
instruments of state-law discipline and malpractice litigation have been
overshadowed by these initiatives.
State health departments have specific positive experiences with
technologically mediated care, such as telemedical outreach to
underserved populations, 8 and increasingly leverage technology to
provide a greater range of intrastate services . 9 State regulators, however,
have failed to articulate any discrete local quality standards and safety
interests in an increasingly national healthcare delivery system. State
medical boards continue to give credence to the fallacy that quality and
safety can be addressed by rooting out the few "bad apples" in the
professions, while appearing to be less than conversant with national
process or system-wide problems of medication errors, wrong-site surgery,
iatrogenic injury, physician fatigue, and the nursing shortage.
2 0
Furthermore, rather than taking a holistic approach to quality of care, state
boards tend to concentrate on discrete, often interpersonal violations of
their codes (e.g., sexual relations with patients, substance abuse and, of
course, Internet prescribing).
In the areas of licensure and discipline, the states continue to take
their police powers very seriously. Yet, they reference only the broadest
notions of quality and the protection of the public health. Despite the
flurry of enforcement activity surrounding Internet prescribing and
dispensing, state medical boards are principally interested in interactions
216. The Leapfrog Group, at http://www.leapfroggroup.org (last visited Apr. 17, 2004).
217. Connecting for Health, at http://www.connectingforhealth.org (last visited Apr. 17,
2004).
218. See, e.g., Telemedicine Reaches over 200 Alaska Locations, ALASKAJ. COMM., Jan. 27, 2003.
219. See, e.g., Virginia Board of Medicine's Practitioner Information Website, at
http://www.vahealthprovider.com/ (last visited Apr. 17, 2004).
220. See generally Lucian L. Leape, Preventing Medical Accidents: Is "Systems Analysis" the
Answer?, 27 AM.J.L. & MED. 145, 147 (2001) (arguing human errors can be "prevented by
redesigning systems.., to make it difficult to impossible for the errors to occur");James
Reason, Human Error: Models and Management, 320 BRIT. MED.J. 768 (2000).
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within their own borders. In some interstate interactions, they do, however,
rightfully assert their right to make policy. For example, medical boards
have to counter negative externalities suffered by their citizens when
neighbor states fail to enforce their licensure rules regarding "exported"
prescribing and dispensing services."'
Both state and federal regulators view Internet prescribing and
dispensing negatively and have derived moral imperatives from its more
dangerous and obviously illegal practices. Regulators have targeted
telemedicine in order to better police cybermedicine and Internet
prescribing. Similarly, they target prescribing and dispensing because of
tangential goals, such as consumer protection and public health. As a
result, regulatory activity tied to Internet prescribing and dispensing is
frequently prophylactic-leveraging the "hard" law of licensure to curtail
conduct that offends other policies or laws-yet it is more difficult to
regulate using "softer" consumer protection laws or offences requiring a
showing of mens rea.
Legally suspect cyber-physicians and e-pharmacies indulge in the same
array of dubious practices as their gambling and pornography fellow
travelers: auction fraud, credit card fraud, and non-delivery of
merchandise.2 2 2 Grey and black-market sites are not interested in
"stickiness" or persistence,2 23 or otherwise creating a marketing and service
atmosphere that promotes repeat business. These operators subscribe to a
more practical and immediate imperative: to keep moving and morphing
to stay ahead of pursuing regulators. Bad service, poor quality products,
and even outright fraud are therefore par for the course.2 2 4
The Federal Trade Commission (FTC) and state consumer protection
225agencies are active in the prescribing and fulfillment domains, but their
221. This is what Goldsmith and Sykes would call a "nonpecuniary externality that affects
citizens outside of the regulating state."Jack L. Goldsmith & Alan 0. Sykes, The Internet and
theDormant Commerce Clause, 110 YALE L.J. 785, 798 (2001).
222. NAT'L WHITE COLLAR CRIME CTR. & FED. BUREAU OF INVESTIGATION, IFCC 2002
INTERNET FRAUD REPORTJANUARY 1, 2002-DECEMBER 31, 2002, at 5 (2003), available at
http://wwwl.ifccfbi.gov/strategy/2002-IFCCReport.pdf (last visited Apr. 16, 2004).
223. For an explanation of this concept, see Martin Nemzow, Array Development
Ecommerce "Stickiness" for Customer Retention, at
http://www.arraydev.com/commerce/jibc/9908-03.htm (last visited Apr. 16, 2004).
224. See Internet Prescribing, Medical Board of California, at
http://www.medbd.ca.gov/buyerbeaware.htm (last visited Apr. 16, 2004) (explaining the
risks associated with ordering prescriptions through the internet).
225. See, e.g., The Internet Sale of Prescription Drugs from Domestic Websites: Hearings Before the
House Comm. on Gov't Reform, 108th Cong. (2003) (prepared statement ofJ. Howard Beales,
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regulatory powers are somewhat limited, often generalized, and frequently
limited to cases where misrepresentation or fraud can be proved. 26 The
FTC has argued that "the Commission has authority to bring an
enforcement action where an online pharmacy makes false or misleading
claims about the products or services it provides. However, the online
prescribing and dispensing of prescription drugs that does not involve a
deceptive or unfair practice generally does not fall within the agency's
scope of authority.,1
7
Regulatory interests are also sparked by concerns over pricing. The
Canadian connection that opens a channel to less expensive drugs is the
exception that proves the rule. Unlike the majority of goods and services
offered over the Web, Internet prescribing and dispensing do not attract
consumers primarily because of lower prices. In fact, many are seeking
drugs that their own physicians refuse to prescribe and are prepared to pay
a premium for back-channel services. Paul Starr recounts how in the late
1890s a patent medicine company pandered to Victorian modesty,
attracting women customers away from male physicians with
advertisements such as "Do you want a strange man to hear all about your
particular diseases?" and "Men NEVER See Your Letters."2 For many
lifestyle drugs, stealth and anonymity may still be the predominant factors
promoting online purchases. 29
The Internet's oft-touted transactional transparency (based on
reduced transaction costs and generally low information costs) 2 " does not
seem to apply to the current traffic in interstate prescription drugs. A
survey by the California State Board of Pharmacy even concluded that
some drugs cost five times as much on the Internet as they did in local
III, Director, Bureau of Consumer Protection of the Federal Trade Commission),
[hereinafter Hearings], http://www.ftc.gov/os/2003/03/030327internetprescriptions.pdf
(last visited Apr. 16, 2004).
226. See, e.g., Press Release, Fed. Trade Comm'n, Online Pharmacies Settle FTC Charges
(July 12, 2000), http://www.ftc.gov/opa/2000/07/iog.htm; see also Press Release, Fed.
Trade Comm'n, FTC Charges Direct Marketers of Ephedra Weight Loss Products with
Making Deceptive Efficacy and Safety Claims (July 1, 2003),
http://www.ftc.gov/opa/2003/07/ephedra.htm.
227. Hearings, supra note 225, at 11 (footnotes omitted).
228. PAUL STARR, THE SOCIAL TRANSFORMATION OF AMERICAN MEDICINE 128 (1982).
229. For the views on patient motives from a doctor who has written more than 10,000
Internet prescriptions for Viagra, see MilesJ. Jones & William Alvis Thomasson, Establishing
Guidelinesfor Internet-based Prescribing, 96 S. MED.J. 1, 2-3 (2003).
230. For a thoughtful analysis, see Robert P. Merges, The End of Friction? Property Rights




This counter-intuitive phenomenon was at the root of the prosecutors'
failed attempt in State ex rel. Stovall v. Confimed. com, L.L. C.2 2 to persuade the
Supreme Court of Kansas that a charge of seventy-five dollars for an online
consultation and dispensing fee was unconscionable. However,
infomediaries such as price "bots" (websites that offer price comparisons
across multiple suppliers) are moving into the prescription drug domain,
providing comparison pricing information across online and bricks-and-
mortar suppliers.2 4
Federal authorities have been extensively involved in attempts to crack
down on abuses such as fraud and diversion. For example, "Operation Web
Slinger," a joint U.S.-Canadian investigation coordinated by the DEA, has
targeted the illegal Internet trafficking of "date rape" drugs such as GHB.3
Similarly, the FTC and FDA are jointly leading "Operation Cure.All,
directing considerable federal law enforcement energies against
companies marketing fraudulent health products over the Internet.
Targeted companies include those that market nutritional supplements,
herbal products, and medical devices that claim to treat ailments as diverse
as cancer, HIV/AIDS, arthritis, hepatitis, Alzheimer's disease, and
diabetes. 23 '7 A particularly disturbing set of cases arose after September 11,
2001 with online entrepreneurs offering "civil defense" products such as
231. Siwolop, supra note 88. A PharmacyChecker.com analysis reported that U.S. sites
not requiring prescriptions charged, on average, fifty-four percent more than sites that do
require prescriptions. Pharmacychecker.Com, Fifty Percent of Internet Pharmacies Not Licensed
According to Pharmacychecker. Com; Canadian Prices Half That of U.S., Pharmacy Checker, at
http://www.pharmacychecker.com/news/news_040703.asp (Apr. 7, 2003).
232. 38 P.3d 707 (Kan. 2002). For a full discussion of Stovall, see infra note 411 and
accompanying text.
233. 38 P.3d at 714 ("[The investigators] at best made a bad bargain, but, lacking any
indication of deceptive bargaining conduct or unequal bargaining power, the $ 75 charge
for the consultation was not unconscionable.").
234. For an example of such a company, see DestinationRx, at
http://www.destinationrx.com (last visited Apr. 16, 2004).
235. Press Release, Drug Enforcement Admin., "Date Rape" Drug Sold over the Internet
(Sept. 19, 2002), http://www.usdoj.gov/dea/pubs/pressrel/pr91902.html.
236. Greg Winter, U.S. Vows More Scrutiny of Health Ads on Net, N.Y. TIMES, June 15, 2001,
at C4; see Press Release, Fed. Trade Comm'n, "Operation Cure.All" Wages New Battle in
Ongoing War Against Internet Health Fraud (June 14, 2001), at
http://www.ftc.gov/opa/2001/06/cureall.htm.
237. See, e.g., Herb Remedy Web Sites Break Law, Study Finds, AKRON BEACONJ., Oct. 28, 2003.
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anti-radiation pills2 38 or Ciprofloxacin, designed to treat Anthrax. " ' Such
cases replicated themselves after other public health scares such as the
SARS outbreak.4 State and federal authorities will likely continue to target
the Internet sale of other dangerous products such as nicotine-laced
lollipops,2 4 1 or those likely to be used for illegal purposes such as "cleaning"
urine. 42 Regulators in the United States face a growing problem of
counterfeit2 43 and contaminated drugs,2 44 and are particularly keen to slowS • 245
the development of new or suspect distribution channels.
B. The Pharmaceutical Industry
It is relatively easy to paint the U.S. pharmaceutical industry as the real
villain in the Internet dispensing controversy. After all, the industry is
246
stimulating demand for pharmaceuticals by marketing to physicians and
through DTC advertising, 47 and the industry also must appreciate that the
drugs for which they create this demand are frequently out-of-formulary248
238. New York Says Pill Seller Invoked Terror Case, N.Y. TIMES, Dec. 4, 2002, at A19.
239. See Press Release, Fed: Trade Comm'n, FTC Cracks Down on Marketers of Bogus
Bioterrorism Defense Products (Nov. 19, 2001),
http://www.ftc.gov/opa/2001 / 11 /webwarn.htm.
240. Internet Is Awash in Ads for Products Promising Cures or Protection, N.Y. TIMES, Apr. 14,
2003, at A12.
241. See, e.g., Press Release, Fed. Trade Comm'n, FDA Warns Sellers of Nicotine
Lollipops & Lip Balm That Their Products Are Illegal (Apr. 10, 2002),
http://www.fda.gov/bbs/topics/ANSWERS/2002/ANSO1144.html.
242. See, e.g., Curtis v. State, 549 S.E.2d 591 (S.C. 2001).
243. See, e.g., Lauren Neergaard, FDA Says Web Site Is Selling Counterfeit Contraceptives,
WASH. POST, Feb. 4, 2004; see also FOOD & DRUG ADMIN., COMBATING COUNTERFEIT DRUGS: A
REPORT OF THE FOOD AND DRUG ADMINISTRATION (2004),
http://www.fda.gov/oc/initiatives/counterfeit/report02_04.html.
244. See, e.g., Lax System Allows Criminals To Invade the Supply Chain, WASH. POST, Oct. 22,
2003, at A01; US. Prescription Drug System Under Attack, WASH. POST, Oct. 19, 2003, at A01.
245. See FOOD & DRUG ADMIN., supra note 150.
246. Robert Pear, U.S. Warns Drug Makers on Illegal Sales Practices, N.Y. TIMES, Apr. 28,
2003, at A16; cf. Press Release, PhRMA, PhRMA Adopts New Marketing Code (Apr. 19,
2002), http://www.phrma.org/mediaroom/press/releases/19.04.2002.390.cfm.
247. See, e.g., Lars Noah, Advertising Prescription Drugs to Consumers: Assessing the Regulatory
and Liability Issues, 32 GA. L. REV. 141 (1997); David W. Opderbeck, How Should FDA Regulate
Prescription Drug Promotion on the Internet?, 53 FOOD DRUG L.J. 47 (1998); Peter S. Reichertz,
Understanding Government Regulation of the Marketing and Advertising of Medical Devices, Drugs,
and Biologics: The Challenges of the Internet, 52 FOOD DRUG L.J. 303 (1997).
248. In 2002, out-of-pocket spending on prescription drugs increased from $6.1 billion
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and potentially off-label, and so are less likely to be satisfied through
traditional prescribing or dispensing channels.1
49
It also seems beyond cavil that U.S. pharmaceutical companies
regularly practice price and distribution discrimination, with the U.S.
market bearing disproportionate and escalating drugs costs. The primary
reason for the lower costs abroad, however, is that non-U.S. healthcare
delivery services are larger, monopsonic, or have otherwise put themselves
into better bargaining positions with pharmaceutical companies. In
particular, non-U.S. national health services are willing to use their
monopoly purchasing power to extract low prices for pharmaceuticals.
Arguably, the real objection to the high costs of pharmaceuticals in the
United States is that the pharmaceutical companies, forced to internalize
costs in foreign markets, disproportionately externalize their research and
development costs to U.S. consumers. The federal government has done
little to reverse this trend and the states have only recently begun to
explore their market power by forming procurement collectives.25 °
Illustrative of the U.S. drug pricing dynamic has been the pharmaceutical
industry's opposition to a Medicare prescription' drug benefit, which is
driven by the fear that centralized government purchasing would drive
to $48.6 billion, or twenty-three percent of out-of-pocket spending. Robert Pear, Health
Spending Rises to Record 15% of Economy, N.Y. TIMES, Jan. 9, 2004. According to the GAO,
Pharmaceutical companies have increased spending on DTC advertising more
rapidly than they have increased spending on research and development.
Between 1997 and 2001, DTC advertising spending increased 145 percent, while
research and development spending increased 59 percent. Promotion to
physicians accounted for more than 80 percent of all promotional spending by
pharmaceutical companies in 2001. Total promotional spending was equivalent
to 12 percent of drug sales in the United States in 2001.
GEN. ACCOUNTING OFFICE, PRESCRIPTION DRUGS: FDA OVERSIGHT OF DIRECT-TO-CONSUMER
ADVERTISING HAS LIMITATIONS 3 (GAO-03-17, 2002) [hereinafter PRESCRIPTION DRUGS].
249. "Ninety percent of the people who buy medications at PlanetRx pay for the
prescriptions themselves, not through their insurance plans, whereas only 20 percent of the
customers at brick-and-mortar pharmacies pay out of their own pocket."Jennifer Couzin,
The Internet's Drug Lords, THE INDUSTRY STANDARD, Apr. 10, 2000. The GAO has also noted:
To date, the few studies that have examined the effects of DTC spending on
prescription drug spending and utilization have found that DTC advertising
increases both. In addition, there is clear evidence from consumer surveys that
DTC advertising encourages consumers to request prescriptions for specific
brand-name drugs from their physicians and that some physicians provide the
requested prescription.
PRESCRIPTION DRUGS, supra note 248, at 11.
250. Milt Freudenheim, Nine States Form Group To Lower Drug Costs, S.D. UNION-TRIB.,Jan.
14, 2003, at Al.
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down prices or that cost-effectiveness analysis would counter
252pharmaceutical marketing and create limited formularies.
C. Physicians and Pharmacists
Although patients are apparently keen to increase the level of
technological intermediation with their healthcare providers, 53 it can be
difficult to find reciprocal interest among physicians254 or institutional
providers. 255 Despite evidence that use of rich and self-documenting




make treatment more effective, many physicians and their representatives
on state boards view email and web contact with patients or potential
patients as further signs (along with managed care, Internet web advice,
and the general "HIPAA-ization" of medical practice) 258 that they are losing
control of the physician-patient relationship.5
9
251. Jim Drinkard, Drug Bill a Well-Financed Victory for Industry; Companies Avert Version
Feared Most, USA TODAY, July 7, 2003, at 4A.
252. Robert Pear, Congress Weighs Drug Comparisons, N.Y. TIMES, Aug. 24, 2003, at 18.
253. See infra notes 275-279.
254. According to one study, seventy-four percent of parents of children wish to
communicate with their children's doctors online, but seventy-nine percent of pediatricians
are unwilling to communicate directly with patients via email. Katie D. Kleiner et al., Parent
and Physician Attitudes Regarding Electronic Communication in Pediatric Practices, 109 PEDIATRICS
740 (2002).
255. Beth Healy, Health Plans Fall Short in Web Service, Study Finds, BOSTON GLOBE, Apr. 9,
2003, at DI ("The more consumers access information about their health in general online,
and the more premiums and copays that are pushed onto their shoulders, the more they
want to be treated like customers." ) (quoting Forrester Research study)).
256. Leonard Holmes, Writing Email About Problems Can Improve Health, About.com., at
http://mentalhealth.about.com/library/sci/0402/blemail402.htm (last visited Apr. 16,
2004); see also Florian Strasser et al., E-motions: Emailfor Written Emotional Expression, 20J.
CLINICAL ONCOLOGY 3352 (2002).
257. See, e.g., 'Virtual Visits' Helping Parents of Preemies, N.Y. TIMES, Dec. 5, 2000, at 14
(reporting that premature infants whose families had web access to updates on the babies'
health, information about medical conditions, explanations of medical equipment and
terminology, and a videoconferencing system with which to interact with medical staff had
shorter stays in neonatal intensive care units).
258. See supra note 56 and accompanying text.
259. See Edd Fleming &Jens Riese, On-line Healthcare: Why Are Physicians Still Dragging
Their Feet ?, HEALTHLEADERS, at
http://www.healthleaders.com/news/featureI .php?contentid=l 1288&CESession=47b8086
16122e9a96290e0574f68fb83 (Feb. 5, 2001).
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Less frequently articulated are genuine concerns about the legal and
operational uncertainties surrounding patient email.2n Although some
guidance for professionals has been published, genuine questions
remain about legal exposure for responding to unsolicited email2 2 and
the related question of exactly what creates a physician-patient relationship
on the Internet. 23 Such uncertainties include: difficulties in positively
identifying online participants; questions about responsibility for "operator
error" or mistakenly forwarded e-mail; the chilling effect of HIPAA's
security and privacy rules; and the scope of document retention,
264
particularly the way that the self-documenting nature of email may increase
malpractice exposure.
Physicians also have understandable "business" concerns. They view
email communications with patients as creating an expectation of around-
the-clock services and something to be delegated to their staff.26  This
antipathy is, no doubt, fuelled by the relative lack of reimbursement for
any such contact with patients.266 In contrast, physicians involved in
subscription-based email services show considerably more enthusiasm.
260. See Katie Hafner, Dear Doctor Meets Return to Sender, N.Y. TIMES, June 6, 2002, at GI;
Francesca Lunzer Kritz, Some Doctors Use Patient E-mail in Their Practices, but Most Aren't Ready
To Log on, WASH. POST, Apr. 1,2003, at HEI.
261. See, e.g., Beverly Kane & Daniel Z. Sands, Guidelines for the Clinical Use of Electronic
Mail with Patients, 5J. AM. MED. INFORMATICS ASS'N 104 (1998),
http://www.amia.org/pubs/other/email-guidelines.html.
262. See, e.g., MV Seeman & B Seeman, E-psychiatry: The Patient-Psychiatrist Relationship in
the Electronic Age, 161 CANADIAN MED. ASS'NJ. 1147 (1999) ("Clearly, the mostjudicious
course of action is not to respond to email queries.").
263. This is analogous to the telephone cases where "it must be shown that it was
foreseeable that the prospective patient would rely on the advice and that the prospective
patient did in fact rely on the advice." Miller v. Sullivan, 625 N.Y.S.2d 102, 104 (App. Div.
1995). Chat functions, and in some instances email, are more likely to trigger this formal
relationship due to the contemporaneous nature of relationship creation and provision of
services.
264. NASD has a three-year rule for retention of email and IM communications. Notice to
Members, at http://www.nasdr.com/pdf-text/0333ntm.pdf (last visited Apr. 17, 2004).
265. See Hafner, supra note 260. See generally CA. HEALTHCARE FOUND., ONLINE PATIENT-
PROVIDER COMMUNICATION TooLs: AN OVERVIEW 19-25 (2003),
http://www.chcf.org/documents/ihealth/PatientProviderCommunicationTools.pdf.
266. See Laura Landro, The Informed Patient: Please Get the Doctor Online Now, WALL ST.J.,
May 22, 2003.
267. See, e.g., GreenField Health System, at http://www.greenfieldhealth.com/. See
generally
E-Mail Could Transform Medical Care, Northwest News Channel 8, at
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As for pharmacists, David Brushwood has argued convincingly that the
changing nature of medical practice and health policy leads to pharmacists
"being asked to do more for each patient, and there are more patients
whose needs pharmacists are being asked to meet. 268 This trend will
continue as medical practice continues to favor pharmaceutical treatment
models while at the same time relying on the pharmacist as the second line
of defense to reduce medication errors.
Just as it is naive to paint pharmaceutical companies as the villains of
ths story, it would stretch credulity to classify most Internet physicians and
pharmacists as victims. They may characterize themselves as guiltless
pioneers protecting the access rights of their customers, but most of their
businesses and business practices too closely resemble those employed by
less reputable Internet sites. Internet physicians and pharmacies market
through spam269 and impede the continuity of care by disappearing and
reappearing under different names and web addresses. 270 The shadow-
writer or ghost-writer physicians they often employ must either possess
superhuman powers or ignore quality of care given the hundreds of
prescriptions they sign per week.7
By the same token, Internet physicians and pharmacists cannot be
viewed as innocent victims of an overly complex regulatory system. Internet
prescribers and dispensers are generally quite sophisticated and structure
their businesses to exploit "soft" states or regulatory gaps. If they were
willing, they could avoid controlled substances, develop track records of
quality practices, decouple their prescribing and dispensing businesses,
http://www.kgw.com/health/stephanie-stricklen/stories/kgw-0423-health-stricklen-emai
1_doctors.lca3lac9.html (Apr. 23, 2002).
268. David B. Brushwood, Responsive Regulation of Internet Pharmacy Practice, 10 ANN.
HEALTH L. 75, 76 (2001).
269. The spam subject line "Check out our new lower prices. Many 'drug' types
available." made SurfControl's list of "Top 10 Most Annoying Spam in 2002." Press Release,
SurfControl, Anti-Spam Leader SurfControl Cites Top 10 Most Annoying Spam in 2002, at
http://www.surfcontrol.com/news/newsitem.aspx?id=543 (last visited Apr. 17, 2004).
According to Clearswift, healthcare spam accounted for almost fifty percent of span in
November 2003. Press Release, Clearswift, Spammers Peddling Viagra and Diet Pills in Run
Up to Party Season (Dec. 16, 2003),
http://www.clearswift.com/news/pressreleases/232.aspx.
270. "It's like rabbits," said Wayne A. Michaels, a senior investigator for the Drug
Enforcement Administration. "Every day, there are more of them. They're up, they're
down, they're foreign, they're domestic." Gilbert M. Gaul & Mary Pat Flaherty, Internet
Trafficking in Narcotics Has Surged, WASH. POST, Oct. 20, 2003, at A01.
271. See Gaul & Flaherty, supra note 18.
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and restrict their operations to one or a small number of states where their
physicians are licensed-either by refusing to prescribe to patients in states
where their doctors are not licensed or by using what Jack Goldsmith has
called "information discrimination technology.,
272
D. Patients
Patient interest in Internet prescribing and dispensing is not difficult
to explain; it is part of a broader pattern of consumer use of health-related
email and web resources.273 Searching for health information and advice is
one of the primary uses of the Internet in the United States, behind only
email and product research.274 Eighty percent of, or 110 million, online
adults use the Internet to access health information.27' Forty-five percent of
U.S. adults use the Internet for healthcare-related purposes, including
health research, prescribing, and comparison-shopping on health
services. 276 Thirty-four percent of Internet users have searched for
pharmaceutical-related information.277 In contrast, only sixteen percent
278
refer to their physicians for health-related information.
Ninety percent of adults online would like to communicate online with
272. Jack L. Goldsmith, Against Cyberanarchy, 65 U. CHI. L. REv. 1199, 1225 (1998).
273. See Fox & FALLOWS, supra note 54.
274. Id. at i.
275. Humphrey Taylor, Cyberchondriacs Update, Harris Interactive, at
http://www.harrisinteractive.com/harrispoll/index.asp?PID=2 9 9 (May 1, 2002). This is
compared to fifty-four million in 1998, sixty-nine million in 1999, and ninety-seven million
in 2001. Id.
276. Press Release, Solucient, Nearly Half of U.S. Adults Turn to Web for Health Care
Needs (July 15, 2003), http://www.solucient.com/news-press/news2 00 3O7l5.shtml (last
visited Apr. 17, 2004).
277. See Fox & FALLows, supra note 54, at 8.
278. Id. Baker and his colleagues report a less robust picture:
Approximately 40% of respondents with Internet access reported using the
Internet to look for advice or information about health or healthcare in 2001. Six
percent reported using e-mail to contact a physician or other health care
professional. About one third of those using the Internet for health reported that
using the Internet affected a decision about health or their health care, but very
few reported impacts on measurable health care utilization; 94% said that
Internet use had no effect on the number of physician visits they had and 93%
said it had no effect on the number of telephone contacts. Five percent or less
reported use of the Internet to obtain prescriptions or purchase pharmaceutical
products.
Laurence Baker et al., Use of the Internet and E-mailfor Health Care Information: Results from a
National Survey, 289JAMA 2400 (2003).
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their physicians to ask questions, fix appointments, refill prescriptions, and
receive test results. 2 79 A significant number aspire for a more robust
experience, wanting more information on drug interactions, access to their
electronic patient records, and increased availability of home or mobile
diagnostic tools. 28 ° A 2003 survey found that thirty-seven percent of
connected and relatively affluent patients were prepared to pay modest
subscription or per-email fees in order to have online interaction with their
21physicians.
Six million U.S. adults have purchased prescription drugs online.2
The drugs most often bought online were Lipitor 28 3 for lowering
cholesterol, Viagra8 4 for erectile dysfunction, and Celebrex, a pain
reliever.8" Seventy per cent of online purchases were for drugs previously
prescribed in the course of a conventional physician-patient relationship. 28 7
The overwhelming majority of purchasers reported being equally satisfied
(56%) or more satisfied (34%) than they were with purchases from a
traditional pharmacy, although a majority believed that buying drugs
online is much more dangerous (39%) or somewhat more dangerous
(22%) than buying them from a pharmacy.8"
Online prescribing and dispensing no doubt attract customers for
many of the same reasons that make other business-to-consumer
storefronts so popular: convenience, round-the-clock availability,
279. Fast Facts, RelayHealth, at
http://www.relayhealth.com/rh/general/news/fastFacts.aspx (last visited July 29, 2004)
(citing Harris Interactive poll from April 2002).
280. See Fox & FALLOWS, supra note 54, at 29.
281. Harris Interactive, Patient/Physician Online Communication: Many Patients Want It,
Would Pay for It, and It Would Influence Their Choice of Doctors and Health Plans, HEALTH CARE
NEWS, Apr. 10, 2002,
http://www.harrisinteractive.com/news/newsletters/healthnews/HI-HealthCareNews202
Vol2_IssO8.pdf.
282. Harris Interactive, Six Million People Have Bought Prescription Drugs Online; Most Are
Satisfied, HEALTH CARE POLL, Mar. 23, 2004,
http://www.harrisinteractive.com/news/newsletters/wsjhealthnews/WSJOnline HIHealth
-CarePoll2004vol3_iss06.pdf.
283. Lipitor, at http://www.lipitor.com/ (last visited Apr. 17, 2004).
284. Viagra, at http://www.viagra.com/ (last visited Apr. 17, 2004).
285. Celebrex, at http://www.celebrex.com/ (last visited Apr. 17, 2004).
286. Harris Interactive, supra note 282, at 3 tbl.5.





comparison-shopping, and variety. It is more difficult to assess what factors
specifically motivate Internet prescribing. As discussed earlier, anecdotal
evidence suggests that lower prices may not be as strong a factor as it is in
other forms of online retailing, although it may still be a consumer
aspiration. Rather, the specific "convenience" sought by those who
purchase prescriptions online is the circumvention of the conventional
physician-patient relationship. Some patients will go online following a
refusal by their usual physician to prescribe a particular drug because of,
for example, off-label use or the potential for abuse. Those seeking lifestyle
drugs no doubt seek a level of anonymity or confidentiality that they
assume to be missing from the traditional office visit. Similar factors
probably explain patient interest in online fulfillment, although the cost
factor is more complex. Customers of lifestyle drugs already face
considerable "sticker shock" because such drugs are infrequently included
in health plan formularies.29 ° Patients who purchase from online
pharmacies without a previously-issued orthodox prescription will seldom
see significant savings over the local bricks-and-mortar pharmacy price
291
and, counter-intuitively, may even find premium pricing. In contrast, we
know that seniors equipped with bricks-and-mortar prescriptions using the
Canadian connection are doing so almost exclusively because of significant
cost savings.29
There may be a more deep-seated, long-term, and disruptive basis for
patient interest in online medicine and other controversial pharmaceutical
channels. There are detectable signs of a fundamental shift in patient
perspectives on prescribing and dispensing. Concomitant with their
growing appetite for alternative medicine,m patients may be losing
confidence in, and respect for, the traditional prescribing process, and
hence its moral imperative. They view the transfer of drugs from legend to
over the counter status as a function of expiring patents and perceive
restrictive managed care formularies to be in stark contrast to the direct-to-
consumer pharmaceutical advertising with which they are deluged and the
free samples with which they are plied. Although a majority of patients still
trust their personal physicians "to do the right thing for them personally
290. See Harrow v. Prudential Ins. Co. of Am., 279 F.3d 244 (3d Cir. 2002) (unsuccessful
action by consumer against health plan that refused to cover Viagra).
291. See supra note 231 and accompanying text.
292. See supra note 138 and accompanying text.
293. See Sheryl Gay Stolberg, Alternative Care Gains a Foothold, N.Y. TIMES,Jan. 31, 2000, at
Al; see also Kathleen M. Boozang, Western Medicine Opens the Door to Alternative Medicine, 24
AM.J. L. & MED. 185 (1998); Nat'l Insts. of Health, What Is Complementary and Alternative
Medicine (CAM)?, at http://nccam.nih.gov/health/whatiscam/ (May 2002).
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and for their health care,, 294 they are more skeptical about interactions
involving pharmaceuticals.9  Increasingly, patients view their physicians'
prescribing decisions as being driven by formulary rules rather than their
needs; the traditional prescribing process and dispensing process is no
longer viewed as providing access, but rather of erecting barriers.96
V. RECURRING REGULATORY THEMES
In law and practice the "interlocking trellis, 297 of regulation that
applies to interstate prescribing and dispensing often appears inconsistent
and uncoordinated. More significantly, the way that our regulatory matrix
deals unhappily with the supply of pharmaceuticals is suggestive of a
difficult regulatory future for the broader e-health domain.
A. Uneasy Federalism
First generation legal scholarship about the Internet was quick to
point out the inherent difficulties of applying extant geographically
"zoned" regulation to geographically incoherent cyberspace.2 98 The
294. Harris Interactive, Health-Care Professionals, Pharmacies, Hospitals Gain the Public's Top
Trust (Jan. 28, 2004),
http://www.harrisinteractive.com/news/newsletters/wsjhealthnews/WSJOnline HIHealth
-CarePoll2004vol3-issO2.pdf (reporting sixty-three percent of patients so trusted their
physicians).
295. Id. Forty-nine percent trust their pharmacies; forty-four percent trust their drugs;
and fourteen percent trust pharmaceutical companies. Id. at 2.
296. One study reported, "The more money people spend out of pocket on drugs, the
more likely they are to shop abroad. Fully 16 percent of those with out-of-pocket costs for
drugs of over $1,000 a year have shopped abroad." Harris Interactive, Drug Companies May
Be Headed for a Bruising Battle as Drug Importation Grows (Oct. 9, 2003),
http://www.harrisinteractive.com/news/newsletters/wsjhealthnews/WSJOnline HI Health
-CarePoll2003vol2-iss8.pdf.
297. State v. Rasmussen, 213 N.W.2d 661, 665 (Iowa 1973).
298. See, e.g., David R. Johnson & David Post, Law and Borders-The Rise of Law in
Cyberspace, 48 STAN. L. REV. 1367, 1375 (1996); David G. Post, Governing Cyberspace, 43 WAYNE
L. REV. 155 (1996);Joanna Zakalik, Law Without Borders in Cyberspace, 43 WAYNE L. REV. 101
(1996). See generally LAWRENCE LESSIG, CODE AND OTHER LAWS OF CYBERSPACE 24-29 (1999).
For contemporary analysis, see Goldsmith, supra note 272, at 1250 ("There is no general
normative argument that supports the immunization of cyberspace activities from territorial
regulation. And there is every reason to believe that nations can exercise territorial
authority to achieve significant regulatory control over cyberspace transactions."); Dan
Hunter, Cyberspace as Place and the Tragedy of the Digital Anticommons, 91 CAL. L. REV. 439
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avoidance of concrete examples by local social policies, such as those
restricting gambling and pornography, has highlighted the tensions
between state and federal systems.2 The issues surrounding interstate
Internet traffic have not been lost on those commenting on the growth of
telemedicine and other forms of technologically-mediated care. °
The uneasy, or perhaps fragile, federalism that regulates the online
health domain is largely a function of the historical divide between federal
and state regulation of healthcare. After Dent v. West Virginia3 0 ' established
the legitimacy and primacy of state regulation of health professionals and
the passage of the FDCA by Congress,302 the stage was set for dichotomized
regulation of approval and distribution. The escalating regulatory
landscape at both federal3 3  and state3 0 4 levels has managed to
simultaneously blur and confirm this dichotomy. Such a patchwork of
regulation of the largest industry in the United States ° is both inefficient
and strained in the face of a developing market for interstate,
technologically mediated care.
1. Inconsistencies and Inefficiencies
Federal and state health policies and regulations frequently seem
disharmonized and inconsistent. Health privacy is just one example. The
existing patchwork of state common law privacy and confidentiality rules
(2003); and Mark A. Lemley, Place and Cyberspace, 91 CAL. L. REV. 521 (2003).
299. See, e.g., Charles R. Topping, The Surf Is Up, but Who Owns the Beach?- Who Should
Regulate Commerce on the Internet?, 13 NOTRE DAMEJ.L. ETHICS & PUB. POL'Y 179 (1999); Stevie
A. Kish, Note, Betting on the Net: An Analysis of the Government's Role in Addressing Internet
Gambling, 51 FED. COMM. L.J. 449 (1999).
300. See, e.g., Ross D. Silverman, Regulating Medical Practice in the Cyber Age: Issues and
Challenges for State Medical Boards, 26 AM.J.L. & MED. 255 (2000); P. Greg Gulick, E-Health
and the Future of Medicine: The Economic, Legal, Regulatory, Cultural, and Organizational Obstacles
Facing Telemedicine and Cybermedicine Programs, 12 ALB. L.J. Sci. & TECH. 351 (2002).
301. See supra note 33 and accompanying text.
302. 21 U.S.C. § 355(a) (2000).
303. The federal regulatory framework includes the FDA, DEA, FFC, Centers for
Medicare and Medicaid Services (CMS), and an array of federal reporting, fraud, and abuse
laws.
304. Malpractice doctrine, privacy laws, state controlled substances law, as well as state
fraud and abuse laws make up the state regulatory framework.
305. In 2001, the U.S. bill for healthcare was $1.4 trillion (14.1 percent of GDP). See
American Health Care: Why So Costly?: Hearing Before the Subcomm. on Labor, Health and Human
Services, Education and Related Agencies of the Senate Appropriations Comm., 108th Cong. 6
(2003) (testimony of Karen Davis & Barbara S. Cooper, The Commonwealth Fund).
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were insufficient to promote consumer confidence in the growing national
health infrastructure. Yet, deficiencies in the resulting federal law cheated
the Centers for Medicare and Medicaid Services (CMS) out of the power to
create a truly comprehensive federal privacy system that superceded and
improved upon state privacy protections. As a result, the federal Privacy of
Individually Identifiable Health Information (PIHI) regulations made
under HIPAA featured what is sometimes called cooperative preemption,
which sets a federal floor that states may exceed.3 0 As flaws in the PIHI
regulations became more obvious and the Bush Administration reduced
federal requirements, the gap between the federal floor and the more
stringent state law became evident, and privacy advocates looked to the
states to carry the federal flag of reducing patient privacy costs externalized
by providers.
Such differences between state and federal law, coupled with interstate
inconsistencies, jeopardize efficient workings of national markets for
technologically-mediated healthcare. The FTC has expressed particular
interest in "state and local regulations, such as occupational licensing and
physical office requirements, that may have pro-consumer and pro-
competition goals, but that nevertheless may restrict the entry of new
Internet competitors or hamper their operations."30'8 One of the businesses
explicitly on the FTC radar is "Healthcare, Pharmaceuticals, and
Telemedicine."30 The agency has already weighed in on Connecticut's
attempts to regulate cross-border sales of replacement prescription contact
lenses. It found that requiring sellers of replacement contact lenses to
obtain Connecticut optician and optical licenses would harm the public
health by increasing costs. Those increased costs would in turn result in
people replacing their contacts less frequently than recommended' 0
Similarly, in its report on online interstate sales of wine, the FTC
306. 45 C.F.R. §§ 160.201-.205 (2003).
307. An example is removing any requirements of consent for data used for TPO
purposes. Id. § 164.506.
308. Hearing Before the Subcomm. on Commerce, Trade, and Consumer Protection of the House
Comm. on Energy and Commerce, 107th Cong. (2002) (prepared statement of Ted Cruz,
Director of the Office of Policy Planning, Federal Trade Commission); see Virginia Postnel,
A Look at Wine Sales over the Internet Shows the Price of Some Regulations in the Name of Consumer
Protection, N.Y. TIMES, July 17, 2003, at C2.
309. Id.
310. In Re: Declaratory Ruling Proceeding on the Interpretation and Applicability of
Various Statutes and Regulations Concerning the Sale of Contact Lenses, Comments of the




concluded that "consumers could reap significant benefits if they had the
option of purchasing wine online from out-of-state sources and having it
shipped directly to them. Consumers could save money, choose from a
much greater variety of wines, and enjoy the convenience of home
delivery.0 1 ' The agency also noted that where such bans have been
successfully challenged "states appear to have found means of satisfying
their tax and other regulatory goals that are less restrictive than an
outright ban."312
From questions posed by the agency to prescribing and dispensing
stakeholders, it seems clear that the FTC is attempting to assess the degree
to which medical licensure laws have chilled interstate drug traffic.3 1 3 What
remains to be seen is whether the Commission can be persuaded of the
benefits of online healthcare and the importance of a national e-health
market, or if states can achieve their public health policies associated with
pharmaceutical distribution with regulation that is less restrictive than
framed local licensure.
2. The Specter of the Dormant Commerce Clause
This picture of uneasy federalism in the United States exists beyond
political and economic domains. State regulation that discriminates
between intrastate and interstate e-health scenarios may face constitutional
challenge. 4 The Commerce Clause that gives Congress the power to
regulate commerce "among the several States, 3 5 not only grants interstate
powers to Congress but also has a "dormant" or "reverse" aspect that limits
the power of the states to regulate interstate commerce. 31 6 No court has
311. FED. TRADE COMM'N, POSSIBLE ANTICOMPETITIVE BARRIERS TO E-COMMERCE: WINE 4
(2003), http://www.ftc.gov/os/2003/07/winereport2.pdf.
312. Id.
313. FED. TRADE COMM'N, PUBLIC WORKSHOP: POSSIBLE ANTICOMPETITIVE EFFECTS TO
RESTRICT COMPETITION ON THE INTERNET, FOURTH SESSION-TELEMEDICINE AND ONLINE
PHARMACEUTICAL SALES 593-664 (2002) [hereinafter PUBLIC WORKSHOP],
http://www.ftc.gov/opp/ecommerce/anticompetitive/02 O1O9antitrans.pdf.
314. In addition to the Commerce Clause arguments discussed in this Section a clumsily-
worded state law could infringe the Privileges and Immunities Clause if it insisted on, for
example, the residence of a physician in the state as a condition of licensure. See supra note
40.
315. U.S. CONST. art. I, § 8, cl. 3.
316. See, e.g., Oregon Waste Sys. v. Dep't of Envtl. Quality, 511 U.S. 93 (1994); Dennis v.
Higgins, 498 U.S. 439, 447 (1991); Passenger Cases, 48 U.S. (7 How.) 283 (1849); Willson v.
Black Bird Creek Marsh Co., 27 U.S. (2 Pet.) 245 (1829). The court in Kassel v. Consolidated
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considered the constitutionality of state statutes that seek to regulate
Internet prescribing or dispensing.317 Notwithstanding recent judicial
approval of state spam regulation,318 decisions striking down state laws
regulating interstate e-commerce in wine 3 9 and protected speech 320 suggest
that overreaching legislative activity affecting cross-border prescribing or
dispensing could face serious constitutional challenge.
While the possibility of a dormant commerce clause challenge is easy
to state, the resolution of such a challenge is far more difficult to predict.
First, modern scholarship has identified judicial overreaching in the early
e-commerce cases, particularly in cases that rely on "chilling" or
"inconsistent regulation" analysis.32' Second, dormant commerce clause
jurisprudence is replete with deferential references to "state legislation in
the field of safety where the propriety of local regulation has long been
recognized. 3 22 Third, there is a threshold question, related to the second
Frieghtways Corp. stated that "[t] he Clause requires that some aspects of trade generally must
remain free from interference by the States. When a State ventures excessively into the
regulation of these aspects of commerce, it 'trespasses upon national interests' ... and the
courts will hold the state regulation invalid under the Clause alone." 450 U.S. 662, 669
(1981) (internal citations omitted).
317. Cf Nat'l Pharms. v. Feliciano-de-Melecio, 221 F.3d 235 (lst Cir. 2000) (interpreting
a Puerto Rican pharmacy statute as not applying to mail-order pharmacies based outside of
Puerto Rico and therefore not reaching the constitutional issues). Pre-Internet cases are
discussed below. See infra text accompanying note 331-336.
318. See, e.g., Ferguson v. Friendfinders, Inc., 115 Cal. Rptr. 2d 258 (Ct. App. 2002)
(holding that a statute governing unsolicited commercial e-mail does not unconstitutionally
burden interstate commerce).
319. See, e.g., Dickerson v. Bailey, 212 F. Supp. 2d 673 (S.D. Tex. 2002) (holding that
Texas Alcoholic Beverage Code that allowed consumers to purchase wines from Texas
wineries and to have the wines shipped to their homes, but expressly prohibited such
activity as to out-of-state wineries, violated the dormant Commerce Clause); see also Heald v.
Engler, 342 F.3d 517 (6th Cir. 2003); Bolick v. Danielson, 330 F.3d 274 (4th Cir. 2003);
Beskind v. Easley, 325 F.3d 506 (4th Cir. 2003); Swedenburg v. Kelly, 232 F. Supp. 2d 135
(S.D.N.Y. 2002).
320. See, e.g., Am. Booksellers Found. for Free Expression v. Dean, 202 F. Supp. 2d 300
(D. Vt. 2002).
321. Goldsmith & Sykes, Dormant Commerce Clause, supra note 221; see alsoJames E.
Gaylord, Note, State Regulatory Jurisdiction and the Internet: Letting the Dormant Commerce Clause
Lie, 52 VAND. L. REv. 1095 (1999).
322. Pike v. Bruce Church, Inc., 397 U.S. 137, 143 (1970) (citing S. Pac. Co. v. Arizona,
325 U.S. 761, 796 (Douglas, J., dissenting)). But see Kassel v. Consolidated Freightways
Corp., 450 U.S. 662, 670 (1981) ("[T he incantation of a purpose to promote the public
health or safety does not insulate a state law from Commerce Clause attack. Regulations
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reservation, as to whether commerce clause analysis appropriately applies
to dangerous or impure goods or services that clearly will be the targets of
some state Internet prescribing and dispensing regulation. 2 3 Fourth, in
challenges to state prescribing and dispensing regulation, the courts will
likely attempt to avoid the constitutional question by first attempting to
interpret the suspect state law as having only intrastate effects.
3 24
Traditionally explained, dormant commerce clause analysis
distinguishes between state regulation that impinges on cross-border
commerce and regulation that facially discriminates between interstate and
intrastate commerce. The former is assessed under a balancing test,325 while• 3 2 6
the latter is assessed under strict scrutiny. Therefore, the first challenge is
to identify the correct test for the various types of Internet prescribing and
dispensing regulation that may be confronted. The majority of state e-
health law is not facially discriminatory. This seems to be the case with state
laws that require physicians who are engaged in the "practice of medicine"
within the state to be licensed or to have telemedicine practice certificates.
In such cases, the out-of-state physician resisting such "foreign" regulation
presumably would have to argue that the state requirement of licensure
impinges on cross-border commerce. If the state law contains granular
consent requirements, the argument could be extended to allege
inconsistent regulation premised on multiple state laws requiring, for
designed for that salutary purpose nevertheless may further the purpose so marginally, and
interfere with commerce so substantially, as to be invalid under the Commerce Clause.").
323. Pike, 397 U.S. at 143; see also Sligh v. Kirkwood, 237 U.S. 52, 59-60 (1915).
324. See, e.g., Nat'l Pharms. v. De Melecio, 221 F.3d 235 (1st Cir. 2000). A direct-indirect
burdens test may also be used. "Occasionally the Court has candidly undertaken a
balancing approach in resolving these issues, but more frequently it has spoken in terms of
"'direct"' and "'indirect"' effects and burdens." Pike, 397 U.S. at 142 (internal citations
omitted).
325. In Pike, the court noted:
Although the criteria for determining the validity of state statutes affecting
interstate commerce have been variously stated, the general rule that emerges
can be phrased as follows: Where the statute regulates even-handedly to
effectuate a legitimate local public interest, and its effects on interstate
commerce are only incidental, it will be upheld unless the burden imposed on
such commerce is clearly excessive in relation to the putative local benefits. If a
legitimate local purpose is found, then the question becomes one of degree. And
the ,fxtent of the burden that will be tolerated will of course depend on the.
nature of the local interest involved, and on whether it could be promoted as well
with a lesser impact on interstate activities.
Id. at 142 (internal citation omitted).
326. Kassel v. Consol. Freightways Corp., 450 U.S. 662 (1981).
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example, different consent specifics. Applying a balancing analysis,
including deference to state public health interests, and assuming that the
state would argue that the physician or pharmacist was capable of
identifying the residence of the patient, it would be a brave court that
would strike down such local regulation on Commerce Clause grounds.327
In contrast, strict scrutiny could well apply to state regulations that
differentiate between intrastate and interstate activities. For example,
Montana applies its telemedicine-specific regulation only to interstate
exchanges between physician and patient,3 8 and West Virginia defines the
"practice of telemedicine" as diagnosis or treatment by out-of-state
S •• 329
physicians, while several states now require their local pharmacists to
reject or further investigate (and hence chill the market in) Internet (and
typically interstate) prescriptions.3 '
Pre-Internet bricks-and-mortar and mail order decisions contribute
little to the analysis. However, in State v. Rasmussen,33 ' an Iowa pharmacy
challenged a state law that made it unlawful for the pharmacy to dispense
prescriptions written by out-of-state physicians who were not licensed in
Iowa. The court rejected strict scrutiny because the "Iowa statute does not
discriminate in its language between foreign practitioners and those
registered in Iowa-all are required to register under the provisions of the
Iowa Act in order to dispense drugs in Iowa. 3 3 2 Due to its indirect
protectionist effects, the court still viewed the regulation as constitutionally
infirm under a balancing test.333 Given that the state-federal regulatory mix
was more sophisticated and structured than anything seen to date in the Internet
prescribing or dispensing domains (the Iowa statute was passed pursuant to the
Uniform Controlled Substances Act3 '4 and synchronized with the federal
Comprehensive Drug Abuse Prevention and Control Act of 1970335 implicitly
327. See Tenn. Op. Atty. Gen. No. 98-202, 1998 WL 851333 (Oct. 28, 1998). An
alternative set of arguments could apply in the case of a First Amendment argument. See
generally Gaylord, supra note 321.
328. MONT. CODE ANN. § 37-3-342 (2003).
329. W. VA. CODEANN. § 30-3-13 (Michie 2002).
330. CAL. Bus. & PROF. CODE § 2242.1(b) (West 2003); TEX. ADMIN. CODE §§ 291.34,
291.36 (West 2004).
331. 213 N.W.2d 661 (Iowa 1973).
332. Id. at 667.
333. Id. at 667-68; cf Nichols v. Bd. of Pharm., 657 P.2d 216 (Or. Ct. App. 1983) (holding
that an Oregon statute which permitted pharmacies to fill only prescriptions written by
practitioners licensed only in Oregon was not in "positive conflict" with federal law).
334. UNIFORM CONTROLLED SUBSTANCEs AcT (1994).
335. 21 U.S.C. § 801(a) (2000).
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reducing the role of state-based regulation of interstate activities), some might
argue that a limited reading of Rasmussen is appropriate. Nonetheless,
Rasmussen is familiar to state attorneys general and clearly informs some
conservative opinions warning state legislatures to stay clear of protectionist
policies or interstate regulation.
3
36
B. The Failure of Self-Regulation
Various types of self or private regulation have been promoted as a
solution to emerging issues in technologically-mediated care. This is
consistent with the broader world of Internet interaction and e-commerce.
There, the call for self-regulation has been a product of: 1) utopian views
of how cyberspace regulation should be disconnected from traditional
regulation;' 2) a desire not to impede e-commerce with extensive
governmental regulation; and 3) a reflection of the general lack of
preparedness of traditional regulatory standards and agencies to deal with
Internet phenomena. In the health arena, self-regulation is of particular
significance because of the historical impact of American Medical
Association (AMA) ethical standards and, more narrowly, because of the
frequently praised VIPPS accreditation system.
Four types of self-regulatory systems have demonstrated traction in the
e-health domain. The first system is purely aspirational: a code of conduct
promulgated by some group, often a not-for-profit organization, with a
hope of voluntary compliance.339 Obviously, codes that are promulgated by
important stakeholders or that reach a critical mass of adopters tend to be
more effective in catching the attention of consumers and attracting
further adopters. Typically, compliance is voluntary and not policed. The
second system is one that signifies participation in the self-regulatory
process by making available a "kitemark" or "trustmark. 3 40 Such a scheme
336. See, e.g., Tex. Atty. Gen. Op. JM-555, 1986 WL 219401.
337. As Dan Hunter puts it, "[T]he received wisdom has confused the descriptive
question of whether we think of cyberspace as a place with the normative question of
whether we should regulate cyberspace as a regime independent of national laws." Hunter,
supra note 298, at 443.
338. For more information on the accreditation system, see VIPPS, at
http://www.nabp.net/vipps/ (last visited Apr. 17, 2004).
339. See, e.g., eHealth Code of Ethics, Internet Healthcare Coalition, at
http://www.ihealthcoalition.org/ethics/ehcode.html (last visited Apr. 17, 2004); Hi-Ethics
Ethical Principles For Offering Internet Health Services to Consumers, Hi-Ethics, at
http://www.hiethics.org/Principles/index.asp (Apr. 17, 2004).
340. See, e.g., The Health on the Net Foundation (HonCode), at http://www.hon.ch (last
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assumes the existence of a rudimentary code authority that owns the
intellectual property in the trustmark and, at least in theory, will act to stop
fraudulent use of the trustmark or its continued use by those out of code
compliance. Along with the simpler code model, it is primarily dependent
upon self-rating and, as the number of adopters grows, the likelihood of
non-compliance will increase. 34
The third type of system is a variant of the second, except that it is not
wholly dependent upon self-rating. The scheme uses either a centralized or
peer (de-centralized) system that applies (or checks the application of) the
code's quality criteria .34 It is not necessarily self-regulatory or voluntary in
that the rating authority may apply quality criteria regardless of the
content owner's wishes, a characteristic that is itself the source of potential
legal problems. 4 The fourth type of system is a code that operates
conterminously with an existing membership or ethically-constraining
system, such as when a medical society issues guidelines for how its
membership might navigate particular web or email issues.344
Some codes of conduct that associate membership or compliance with
a data object (such as a trustmark or an Internet domain such as
dot.health) attempt to increase their robustness and penetration by
leveraging web technologies. Again, there are several models. For example,
a trustmark system whose data object complies with the Platform for
visited Apr. 17, 2004); Truste, eHealth Privacy Seal Program, at
http://www.truste.org/programs/pub-ehealth.html (last visited Apr. 17, 2004).
341. There are two reasons for this decline in compliance: First, the larger the number of
adopters the higher are the costs of discovering non-compliance; second, as the number of
adopters grows so more marginal players will be attracted to the model because the
trustmark will have increasing market-access or marketing value.
342. See, e.g., About MedCIRCLE, MedCIRCLE, at
http://www.medcircle.org/about.php?lanxid=641562d82ald56a797812c7fOdfabb2d (last
visited Apr. 17, 2004).
343. See generally Nicolas P. Terry, Rating the "Raters": Legal Exposure of Trustmark Authorities
in the Context of Consumer Health Informatics, at 2 J. MED. INTERNET RES. e 18 (2000), available at
http://www.jmir.org/2000/3/e18/.
344. See, e.g., AM. MED. ASS'N, ETHICAL GUIDELINES FOR THE USE OF ELECTRONIC MAIL
BETWEEN PATIENTS AND PHYSICIANS (CEJA Report 3-1-02, 2002) [hereinafter A. MED. ASS'N,
ETHICAL GUIDELINES], http://www.ama-
assn.org/amal/pub/upload/mm/369/ceja-report_3iO2.pdf; Press Release, Am. Med.
Ass'n, AMA Adopts New Guidelines To Help Physicians Ensure Safe and Secure Internet




Internet Content (PICS) specifications 45 could leverage "downstream
filtering, ''S 4b allowing a patient to use browser or third party software to rate
or exclude content by reference to the data object 47 A second type is
"upstream filtering," which is more likely to leverage a distinct "top-level
domain" (TLD) , 8 a system favored by the World Health Organization. 9
Assume, for example, that only certain health content providers (e.g.,
professional bodies or peer-reviewed sites) would be granted a dot.health
TLD name. Then web directories could list them separately or search
engines could prioritize them in search results. A third type of technology
layer added to self-regulatory systems may be described as closed-loop
verification. Most trustmark systems allow or compel the trustmark user to
"link" the trustmark: Rudimentary systems link back to the trustmark
authority's principles or code of conduct. More sophisticated systems,
however, close the loop by linking to a specific page on the trustmark
authority's site that verifies the good standing of the trustmark user. Such
an interlinking model decreases fraudulent use of the trustmark and
encourages code compliance by facilitating consumer feedback to the
trustmark authority.
1. Content Regulation
The integrity and reliability of Internet health information has been of
acute concern to the medical profession, 35' although patients seem to be
345. PICS is a specification frequently used in filtering applications and allows labels to
be associated with specific internet content.
346. Filtering generally will likely become more common on the web following the
Supreme Court's opinion in United States. v. Am. Library Ass'n, Inc., 123 S. Ct. 2297 (2003)
(upholding Children's Internet Protection Act that conditioned federal assistance of public
libraries on the installation of filtering software to block obscene or pornographic images).
347. See, e.g., MedCIRCLE, at http://www.medcircle.org/ (last visited Apr. 17, 2004).
348. See ICANN, at http://www.icann.org/tlds/ (last visited Apr. 17, 2004).
349. TLD Applicationfor. health, ICANN, at http://www.icann.org/tlds/healthl / (last
visited Apr. 17, 2004). The WHO's initial application was denied, but is being renewed. See
Domain Firms Get Second Shot at ICANN Approval, COMPUTERWIRE, June 25, 2003.
350. See, e.g., healthAtoZ, at http://www.healthatoz.com/ (last visited Apr. 17, 2004)
(linking to its HONCode verification page at
http://www.hon.ch/HONcode/Conduct.html?HONConduct386169).
351. See Site Reading Physicians Grapple with Recommending Web Sites, AMNews, at
http://www.ama-assn.org/sci-pubs/amnews/pickOO/tesalO23.htm (Oct. 23/30, 2000); see
also Berland et al., Health Information on the Internet: Accessibility, Quality, and Readability in
English and Spanish, 285JAMA 2612 (2001); KM Griffiths & H. Helen Christensen, Quality of
Web Based Information on Treatment of Depression: Cross Sectional Survey, 321 BRT. MED.J. 1511
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more accepting of the medium's flaws. 2 The pursuit of Internet content
quality assurance exists in something of a legal vacuum. Public law
intervention tends to be limited to obviously dangerous health content
where government agencies 353 can apply their traditional consumer
protection, drug regulation, and fraud powers. '4 More robust public law
regulation or private litigation is likely to conflict with guarantees of free
speech.3 5 Several well-known codes of conduct have sought to fill this
vacuum. 35 6 Specifically, the European Commission has endorsed this
approach by publishing its own "Quality Criteria for Health Related
Websites. ''35
In the area of medical web content, the focus of self-regulatory systems
has been to strengthen the role of the market by reducing the patient's
information costs regarding the integrity and reliability of health
information on the web. Such improvements could positively influence the
growth of, and regulatory attitudes towards, Internet prescribing and
dispensing because prescribing sites tend to contain medical and health
information and content sites frequently link to prescribing or fulfillment
sites.
Unfortunately, the self-regulatory content system is dangerously
flawed. Trustmarks are easily copied and pasted into non-compliant sites
with the link back to the trustmark authority conveniently omitted.
Content and prescribing sites also use counterfeit trustmarks that resemble
well-known trustmarks. There are also no constraints on who can create a
(2000), http://www.bmj.com/cgi/content/full/321/7275/1511.
352. Cyberchondriacs Continue To Grow in America, HEALTH CARE NEWS, May 8, 2002,
http://www.harrisinteracfive.com/news/newsletters/healthnews/HI_HealthCareNews202
Vol2_IssO9.pdf. According to a Harris Interactive survey in 2000, fifty-six percent of
respondents were of the opinion that the Internet helped them gain an understanding of
their health problems; this compares to seventy-three percent in the 1999 survey. There
were also declines in how patients viewed the Internet as helping them manage their
personal healthcare overall (sixty percent down to forty-one percent) and communicate
with their doctor (fifty-one percent down to twenty-nine percent).
353. See, e.g., Press Release, Fed. Trade Comm'n, Eli Lilly Settles FTC Charges
Concerning Security Breach (Jan. 18, 2002), http://www.ftc.gov/opa/2002/01/elililly.htm.
354. See supra notes 235-242 and accompanying text.
355. See Nicolas P. Terry, Cyber-Malpractice: Legal Exposure for Cybermedicine, 25 AM.J.L. &
MED. 327 (1999).
356. See supra notes 339-340.
357. Quality Criteria for Health Related Websites, Information Society, at
http://europa.eu.int/information-society/eeurope/ehealth/quality/draft-guidelines/ind
exen.htm (last visited Apr. 17, 2004).
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self-regulatory or trustmark system. For example, the Council for
Responsible Telemedicine (CRT) 36  was formed by three Internet
prescribing companies that have been involved in several regulatory
skirmishes with state boards. The AMA was less than impressed by the
CRT's position on supplying lifestyle drugs: Even assuming that a
trustmark is valid and that users accurately self-rate themselves, the sheer
shallowness of most self-regulatory standards creates concern.3 0 Overall, it
is arguable that all benefits to patients from self-regulatory codes are
outweighed by the risks of overconfidence generated by valid trustmarks or
outright fraud from the counterfeit ones.
One system that has the potential to counter this negative conclusion
is the Health Web Site Accreditation Program instituted by the Utilization
Review Accredidation Commission (URAC) .36 There are several reasons
for this optimism: the URAC standards are robust;362 an accreditation
model is substituted for suspect self-rating or unfunded and impractical
external review; trustmark posting is subject to closed-loop verification;
and URAC offers sophisticated downstream filtering via an external search
S 363
engine.
2. The Physician-Patient Relationship
As already noted, there has been considerable professional angst about
the legal and ethical issues surrounding electronic communicationsbetw en p ysic ans nd 364
between physicians and patients. The most authoritative discussion of
this issue has been the guidelines issued by the American Medical
358. Council for Responsible Telemedicine, at
http://www.councilforresponsibletelemedicine.org/ (last visited Apr. 17, 2004).
359. Questions Linger over Group's "Responsible" Prescribing, AMNews, at http://www.ama-
assn.org/sci-pubs/amnews/pick02/biscl014.htm (Oct. 14, 2002).
360. See, e.g., HON Code of Conduct (HONcode) for Medical and Health Web Sites, Health on
the Net Foundation, at http://www.hon.ch/HONcode/Conduct.htmI (last visited Apr. 17,
2004).
361. URAC, at http://webapps.urac.org/websiteaccreditation/default.htm (last visited
Apr. 17, 2004). URAC is also known as the American Accreditation HealthCare
Commission.
362. Health Web Site Standards, URAC, at
http://webapps.urac.org/websiteaccreditation/Portal/Business/Docs/web%20site%2stds
%20vl-0.doc (last visited Apr. 17, 2004).
363. VitalSeek, at http://www.vitalseek.com/ (last visited Apr. 17, 2004).
364. See supra notes 254-267 and accompanying text.
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365Informatics Association. As with the more recent amendments to the
AMA Ethics Policy, 36 these guidelines assume an existing physician-patient
relationship. The AMA policy seems even more restrictive, asserting that
"[e]-mail correspondence should not be used to establish a patient-
physician relationship. Rather, e-mail should supplement other, more
personal, encounters."
368
That idea of enhancing an existing relationship, coupled with a firm
belief that interpersonal interaction is at the core of the patient-physician
relationship, has dominated the way the AMA has addressed online
medicine. In the process, it has taken a position that has been consistently
hostile to Internet prescribing and dispensing. For example, an AMA
policy pledges that the organization will "work with state medical societies
in urging state medical boards to ensure high quality medical care by
investigating and, when appropriate, taking necessary action against
physicians who fail to meet the local standards of medical care when
issuing prescriptions through Internet web sites that dispense prescription
medications., 369 That same policy pledges to "work with federal and state
regulatory bodies to close down Internet web sites of companies that are
illegally promoting and distributing (selling) prescription drug products in
the United States.,
370
This approach was reiterated and expanded upon by AMA guidelines
issued in 2003 that deal specifically with Internet prescribing. The
Guidance for Physicians on Internet Prescribing endorses requiring
licensure in the patient's state of residence.37 ' Further, it reiterates the
AMA's position that an existing physician-patient relationship and a
physical examination are prerequisites for online prescribing.72 In
365. See supra note 261.
366. AM. MED. ASS'N, ETHIcAL GUIDELINES, supra note 344.
367. However, the American Medical Informatics Association's (AMIA) guidelines use
the more ambiguous term "contractual relationship." See supra note 261.
368. CEJA REPORT, supra note 344, at para. 1.





370. Id. at H-120.956(6).
371. AM. MED. ASS'N, GUIDANCE FOR PHYSICIANS ON INTERNET PRESCRIBING (Resolution 518,
A-02, 2003), http://www.ama-assn.org/amal /upload/mm/annualO3/bot7aO3.doc; see also
AMA Adopts, supra note 344.
372. AMA Adopts, supra note 344. The release states:
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commentary, the guidelines state that "[w] eb sites that offer a prescription
solely on the basis of an online questionnaire (or online consultation) with
no other interaction between the physician and patient are insufficient."3 73
This type of regulation is typical of a code model that operates
conterminously with a closed professional system. It is noticeably
conservative and uncompromising in the hard position it takes towards
online prescribing.
3. Pharmacy Regulation and VIPPS
The National Association of Boards of Pharmacy (NABP) has been no
less hostile to Internet dispensing, but it has shown more interest in
leveraging web technology to decrease patient information costs. Its well-
known response to Internet dispensing and fulfillment is the Verified
Internet Pharmacy Practice Sites, or "VIPPS," program. 374 VIPPS is a code
model that operates conterminously with the closed system of multi-state
pharmacy licensure. Indeed, one state allows its Internet pharmacies to
choose whether to display its state permit number or VIPPS trustmark.373
VIPPS resembles an accreditation model, charging participants a fee and
performing on-site physical inspection, complaint investigation, and
periodic re-inspections. 6 Its trustmark uses closed-loop verification to
reduce fraud.
David Brushwood has argued that "[p]romotion of the VIPPS program
is the best assurance regulators can provide to the public that individual
Physicians who prescribe medications via the Internet shall establish, or have
established, a valid patient-physician relationship, including, but not limited to,
the following components. The physician shall: obtain a reliable medical history
and perform a physical examination of the patient, adequate to establish the
diagnosis for which the drug is being prescribed and to identify underlying
conditions and/or contraindications to the treatment recommended/provided;
have sufficient dialogue with the patient regarding treatment options and the
risks and benefits of treatment(s); as appropriate, follow up with the patient to
assess the therapeutic outcome; maintain a contemporaneous medical record
that is readily available to the patient and, subject to the patient's consent, to his
or her other health care professionals; and include the electronic prescription
information as part of the patient medical record.
Id.
373. Id.
374. VIPPS, at http://www.nabp.net/vipps/intro.asp (last visited Apr. 17, 2004).
375. ARK. CODE ANN. § 17-92-1005(4) (Michie 2002) (requiring Internet pharmacies to
clearly display their state permit number or VIPPS seal on their internet site).
376. VIPPS® Certification Process, at http://www.nabp.net/vipps/pharmacy/intro.asp
(last visited Apr. 17, 2004).
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Internet pharmacy users are being protected by the professionalism that
state-licensed pharmacists offer through their oversight of the medication
use process. '' 17 While it is correct that VIPPS certification tells us
something positive about the few accredited pharmacies, its absence tells
us little about the level of risk that the consumer might expect when the
pharmacy is not accredited. 7 Thus, VIPPS tends to confirm the status quo
without substantially aiding patients who choose to operate outside of the
traditional dispensing paradigm.
VIPPS has accredited relatively few sites.379 VIPPS's apparent
requirement of licensure in the patient's state of residence means that, as
presently constituted, it is not a solution to the Internet dispensing
conundrum, as evidenced by the chilly reception given by Canadian
Internet pharmacies towards proposals to extend the program north of the
border.80
C. Under-regulation: Patient Incurred Costs
The goal of medical and pharmacy licensure systems is to promote
provider quality and patient safety. In practice, however, the state board
processes tend to concentrate on the more inter-personal aspects of the
physician-patient relationship, and when quality is addressed, it is done
retrospectively.32 The healthcare system continues to externalize most of
its quality and safety risks to patients. This is exacerbated in the areas of
Internet prescribing and dispensing, in which regulators concentrate on
the method of providing services: technology, questionnaire prescribing,
and importation. In practice, patients seeking online care face
considerable privacy and quality risks. In Internet prescribing and
377. Brushwood, supra note 268, at 102-03.
378. An absolutist would argue that absent accreditation, the risk is too high. A relativist
interested in the market determining the better or safer online unaccredited pharmacists
would need more than a null response.
379. See VIPPS Database Search Results, at http://www.nabp.net/vipps/consumer/listall.asp
(last visited Apr. 17, 2004).
380. See, e.g., Carl Bialik, U.S., Canada Pharmacy Groups Seek To Deter Exporting of Drugs,
WALL ST.J., Nov. 13, 2002, at D3.
381. 1 AVEDIS DONABEDIAN, THE DEFINITION OF QUALITY AND APPROACHES TO ITS
ASSESSMENT 4 (1980) ("Technical care is the application of the science and technology of
medicine, and of the other health sciences, to the management of a personal health
problem. Its accompaniment is the management of the social and psychological interaction
between client and practitioner.").
382. See Leape, supra note 220.
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dispensing, these risks are undervalued and under-regulated.
1. The Privacy Externality
As with other information domains, technology has dramatically
changed the way patient health data is acquired, stored, aggregated,
processed, accessed, and distributed. Additionally, there are inherent
tensions in the health information domain between the key stakeholders
and their needs: government access and security for public health;
38 3
healthcare institutions' access for quality assurance and marketing; and
patient interests in confidentiality, privacy, and anonymity.
384
Few pieces of legislation or regulation in contemporary healthcare law
have been as controversial as the privacy385 and security386 regulations
promulgated under HIPAA 8 7 Designed to force providers to internalize
privacy and security risks associated with technologically-mediated care,
record-keeping, and billing, the HIPAA regulations are primarily
applicable to bricks-and-mortar care providers. 8 Technical limitations in
the HIPAA statute were primarily responsible for this limitation,388 though
it is also the case that, principally, the regulations were drafted prior to the
explosive growth of Internet prescribing and dispensing. Conceptually, the
PIHI standards, as they exist today, are similar to, but not co-extensive with,
the statutory controls that exist in a small minority of U.S. states,3 0 and the
383. See, e.g., Senate Blocks Privacy Project, N.Y. TIMES, Jan. 24, 2003, at A3 (reporting U.S.
Senate vote against Pentagon project to search for terrorists by scanning information in
Internet mail and, inter alia, databases of health companies).
384. See generally Nicolas P. Terry, Privacy and the Health Information Domain: Properties,
Models and Unintended Results, 10 EUR.J. HEALTH L. 223, 223-27 (2003).
385. Privacy Standards (Privacy of Individually Identifiable Health Information or PIHI),
Final Rule, 67 Fed. Reg. 53182 (Aug. 14, 2002) (to be codified at 45 C.F.R. pts. 160, 164).
386. Security Standards Final Rule, 68 Fed. Reg. 8334 (Feb. 20, 2003) (to be codified at
45 C.F.R. pts. 160, 162, 164).
387. See supra note 207.
388. See generally ANGELA CHOY ET AL., HEALTH PRIVACY PROJECT, EXPOSED ONLINE: WHY
THE NEW FEDERAL HEALTH PRIvACY REGULATION DOESN'T OFFER MUCH PROTECTION TO
INTERNET USERS (2001),
http://www.healthprivacy.org/usrdoc/PIPHPP HealthPriv report.pdf; Press Release,
Pew Internet & American Life Project, Federal Health Privacy Regulation Does Not Cover
Most Internet Medical Searches, Services, or Purchases (Nov. 19, 2001),
http://www.pewinternet.org/releases/release.asp?id=33.
389. The limited definition of "covered entity" in the federal regulations is one example.
45C.F.R. § 160.103 (1982).
390. See, e.g., CAL. Clv. CODE § 56.10 (1982); see also UNIFORM HEALTH CARE INFORMATION
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federal rules do not preempt more rigorous state patient privacy
protections.
Patients who go online for medical care or prescriptions are poorly
served by PIHI or PIHI-like3 91 regulations. Such regulations are usually
described as protecting patient privacy. In fact, it is more accurate to
describe them as disclosure-centric rules that protect patient confidentiality.
Confidentiality places limits on disclosure, while privacy, much like
anonymity,392 is functionally an antecedent to confidentiality, limiting data
collection. Federal and state "privacy" rules generally fail to protect against
the collection of patient data or frustrate its collection with anonymity
rights.393 True health privacy protection is, in most U.S. jurisdictions,
limited to older common law rules that are limited and lack generalized
robustness. They tend to be nominate and discrete rules rather than
applications of any general privacy principle.
394
Amongst those who provide online care, traditional telemedicine
practitioners are likely to be PIHI-covered entities.39" As a result they will be
over-regulated when they also fall under revised telemedicine statutes that
require specific disclosures or protections relating to privacy and
security.396 In contrast, non-traditional providers, such as those engaged in
Internet prescribing and dispensing (larger e-pharmacies and PBMs aside),
generally are not covered by disclosure-centric regulation. Thus, they tend
to be under-regulated. Privacy regulation affecting this latter group
generally will be limited to scenarios where the business has published a
privacy policy that it then breaches.39'
ACT, PROPOSED REVISIONS (2000), http://www.law.upenn.edu/bll/ulc/uhcia/hci06OO.pdf.
391. Even in states with relatively strong privacy protection. See, e.g., CAL. CIV. CODE § 56-
56.37 (1982); MONT. CODE ANN. §§ 50-16-501 to 50-6-504 (2003); R.I. GEN. LAwS § 5-37-22
(2004); WASH. REV. CODE §§ 70.02.005 to 70.02.904 (2002); Wis. STAT. §§ 146.83, 610.70(3)
(1997).
392. Anonymity enhances privacy by frustrating the collection of personal identifiers.
393. See Terry, supra note 384, at 223-37.
394. RESTATEMENT (SECOND) OF TORTS § 652A(2); see, e.g., Knight v. Penobscot Bay Med.
Ctr., 420 A.2d 915 (Me. 1980) (involving doctor taking photographs of dying cancer
patient); Berthiaume v. Pratt, 365 A.2d 792 (Me. 1976) (finding that where nurse's husband
watched plaintiffs wife's delivery the claim failed on the facts because there was no proof of
intentional intrusion).
395. See supra note 389 and accompanying text.
396. See supra notes 85-86 and accompanying text.
397. See, e.g., Press Release, Fed. Trade Comm'n, supra note 353.
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2. The Error/Risk Externality
Patient utilization and enthusiasm for all aspects of online care
continue to increase 398 despite considerable skepticism from the medical
profession as to its quality. 399 Indeed, there are signs that patients who
search for advice are cognizant of declining quality,400 although not
particularly troubled by that phenomenon.4u Clearly, however, patients
using online care (e.g., advice sites, email contact with physicians,
telemedicine, telehealth, or Internet prescribing and fulfillment) are
internalizing certain costs (risks) that are either not present or not as high
in traditional healthcare delivery.
In the Internet prescribing and fulfillment domains, these enhanced
risks include: 1) the identity and qualifications of the prescriber; 2) the
choice of drug; 3) the quality of the drug; 4) follow-up treatment or advice;
and 5) indeterminacy of recourse. °2 Internet users likely have some
awareness of the first of these risks, while those who opt for Internet
prescribing or dispensing services are likely to have already made the drug
choice. Non-traditional channels clearly do not offer the persistence of a
physician-patient or pharmacist-patient relationship that tends to
guarantee quality care. In the event of a problem with the drug, whether
because of fraud or error, recourse against an online provider will be
problematic.
It is extremely difficult to map out a constitutionally acceptable legal
strategy to control web content or advice4 03 in the absence of obviously
dangerous activities, products, or services." Not surprisingly, therefore,
considerable faith is placed in technological or self-regulatory solutions in
an attempt to reduce patient-incurred risks.
Many of the novel risks introduced by online care involve information
398. See supra note 352.
399. See supra note 351 and accompanying text.
400. See supra note 352.
401. Online Medical Advice Expands: Some Data Shaky, but Public Unfazed, MIAMI HERALD,
Jan. 05, 2003.
402. See generally C. Anderson, A Call for Internet Pharmacies To Comply with Quality
Standards, 12 QUALITY SAFETY HEALTH CARE 86 (2003) (discussing poor quality of consumer
information on Internet prescribing and dispensing sites (particularly drug interaction
information), out-of-date stock, and substitution).
403. See generally Nicolas P. Terry, Cyber-Malpractice: Legal Exposure for Cybermedicine, 25 AM.
J.L. & MED. 327 (1999); Nicolas P. Terry, A Transatlantic Perspective on Regulating Health
Information, 324 BRIT. MED.J. 602 (2002).
404. See supra notes 235-236 and accompanying text.
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costs incurred by patients. These include the quality-related risks such as
the identity and qualifications of the prescriber as discussed above.
Specifically, the cost-quality-access formula has different values in the
online context. The conventional health law tool for dealing with
information asymmetry or choice is informed consent. Case law has not yet
developed in this area, but as already noted,4 5 some state legislatures have
introduced enhanced consent provisions for some aspects of online care
that may affect prescribing or dispensing. These provisions, however, tend
to focus on warning of risks associated with Internet prescribing and
dispensing, or on the mechanics of telemedical services, such as security,
privacy, or other unarticulated "technology" risks that seem less conducive
to improving patient choice.
D. Over-regulation
There is no doubt that states, encouraged by federal regulators and
professional organizations, are attacking Internet prescribing and
dispensing with reformulated regulatory standards and renewed
enforcement vigor. Across the country, medical boards, assisted by
compliant attorneys general, are seeking injunctive relief against physicians
and pharmacists who stray into their states' web space. Some of this
regulation and enforcement is prophylactic. States are finding it easier to
use licensure regulation than prove the more difficult burdens associated
with, say, the mens rea component for illegal drug distribution or the
elements of consumer fraud.
The state boards and the AMA have articulated two primary objections
to Internet prescribing. First, it operates independent of a physician-
patient relationship, and second, drugs are prescribed in the absence of a
physical examination. These two features are deeply offensive to the
medical establishment's view of how healthcare is or should be delivered.
That paradigm is centered on an in-person office consultation between an
informed professional and compliant patient who are in a long-term
relationship. The physician performs a fact-finding inquiry, including a
physical examination, that informs the diagnosis and, where appropriate,
the writing of a prescription. The patient takes the prescription to a bricks-
and-mortar pharmacy or a VIPPS certified e-pharmacy, where an
additional layer of error-checking occurs and additional effects and
interaction information may be provided.
For some regulators, the absence of a physician-patient relationship or
405. See supra notes 77-83 and accompanying text.
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physical examination is little more than code for technophobia or a
conflation of normative objections to Internet prescribing with regulatory
language that best identifies its practitioners. Both of these traditional
indicators, however, have deeper constructs and cannot be lightly
dismissed.
The "physician-patient relationship" concept exists in three
overlapping domains: ethical, legal, and operational. As an ethical
construct, it is the foundation of competence, respect, and confidence.4 °6
In the legal domain, the existence of a "physician-patient relationship"
establishes the contractual responsibilities of the parties (such as service
and payment) and is the touchstone for legal duty, signifying that the
physician must internalize some of the patient's treatment risks.
0 7
In the Internet prescribing debate, the "physician-patient relationship"
is primarily used in its third operational sense where it is coterminous with
"continuity of care." Continuity of care has several components; the most
important of which are access to the patient's existing record (and the
correlate responsibility of adding to that record to minimize fragmentation
of patient data) and availability of follow-up care. Continuity also lowers
transaction costs, such as positively identifying the patient and matching
her to any ongoing treatment plan (replete with information about
possible drug interactions), while its sense of longevity may translate into a
more holistic therapeutic plan, rather than purely pharmaceutical
treatment. In contrast to this "continuity" model, Internet prescribing is
centered on an opportunistic physician-patient relationship, defined by a
single pharmaceutical transaction.
The concept of "physical examination" is also multi-layered. It too
reduces transactions costs by facilitating the positive identification of the
patient and makes it more likely that the white-coated person in the office
is actually a licensed physician. Therapeutically, a physical examination
may add to the quality of the diagnosis, and a face-to-face interaction may
406. See, e.g., Am. Med. Ass'n, Principles of Medical Ethics, June 2001, at http://www.ama-
assn.org/ama/pub/category/2512.html (last visited Apr. 17, 2004).
407. See, e.g., Sterling v. Johns Hopkins Hosp., 802 A.2d 440 (Md. 2002) (holding that a
hospital that accepted the transfer of a patient without having any direct contact with that
patient and whose doctor engaged in discussion with patient's doctor over transport
options was entitled to summaryjudgment because its doctor did not have a physician-
patient relationship with the patient, who was still under the care of her doctor); Kruger ex
rel. Estate of Kruger v. Jennings, 2002 WL 344268 (Mich. Ct. App. 2002) (holding that an
on-call surgeon who offered advice to the physicians working with a patient could be held
to have been in physician-patient relationship because he actively participated in the course
of treatment), superseded by Kruger v. Jennings, 2002 WL 652098 (Mich. Ct. App. 2002).
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provide the physician visual clues as to the patient's health and, perhaps,
truthfulness in answering questions. Again, there is a legal and regulatory
subtext. An examination places the patient-physician interaction in
physical space, facilitating regulatory scrutiny while making it more likely
that the provider is a bricks-and-mortar provider covered by modern
privacy laws.
Whether or not medical boards articulate or fully explain these
objections to Internet prescribing, they know them when they see them;
the primary identifier for regulators is substitution of an online
questionnaire for aspects of the traditional paradigm.
1. Questionnaire Prescribing
There are no easy answers to the inquiry into exactly what is occurring
in the online prescribing interaction between patients and Internet
prescribers. It is self-evident that there are websites supplying U.S. patients
with prescription drugs without even the most rudimentary safeguards. In
such cases, the only requirement for consumer access to controlled
substances or prescription drugs is a credit card. The .drugs may or may not
be fakes; they may or may not be delivered or delivered in good condition;
and obtaining the consumer's credit card information may well be the first
step in an identity theft fraud. For some regulators, the existence of this
unquantified criminal activity may itself be justification for closing down all
Internet prescribing and dispensing.
From the perspective of regulators, the Internet prescribing case is
well-represented by United States v. Nelson, in which the United States Court
of Appeals for the Tenth Circuit upheld a physician's conviction for
conspiracy to prescribe controlled substances and money laundering.48
Nelson and his co-conspirators created NationPharmacy.com, which
distributed controlled substances, particularly the Schedule II painkiller
Hydrocodone. 40 9 Nelson periodically visited the pharmacy and signed
410thousands of "questionnaire" prescriptions at a time.
We know little about the slightly less seamy side of Internet prescribing
and dispensing. This is because state medical boards tend to work off an
absolutist model and the physicians and pharmacies they prosecute have
little to gain from fighting the charges. It makes more sense for culprits to
408. 72 Fed. Appx. 837 (10th Cir. 2003).
409. See U.S. Drug Enforcement Admin., Hydrocodone, at
http://www.usdoj.gov/dea/concem/hydrocodone.html (last visited Apr. 17, 2004).
410. 72 Fed. Appx. at 839.
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agree to a consent decree, and then register or spoof a new domain name
or move on to states with less committed or effective enforcement. An
exception is the Kansas case, State ex rel. Stovall v. Confimed.com, L.L.C.411
The first Internet prescribing case to reach a state high court, Stovall
involved a successful "sting" operation that caught out-of-state prescribers
and dispensers delivering prescription drugs. Stovall suggests, however, that
there are grey areas of Internet prescribing and dispensing and, further,
that the courts may not always share the black-and-white antipathy of state
boards and prosecutors.
An investigator and the supervised minor son of another investigator
purchased Viagra 12 from a website operated by an out-of-state physician;
neither the physician nor the pharmacy were licensed to practice in
Kansas. The site appeared to be quite robust. It had the usual e-commerce
functions, a liability waiver, warnings about the drug, recommended
dosage, links to information on the drug manufacturer's site, and required
the patient to represent that he had received a recent physical. The female
investigator and the minor filled out the diagnostic questionnaire. The
minor did not fill out all the diagnosis questions on the form, though he
did give symptoms suggesting erectile dysfunction. The minor's order was
filled but the female investigator's request for Viagra was initially denied.
An employee of the physician-pharmacy contacted the agent and informed
her that Viagra could not be supplied to a female. The drug was supplied
when the agent resubmitted the order and questionnaire under a false,
male name.
Predictably, the trial court granted the state's application to enjoin the
defendants from dispensing medication or practicing medicine in
Kansas.1 3 The issue was whether such conduct breached the state's
consumer protection act 1 and enabled the prosecutors to recover attorney
fees, investigative fees, and penalties. The trial court held that the
consumer protection act was not breached, noting:
[T]here was no actual harm done to anyone. Nothing was
misrepresented. All drugs furnished were authentic. The pharmacy
expert testified that if the waivers in the orders signed by the investigators
were true, more would have been understood by them than 'regular'
411. 38 P.3d 707 (Kan. 2002).
412. A companion case, State ex rel. Stovall v. DVM Enters., 62 P.3d 653 (Kan. 2003), dealt
with a similar sting involving controlled substances, but the court came to the same basic
conclusion.
413. 38 P.3d at 709.
414. KAN. STAT. ANN. §§ 50-636, 59-623, 59-627 (2004).
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doctors and druggists typically advise their patients or customers....
The Supreme Court of Kansas affirmed, refusing to hold that a
seventy-five dollar consultation fee, prescribing without a physical
examination, or supplying the drug to a minor constituted consumer
fraud.416 Neither the trial court nor the Supreme Court approved of the
conduct of the defendant,417 but the courts were also clearly not pleased by
the agents' false representations in conducting the sting. Notably, the
Supreme Court made a point of referring to the state's pharmacy expert's
statement that "had the purchasers in fact read the manufacturer
information about Viagra, they would know more information than [the
expert] provides his own customers. He also admitted that the questions asked
on the computerized consultation form were more in depth than those he poses to
individuals who have been prescribed Viagra.',
41 8
Of course, not all questionnaires are created equal. For example, some
are rudimentary and merely tacked onto the end of order forms, showing
contempt for the medical process of prescribing. Some electronic forms
have their defaults set in a more dangerous fashion. For example, if
medical history questions are pre-answered as "none," the patient has to
affirmatively overrule the default.49 The snapshot of Internet prescribing
and dispensing supplied by Stovall is not necessarily representative.
However, what we learn is that licensed professionals do staff at least some
of these sites and that not all prescription requests are automatically filled.
2. A Suspect Paradigm: The Realities of Modern Bricks-and-Mortar Medicine
A major component of the "bad medicine" premise behind the
targeting of Internet prescribing is that it compares so unfavorably with the
bricks-and-mortar paradigm. As succinctly addressed by the physician's
attorney in the Kansas Viagra case, "Doctors who prescribe in the office
don't examine your equipment, so what is the real medical issue that is not
being addressed?, 42 In fact, the prescribing paradigm relied on by state
415. 38 P.3d at 710 (describing lower court findings).
416. Cf ARK. CODE ANN. § 17-92-1007 (Michie 2002) (deeming breach of the Arkansas
Internet Prescription Consumer Protection Act to constitute unconscionable conduct
under the state consumer protection statute); see also id. § 4-88-107.
417. The court quoted the trial judge's statement that "these people ought to be de-
frocked as medical practitioners, as pharmaceutical practitioners." 38 P.3d at 715.
418. 38 P.3d at 714 (emphasis added).
419. Siwolop, supra note 88.
420. Web Prescriptions Thrive Despite Sting, WASH. TIMES, Mar. 5, 2002, at Al (quoting James
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regulators bears only passing resemblance to the realities of modern
healthcare delivery.
The cradle-to-grave physician-patient relationship has long since
disappeared. Continuity of care may be a valid goal, but not one that seems
able to co-exist with managed care; it is now employers and HMOs that
decide whether the patient has the same physician from one year to the
next. Continuity of care is also hard to detect in treatment provided by fee
per visit walk-in centers,42' the pejoratively labeled "doc-in-a-box" or "mall
medicine." Here, the AMA has been consistent, approaching these new
forms of transient relationships with the same type of concern displayed
toward online care, primarily objecting to any misleading use of the term
"emergency" in the branding or marketing of these walk-in centers.422
The "physician" component of the paradigm is also overstated;
collaborative, protocol, or formulary prescribing by nurse practitioners is• 4 2 3
now widespread, and New Mexico has become the first jurisdiction to
permit prescribing by psychologists, independently within a formulary and
collaboratively in other cases.424 The paradigm's reference to a single
"physician" is also inaccurate; we now recognize the growth and
importance of "shared care, '42 ' referring either to more than one physician
taking care of a patient or to the growing role and responsibilities of the
patient herself in sharing her care with her physician. 2" Research suggests
that this is the context for the use of Internet-sourced medical information
by patients, not as a substitute for traditional physician-patient
relationships, but as a way of increasing their knowledge and asserting
R. Jarrow).
421. See Milt Freudenheim, Shopping Mall Medicine, N.Y. TIMES (MAGAZINE), Dec. 5, 1982,
at 6-146.
422. SeeAM. MED. ASS'N, FREESTANDING EMERGENCY MEDICAL CARE POLICY (1993),
http://www.ama-assn.org/apps/pfnew/pfonline?f n=browse&doc=policyfiles/HnE/H-
130.990.HTM (last visited May 1, 2004).
423. See, e.g., ALA. CODE § 34-21-81 to -87 (1975).
424. N.M. STAT. ANN. § 61-9-1,7.2 (Michie 2004). This statute has been repealed, effective
July 1, 2010.
425. See Steve O'Dell &Jim Hansen, The Next-Generation Health Plan: Not If but When and




426. David Brushwood puts a normative and questioning spin on this sharing of care
between patient and medical professional. Brushwood, supra note 268, at 96-97.
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We also do not spend much time in the physical presence of our
physicians. Routinely, we contact them by phone, poorly describe our
symptoms, and expect a prescription to be phoned into a pharmacy. Such
a practice is viewed as permissible because there is an existing physician-
patient relationship, and the physician has access to some part of our
medical record. The prescribing, however, is no less rote than we see in
online interactions.
"Traditional" office visits are seldom more robust, with the average
primary care visit now lasting approximately fifteen minutes.2 8 Patient
access to pharmaceutical information, particularly DTC advertising, means
that the conversation is as likely to start with a patient's request for a
specific drug rather than a physician inquiry as to symptoms.4 2 Not to
mention the way that managed care compresses the dialogue space and
leaves little room for extensive interaction. Many of today's office visits are
seldom more didactic than a completed Internet questionnaire. The most
compelling argument in favor of the depleted paradigm may be that -a
bricks-and-mortar physician is less likely to have a financial interest in the
dispensing part of the business than her online counterpart.430 The
traditional paradigm is not just collapsing in the medical domain; our
regulatory systems themselves recognize that things are not as they once
431were.
427. See Fox & FALLOWS, supra note 54, at 15-16.
428. D. Mechanic et al., Are Patients' Office Visits with Physicians Getting Shorter?, 344 NEw
ENG.J. MED. 198 (2001).
429. See generally Harris Interactive, The Impact of Direct-to-Consumer Advertising of
Prescription Drugs on Consumer Behavior, Diagnosis and Treatment, HEALTH CARE NEWSJune 23,
2003,
http://www.harrisinteractive.com/news/newsletters/healthnews/HI-HealthCareNews2003
Vol3Issl 1 .pdf (finding that seventy-two percent of office visits initiated by a patient after
DTC exposure led to a prescription being written, and forty-three percent of times for the
specific advertised drug).
430. This results in no small part because of prevailing fraud and abuse laws. See infra
note 478.
431. See, e.g., ALA. ADMIN. CODE § 540-X-9-.11(2) ("Prescribing for a patient whom the
physician has not personally examined may be suitable under certain circumstances. These
may include, but not be limited to, admission orders for a patient newly admitted to a
healthcare facility, prescribing for a patient of another physician for whom the prescriber is
taking call, or continuing medication on a short-term basis for a new patient prior to the
patient's first appointment."); N.D. CENT. CODE § 43-15-31.3 (2001) (permitting
oral/telephone transmission of prescription information from doctors to pharmacists).
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3. Imperiled Next Generation Models
Some medical boards clearly equate questionnaire prescribing with the
most undesirable forms of Internet prescribing. For these regulators, the
questionnaire is an artifice, an attempt to fool regulators and patients into
believing that individuated diagnosis precedes the shipment of dangerous
drugs across state borders. Therefore, for the boards to crack down on
questionnaire prescribing is to move against the worst excesses of the
trade, cynical pill-mills that jurisdiction hop to avoid health and safety
scrutiny. The analysis gets more interesting, however, when we examine
how a state board reacts to questionnaire prescribing integrated into an e-
health model that seems to lack some or all of these undesirable indicia,
such as "online doc-in-a-box,"432 e-businesses,433 and, potentially, "second
opinion" sites.
MyDoc.com 34 was first launched in Indiana and then briefly expanded
to Illinois in April 2002.435 Originally a division of Swiss-based Roche
436.diagnostics, it was sold to U.S. Health Services in 2003, a unit of Standard
Management Corp., which markets pharmaceutical products and services
to consumers.3 7 MyDoc.com's business model was somewhat unique in that
it was owned by a well-known healthcare company and charged on a pay as
you go, annual subscription, or employer-paid subscription basis.38 It also
432. If patients are not already asking the question, "What's your email address, doctor?,"
they will be soon. Dorothy L. Pennachoi, What's Your Email Address, Doctor?, 80 MED. ECON.
66 (2003).
433. See, e.g., VirtualMedicalGroup, at http://www.virtualmedicalgroup.com/ (last visited
Apr. 17, 2004). It promises:
You are in the right place if you want to experience quality health care.
VirtualMedicalGroup Board Certified physicians who are licensed in your home
state, treat minor, non-emergent medical conditions in the privacy of your own
home or office. We have been in business for over three years - longer than
anyone on the web - as a result of our focus on patient confidentiality,
convenience and quality care.
Id.
434. The website for MyDoc.Com (formerly at http://www.mydoc.com) is no longer
accessible.
435. Mave Davis, Internet Doctors Make a Move to Illinois, CHI. TRIB., May 5, 2002, at 6A.
436. Online Firms Tout Cyber Physicians; But Some Docs Question Virtual Visits, CRAIN'S CHI.
Bus., Aug. 5, 2002, at SRI 1; see supra note 421 and accompanying text (discussing of doc-in-
box medicine).
437. Roche Diagnostics Unloads MyDoc. com; U.S. Health Services Corp. Buys Internet Doctor
Service and Plans To Keep It Operating, INDIANAPOLIS STAR, June 13, 2003 at 1C.
438. MyDoc.Com (on file with author).
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had features that distanced it from the typical Internet pill-mill. First, it
treated or prescribed only to residents of Indiana. Second, it employed
physicians who were board-certified in Indiana and, unlike the "pill-mills,"
their identities were disclosed on the website. 439 Third, it refused to
prescribe controlled substances or lifestyle drugs4° and referred complex
inquiries to specialists or the patient's existing physician. Fourth, the site
featured "next generation" questionnaire prescribing that is better
described as questionnaire triaging. Once a patient completed a
questionnaire, it was analyzed by an expert system that could then pose
additional online questions to the patient. The attending physician could
then follow-up in real-time to acquire further information. Finally, any
prescribed drugs were not supplied directly by the site; a prescription was
communicated to a pharmacy chosen by the patient.44'
While MyDoc.com prospered in Indiana-at least briefly,4 4 1 when it
attempted to commence business in Illinois, the State Department of
Professional Regulation issued a cease-and-desist order in October 2002 on
the basis of "unlicensed practice of medicine including, but not limited to,
treating patients over the Internet and prescribing medication to patients
over the Internet without the benefit of performing a physical examination
on the patient."4 3 The company complied with the order.444 The medical
establishment commended Illinois's action; the AMA stated that it
"applauds the efforts of state authorities to aggressively police Web
prescribing sites that bypass medical safeguards with disclaimers that
suggest a physical examination or review of reliable medical history are
irrelevant to the safety of the patient." 445
Even more benign than virtual walk-in centers are web-based "second
opinion" services. In this model, a patient makes web contact with an
online medical consultancy, many of which are affiliated with large
teaching or research hospitals such as the Cleveland Clinic,' and
439. Id.
440. Id.
441. Davis, supra note 435.
442. Jeff Swiatek, Illinois Sidelines MyDoc.com Service, INDIANAPOLIS STAR, Oct. 31, 2002, at
1C.
443. Ill. Dep't of Prof l Regulation, Disciplinary Report for October 2002,
http://www.ildpr.com/news/discpln/0210_dis.pdf (last visited May 17, 2004).
444. See Ann Carrns, Illinois Orders Indiana Web Site To Stop Offering Medical Service, WALL
ST.J., Oct. 30, 2002, at D4.
445. Tyler Chin, Firm Treating Strangers by Web Shut Out by Illinois, AMNews, Nov. 4, 2002.
446. See E-Cleveland Clinic, at http://www.eclevelandclinic.com (last visited Apr. 17,
2004); see also Virtual Medical Group, at http://www.virtualmedicalgroup.com/ (last visited
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authorizes access to her medical record and a credit card charge ranging
from $500 to several times that amount.447 A consultant reviews the record
and emails a diagnosis back to the patient. One such system has published
a retrospective review demonstrating improved response times compared
to traditional second-opinion references, but only a small number of
dissenting diagnoses.448
Such second opinion sites have opportunistic characteristics in that a
prior relationship with the consulting physician is unlikely. Also, they tend
to feature record review rather than a physical examination. However, such
services tend not to get involved in prescribing, and their record review
process furthers continuity of care by involving or at least copying their
opinions to the patient's existing physician . It has also been argued that
physical contact with the patient is less important in second opinion
consultation cases, where most of the analysis flows from review of blood
work, scans, and pathology tests and primarily concerns treatment options
rather than core diagnoses.
VI. RETHINKING THE REGULATION OF INTERNET PRESCRIBING AND
DISPENSING
This Article does not argue for anything less than a rigorous drug
approval system, a licensure system for physicians and pharmacists, and
robust enforcement of gatekeeper and quality standards. It accepts with
only limited reservations (such as cases of protectionist discrimination or
where there are less restrictive means) that it is entirely legitimate for states
to enforce their licensure systems and professional standards in a way that
has an impact on Internet prescribers and dispensers both inside and
outside their borders.
Rather, this Article argues that the current regulatory matrix is
inefficient, incoherent, and imprecise in its targeting. It is inefficient
because the general deterrence model that the state regulators use
(stinging pill-mills where they can find them in the vain hope that others
Apr. 17, 2004); MDExpert.com, at http://www.mdexpert.com (last visited Apr. 17, 2004).
447. MDExpert.com quotes fees ranging from $2800 to $3200 depending on complexity.
MDExpert.com, Frequently Asked Questions about MEDExpert, at www.mdexpert.com (last
visited Apr. 17, 2004).
448. Iris Kedar et al., Internet Based Consultations To Transfer Knowledge for Patients Requiring
Specialised Care: Retrospective Case Review, 326 BRIT. MED.J. 696 (2003).
449. See Daniel Costello, Virtual Second Opinions, L.A. TIMES, Dec. 30, 2002, at Fl.
450. See Tara Parker-Pope, Virtual Second Opinions: When the Web Can Be Better than Seeing a
Local Doc, WALL ST.J., Aug. 12, 2003, at D1.
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will be deterred) does not map well to a technologically sophisticated
underground online industry that continually changes its real space and
cyberspace identities and locations. It is an enforcement model that is
ultimately doomed because the demand side is robust and unconvinced
that the regulators have a valid moral imperative. The vast majority ofS 451
patients want less expensive and more responsive services; increasingly,
they want to buy their medical services and pharmaceuticals online and are
unconvinced that traditional distribution channels are any better attuned
to their needs.
The current model is incoherent due to the over-complexity of the
regulatory matrix. State, federal, and self-regulatory bodies administer an
overlapping series of systems that are united in conservatism and tunnel
vision. At the extremes, they exhibit parochialism and even technophobia.
Their models are imprecise because they are not derived from forward-
looking national or local health information infrastructure planning. As
such, they derive their mandates from an outdated model of healthcare
delivery and not from a conceptual model that distinguishes between types
of online health interaction that should be encouraged rather than chilled
or deterred.5 The model is also operationally flawed. It fails to adequately
carve out regulatory approval (or appropriate levels of regulation) for
traditional telemedicine, while the blunt tools it uses to identify rogue
practitioners (i.e., physician-patient relationships and physical
examinations) poorly serve the regulators and regulated alike in the face
of next generation delivery models.
The United States is moving inextricably towards a more efficient
national healthcare infrastructure that is firmly rooted in technologically-
mediated exchanges.453 The system being built is not only transactional,
451. Earlier I discussed today's online market for lifestyle drugs-including patients who
may be willing to pay more for the convenience of purchasing such drugs in a covert
fashion over the internet. See supra paragraph preceding note 101. While these patients
have been some of the first to purchase drugs over the Internet, they represent a subset of
the overall patient population; going forward an increasing number of patients will
consider purchasing their medications online, and this mainstream consumer population
will be motivated in significant part by potential cost savings.
452. For discussion of chilling in this context, see PUBLIC WORKSHOP, supra note 313, at
652.
453. The National Committee on Vital and Health Statistics (NCVHS), see U.S. Dep't of
Health & Human Servs., Nat'l Comm. on Vital and Health Statistics, at
http://ncvhs.hhs.gov/ (last visited Apr. 17, 2004), is responsible for the National Health
Information Infrastructure, Health Insurance Portability and Accountability Act of 1996,
Pub. L No. 104-191, § 263, 110 Stat. 1988 (1996). The broad goals of NCVHS are to deliver
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requiring correlate security and privacy protections, but will integrate the
Institute of Medicine's (IOM) technology-based solutions to medical and
medication error.5 4 Moving forward requires not only persuading
regulators that unlawful cross-border Viagra peddling is distinguishable
from the "war on drugs" but also that it is a transitional phenomenon, an
experiment in online care that is filling the vacuum created by skepticism
regarding technologically mediated care. Improvements in the regulatory
matrix, therefore, will necessitate not only far more circumspection about
practice models that require policing or deterring, but also affirmative
steps to encourage innovation by lawful players.
A. Improving the Prescribing Regulatory Model
• • 455
There is little doubt that e-prescribing will become the default
interface for prescribing in secondary and tertiary care environments.
While supervised by physicians or nurse-practitioners and integrated into
sophisticated risk-management systems, prescriptions will increasingly be
the product of expert systems rather than traditional physician-patient
interactions. Online prescribing will take on a similar role in primary care• 456
environments. The current regulatory atmosphere is chilling the
development of responsible open or public systems; instead, innovative
models are developing more slowly as adjuncts to traditional care models
within existing health plans5 7 or in proprietary systems like Medem.45 s
information to consumers, patients, and professionals that is to be used to make informed
decisions about health and health care. U.S. DEP'T OF HEALTH & HUMAN SERVS., NAT'L
COMM. ON VITAL AND HEALTH STATISTICS, NHII WORKGROUP ON THE NAT'L HEALTH INFO.
INFRASTRUCTURE, INTERIM REPORT, TOWARD A NATIONAL HEALTH INFORMATION
INFRASTRUCTURE (2000), at http://ncvhs.hhs.gov/NHII2kReport.htm. States are making
their own modest contributions by, for example, permitting electronically created and
transmitted prescriptions. See supra note 17 (discussing such a provision in Massachusetts
law).
454. See, e.g., COMM. ON QUALITY OF HEALTH CARE IN AMERICA, CROSSING THE QUALITY
CHASM: A NEW HEALTH SYSTEM FOR THE 21ST CENTURY (2001) [hereinafter CROSSING THE
QUALITY CHASM].
455. For a definition of e-prescribing, see supra note 17.
456. See, e.g., Bye-Bye, Paper Rx? E-Prescribing Could Boost Convenience, Safety-Given Time,
WASH. POST, July 1, 2003, at HEO (using term "e-prescribing" to describe Internet delivery
of prescriptions from HMOs and doctors' offices to pharmacies).
457. See, e.g., Virtual Doctors on the Horizon in Seattle, 354 LANCET 9182 (1999) (reporting a
Virtual Clinic closed system provided by a Seattle hospital to Microsoft employees).
458. The Medem Network: Connecting Physicians and Patients Online, at
http://www.medem.com (last visited May 15, 2004).
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Medem was founded in 1999 by the AMA and several other professional
associations and is a proprietary, for-profit physician-patient
communications network that enables physicians to use secure email and
messaging with existing patients.4 5 " To an extent, Medem is online
healthcare's AOL, a halfway house for physicians on the way to e-health.46
States will be increasingly forced to recognize the benefits of online
care4 6 1 and its importance to the future of safe and efficient healthcare
delivery. 62 The challenge, therefore, is to design a regulatory system for
Internet prescribing and dispensing that will not chill existing, responsible
models of online practice (i.e., traditional telemedicine and home
telehealth) or impede the development of millennial delivery models (i.e.,
those for prescribing and dispensing that are part of our e-health future).
The classic answer to this question is a national licensure system for
physicians, but this is an unlikely short or medium term option. States are
no more of a mind to forego their licensing powers than the federal
government is to expand its regulatory purview.4 63 Even if the political and
policy climate were more favorably disposed toward such a move, federal
licensure would not necessarily solve the Internet prescribing issue.
Although a national system would reduce the chilling effect that comes
from questions as to whether multiple licenses are required and
459. See Press Release, Medem, Physician Associations Announce Health Care
Information and Communications Web Site (Oct. 28, 1999),
http://www.medem.com/press/pressmedeminthenews-detail.cfm?ExtranetPressNewsKey
=1 (last visited May 15, 2004).
460. Cf James Surowiecki, The Future of AOL: Spin Off and Prosper, WIRED (October 2002)
(suggesting AOL could improve its financial position through innovation if Time Warner
would spin off the division).
461. See, e.g., ALA. CODE § 34-24-500 (2000) ("The Legislature hereby finds and declares
that, because of technological advances and changing practice patterns, the practice of
medicine ... is occurring with increasing frequency across state lines and that certain
technological advances in the practice of medicine ... are in the public interest ...."; see
also HealthyOregon, at http://www.healthyoregon.org/ (last visited Apr. 17, 2004).
462. See CROSSING THE QALrY CHASM, supra note 454, at 168-69 (listing "Health-Related
Applications for the Internet").
463. Cf Medicare Telehealth Validation Act of 2002, S. 2750, 107th Cong. § 2(c) (1)
("[T] he Secretary... in consultation with representatives of States, physicians, healthcare
practitioners, and patient advocates, encourage and facilitate the adoption of State
provisions allowing for multi-state practitioner licensure across State lines."). The same
language is adopted in Medicare Telehealth Validation Act of 2003, H.R. 1940, 108th Cong.




inconsistent regulation, federal licensure by itself does not go to the root
issues of opportunistic relationships and suspect care.
Short of national licensure, however, the states can still build a better
mousetrap. They must begin by recognizing that, today, the case for
regulatory heterogeneity and the disfavoring of technologically-mediated
care is quite weak. State regulators can work cooperatively with one
another-witness the work of the Federation of State Medical Boards4 64-
and develop a uniform licensure and practice code. This code should
adopt a standardized test for the "practice of medicine" and set common
standards and limitations for online interactions.
The most immediate standardization must come from closed (as
contrasted to public Internet) systems, telemedicine, and telehealth
applications such as home monitoring. The closed nature of these systems
immunizes them from the problems associated with opportunistic
interactions, and they are far less likely to involve prescribing. The old
telemedicine consult model may no longer be accurate, and nationally
consistent standards of consent and record-keeping may be appropriate.
There is no reason, however, to chill these practices with inconsistent state
regulations or standards that discriminate between chosen technologies
and those that feature interstate, as opposed to intrastate, interactions. As
with other proposals discussed herein, regulatory scrutiny is required not
only for the direct cross-border issues but also for more indirect changes
designed to protect consumers engaging in online medicine and promote
confidence in the systems that develop. For example, privacy protections
for online patients not obviously covered by the PIHI regulations are
required. It is unlikely that the United States will move anytime soon to a
full collection-centric privacy model. However, both federal
46' and state466
legislators have considered bills that would remove some of the
voluntarism presently found in the publication of privacy policies, for
example, by mandating compliance with published privacy policies and
disclosure of breaches of privacy or security.
Open (or public Internet) systems are more problematic given the
464. See, e.g., FED'N OF STATE MED. BDS., REPORT OF THE SPECIAL COMMIT'TEE ON
PROFESSIONAL CONDUCT AND ETHICS (2000),
http://www.fsmb.org/Policy%20Documents%20and%2OWhite%2OPapers/internet-use-gu
idelines.htm; FED'N OF STATE MED. BDS., REPORT OF THE AD Hoc COMMITTEE ON
TELEMEDICINE (1996),
http://www.fsmb.org/Policy%20Documents%20and%2OWhite%2OPapers/telemed.htm.
465. See, e.g., Online Personal Privacy Act of 2002, S. 2201, 107th Cong. (2002).
466. See, e.g., California Online Privacy and Disclosure Act of 2002, A.B. 2297 (Cal. 2002).
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potential for opportunistic relationships and sub-standard care. The
emerging regulatory touchstones for lawful interaction (an existing
physician-patient relationship and physical examination) are too restrictive
and chill the development of next generation models. There are less
restrictive means to oudaw pill-mills, regulate responsible practice, and
encourage innovation. Such standards should be the criteria for a uniform
online practice certification.
As argued above, there is little literal magic in the requirement of a
"physician-patient relationship." Rather, in this context, regulators are (or
should be) concerned about the absence of "continuity of care."
Therefore, continuity of care, or rather its deconstructed elements, should
be made a requirement for online systems. Rather than demanding an
extant relationship (a requirement not imposed on bricks-and-mortar
walk-in centers), harmonized state laws should require online providers to
establish contact with the patient's existing record and assume the
correlate responsibility of adding to that record. Online providers must
also show a commitment to continuing or follow-up care.
Similarly, there are less restrictive ways for harmonized state standards
to achieve the goals that underlie the requirement of a physical
examination. Positive identification of both patient and physician can be
achieved using digital certificates.467 The therapeutic aspects of physical
presence can be approximated by establishing protocols for the non-
physical interactions, such as the development of model questionnaires
which would include questions that allow for cross-checking responses.
There should always be a requirement that the online system is only an
initial step, a triage, and the physician has to establish an appropriate
system for individual follow-up, by phone, email, or messaging. Such
standards must factor in the availability and use of "physical," but
technologically-mediated, examinations, such as those being incorporated
in telehealth appliances in the home or integrated into mobile devices
such as cell phones.
As part of the incubation of, and experimentation with, online care,
there should be limitations placed on its utilization. Protocols should
address the situations when the online interaction must be halted and the
patient referred to a bricks-and-mortar provider. Equally, we must move
away from a monolithic approach to online care. Some diagnoses and
467. See, e.g., Steve Gold, Site Employs Biometrics, Newsbytes, at
http://www.computeruser.com/newstoday/0O/04/18/news6.html (Apr. 18, 2000)
(detailing use of BioNetrix biometrics technology to authenticate the identities of doctors
ordering patient prescriptions over the Internet from the online pharmacy).
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some prescribing may be more consistent with technologically-mediated
care than others. An online practice certificate should be conditioned on
specialized training and restricted to developed protocols that place limits
on the types of treatment and any resultant prescribing. Such a model can
be adapted from that applied to nurse-practitioners. Similarly, online
practice and prescribing can be limited by protocol, and prescribing can
be further limited to a specific formulary of legend drugs or the exclusion
of controlled substances." Current overreaching pharmacy regulations
that require the dispenser to be satisfied that prescribing was preceded by
a physical examination could be reworked to prohibit the filling of an
online prescription for a non-protocol drug or by a certified practitioner (a
practitioner having undergone the appropriate training).
B. Reforming Online Dispensing
Such a system of online practice certification and limitation by
protocol does not require FDA action. The protocol or formulary
prescribing limitations, however, could be encouraged and reinforced if
the drug approval process adapted the controlled substances schedule
approach 469 to all prescription pharmaceuticals. If sub-categories of
ordinary prescription drugs were developed, the FDA and manufacturers
could then evolve warning and labeling requirements that would better
meet the needs of online prescribing.
Continuing to require multi-state licensing of pharmacies is a much
closer case. There is a good argument that we should move away from a
paternalistic paradigm and allow patients more choice, including interstate
supply.470 Such a paradigm shift in how we view patient choice in the drug
arena is not unheard of. For example, the learned intermediary rule that
requires drug warnings to be delivered to physicians rather than patients is
riddled with exceptions when robust drug information is or could be
delivered directly to patients through package inserts471 or DTC
advertising.472
A relaxation of cross-border traffic for pharmaceutical dispensing,
however, should not be unconditional. Through a model act,473 the states
468. See, e.g., ALA. CODE § 34-21-87 (1975).
469. See, e.g., UNIFORM CONTROLLED SUBSTANCEs AcT (1994).
470. Brushwood, supra note 268, at 95-96.
471. See, e.g., Stephens v. G.D. Searle & Co., 602 F. Supp. 379 (E.D. Mich. 1985); Samuels
v. American Cyanamid Co., 495 N.Y.S.2d 1006 (Sup. Ct. 1985).
472. See, e.g., Perez v. Wyeth Laboratories Inc., 734 A.2d 1245 (N.J. 1999).
473. This action was likely guided by the NABP. See, e.g., NAT'L ASS'N OF BDS. OF
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must commit themselves to regulating the online pharmacies physically
located within their borders. 474 In a 180-degree switch from the current
regulatory model, pharmacies with interstate businesses could be required
to have an exporting state's certificate requiring, for example, additional
reporting and available online post-dispensing advice. The states should
establish a clearinghouse for complaints about licensed interstate
pharmacies and make those complaints and other quality and
performance information publicly available, mimicking the models
emerging for informing patients about hospital ratings,475 nursing home
ratings476 and malpractice/disciplinary proceedings against physicians.477
Crucially, online prescribers and dispensers should be prohibited from
cross-ownership interests or payments, which would be consistent with• 4781
mainstream health's approach to self-dealing. Online pharmacies should
not be permitted to refer to specific online physicians and vice versa.
As for international dispensing, any move to legalize the Canadian
connection should be viewed as a red (and white) herring. The fact that
pharmaceuticals are less expensive across the northern and southern
borders of the United States is not some accident of pharmacy licensing.
Congress and the White House, unlike a majority of consumers, 479 do not
PHARMACY, MODEL STATE PHARMACY ACT AND MODEL RULES OF THE NATIONAL ASSOCIATION OF
BOARDS OF PHARMACY (2003),
http://www.nabp.net/ftpfiles/NABP01/ModelActjune2003.doc.
474. See, e.g., N.Y. EDUC. LAw § 6808-b (6) (Consol. 2003). The legislation states:
[T]he department shall not prosecute a complaint or otherwise take formal
action against a nonresident establishment based upon delivery of a drug into
this state or a violation of law, rule, or regulation of this state if the agency having
jurisdiction in the state where the nonresident establishment is based commences
action on the violation complained of within one hundred twenty days from the
date that the violation was reported.
Id.
475. See, e.g., Ceci Connolly, Pilot Test Will Pay Hospitals for Quality: Government Hopes Care
Will Improve, WASH. POST, July 11, 2003, at A03.
476. See, e.g., Nursing Home Compare, Medicare, at
http://www.medicare.gov/nhcompare/home.asp (last visited Apr. 17, 2004).
477. See, e.g., Virginia Board of Medicine's Practitioner Information, HealthCareProvider, at
http://www.vahealthprovider.com/ (last visited Apr. 17, 2004). See Sandra G. Boodman, Va.
Doc Site Adds Key Info, WASH. POST, Oct. 16, 2001, at F2.
478. See, e.g., 42 U.S.C. § 1320a-7b(b) (2000) (enacting criminal penalties for Medicare &
Medicaid kickbacks); 42 U.S.C. § 1395nn (2000) (creating federal limits on patient
referrals).
479. Harris Interactive, Prescription Drug Prices, Hospital Costs and Doctors'Fees, HEALTH
CARE NEws, June 13, 2003, at
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favor price controls and therefore keep pharmaceutical prices high; it may
be bad policy for U.S. consumers to contribute to a disproportionate share
of pharmaceutical research and development and profit, but the remedy
does not lie in the opening of U.S. borders.480 Canada may have "become
the United States' favorite drugstore for seniors-and its defacto Medicare
drug benefit,, 4 ' but if price controls are to be introduced, they should be
implemented directly, not imported. Opening up the heretofore closed
U.S. distribution system is not without risk, though the FDA is probably
exaggerating it. However, congressional action is merely a political artifice
designed to pressure U.S. pharmaceutical interests and the politicians
whom they financially support, and it will do nothing to improve the
regulatory atmosphere surrounding interstate online prescribing and
dispensing. When the dust has cleared, though, the FDA and DEA need to
revisit their personal importation safe harbors and strive for greater clarity
in, and better synchronization of, their policies.
C. Reformulating Self-Regulation
Self-regulatory or non-governmental systems can fill important needs
when applied to novel or emerging business models. Because they are
intrinsically more nimble and adaptive than governmental systems and
unhampered by regulatory gaps or constitutional concerns, they can
inform consumer choice and improve an industry's quality values prior to
the maturation of formal standards. In commodity markets such as
http://www.harrisinteractive.com/news/newsletters/healthnews/HI-HealthCareNews2003
Vol3IssO9.pdf (noting that fifty-seven percent of those polled think drug prices are
unreasonably high and thirty-two percent think that they are somewhat high, while a
declining majority of fifty-six percent to thirty-nine percent favors government price
controls).
480. This observation may be tempered, if not contradicted, by Frank Lichtenberg's
arguments that sustained high levels of spending on new drugs disproportionately reduces
other health costs. See Scott Hensley, Follow the Money: Money Spent on Latest Drugs Is Worth
Cost, Economist Says, WALL ST.J., Sept. 9, 2003, at D6. A Fraser Institute report predicts that
"importing Canadian prices generally into the United States would reduce the profits of
research based drug makers to such a degree that they would reduce annual investment in
research and development (R&D) by US$5 billion to US$15 billion, the latter estimate
being almost half of global pharmaceutical R&D for 2002."John R. Graham, Prescription
Drug Prices in Canada & the US-Part 4, Canadian Prescriptions for American Patients Are Not the
Solution, PUBLIC POLICY SOURCES No. 70 (Sept. 2003), at 3, at
http://www.fraserinstitute.ca/admin/books/files/PrescriptionDrugPricesPart4.pdf.
481. Gilbert M. Gaul & Mary Pat Flaherty, Canada Is a Discount Pharmacy for Americans,
WASH. POST, Oct. 23, 2003, at Al 7.
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Internet prescribing that feature near identical consumer interfaces (e-
commerce engines) and formularies but have not yet seen the
development of trusted brand names, self-regulatory systems can reduce
the acute informational asymmetry suffered by consumers.
Measured against these functions and goals, the current crop of self-
regulatory systems has failed Internet prescribing and dispensing. The
AMA and NABP have done little more than mirror the approach of
traditional governmental regulators, adding another layer of entry barriers
that deter innovators. Credit should be given to the NABP for its VIPPS
system, which translates state licensure into a low-risk, consumer friendly
system for distinguishing between general Internet dispensing and lawful
e-pharmacies. Its value, however, is overstated; in a world where consumers
want information about the relative safety and value of Internet
pharmacies, VIPPS merely confirms the existence of a small number of
relatively well-known e-pharmacy brand names. URAC also deserves praise;
it has pointed to the future of useful content regulation. It leverages a well-
known accreditation brand to encourage providers to internalize the costs
of content quality assurance, without the cost and complexity of other
third-party rating systems.
The logic of the AMA-NABP-URAC approach-approving or
accrediting only licensed providers-is unassailable. The question is how
those organizations and their policy positions or accrediting systems will
react to the liberalization of licensure provisions argued for herein. If the
states move to a harmonized online practice certificate model or permit
shipments from licensed out-of-state pharmacies, the application of
established accreditation systems would drive down consumer information
costs and accelerate the market's identification of quality and value in
online prescribing and dispensing. Synergies with the proposed regulatory
innovations are possible and would be cumulative, for instance, if states
made URAC and NABP accreditation a condition of (or substitute for) an
exporting license.
D. Opening Lawful Channels and Reimbursement
The parallel drawn between the "war on drugs" chilling palliative care
and the crackdown on Internet medicine is certainly valid,4 8 2 particularly
with regard to shared concerns about the supply or diversion of controlled
substances. There are even more telling similarities, however, between
Internet prescribing and the trading of music files over the Internet using
482. See Brushwood, supra note 268, at 78.
IV:2 (2004)
PRESCRIPTIONS SANS FRONTItRES
peer-to-peer networks. The lesson learned by the music industry was that a
clear legal position vigorous enforcement in the face of consumer
demand,484 and half-hearted alternatives85 (e.g., Medem and VIPPS) are
insufficient to stop an illegal practice.8 6 Government regulation and
industry angst and denial have to be supplemented with the development
4817of legal alternatives4' that approximate the traditional interests of
stakeholders4 "88 by leveraging technology (i.e., embedded but not punitive
digital rights management in the case of music, digital certificates and
restrictive formularies for online medicine) so that lawful markets can
develop, driving down prices and increasing consumer satisfaction within a
lawful channel.
483. See A&M Records, Inc. v. Napster, Inc., 239 F.3d 1004 (9th Cir. 2001) (holding that
acts of uploading and downloading files containing copyrighted music violate the copyright
holders' distribution and reproduction rights respectively). But see Metro-Goldwyn-Mayer
Studios, Inc. v. Grokster, Ltd., 259 F. Supp. 2d 1029 (C.D. Cal. 2003) (finding no
contributory or vicarious liability on the part of the distributors of Internet software used by
copyright infringers). See generally Kevin Michael Lemley, Protecting Consumers from
Themselves: Alleviating the Market Inequalities Created by Online Copyright Infringement in the
Entertainment Industry, 13 ALB. L.J. SCi. & TECH. 613 (2003) (discussing problems in
protecting the record industry from peer-to-peer file sharing and possible ways to overcome
such obstacles).
484. Amy Harmon, Subpoenas Sent to File-Sharers Prompt Anger and Remorse, N.Y. TIMES, July
28, 2003, at Cl.
485. Bob Tedeschi, Downloading Music over the Internet Without Feeling Like a Criminal, N.Y.
TIMES, June 7, 2003, at A14.
486. See PEW INTERNET PROJECT, PEW INTERNET PROJECT DATA MEMO (2003),
http://www.pewinternet.org/reports/pdfs/PIP_Copyright_Memo.pdf (last visited Apr. 17,
2004) (finding that twenty-six million U.S. adults share and thirty-five million download
music files online and that "[t]wo-thirds of those who download music files or share files
online say they don't care whether the files are copyrighted or not").
487. Eg., iTunes, at http://www.apple.com/music/store/ (last visited Apr. 17, 2004);
BuyMusic.com, at http://www.buymusic.com/ (last visited Apr. 17, 2004).
488. "This is a very ugly issue for the pharmaceutical industry," said Humphrey Taylor,
chairman of The Harris Poll at Harris Interactive. "As importation of drugs grows-and it
looks set to grow a lot more-drug companies run a big risk of making more enemies as
they fight to prevent importation. This would fuel the growing backlash against the
industry." Harris Interactive, Drug Companies May Be Headed for a Bruising Battle As Drug
Importation Grows, HEALTH CARE POLL, Oct. 9, 2003,
http://www.harrisinteractive.com/news/newsletters/wsjhealthnews/WSJOnline HIHealth
-CarePoll2003vol2_iss8.pdf.
489. See, e.g., Bob Tedeschi, Services for Downloading Music-Legal and with Making a Profit
in Mind-Are Gaining Momentum, N.Y. TIMES, July 28, 2003, at C5; SandeepJunnarkar,
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As recognized by one state legislature, "The full potential of delivering
health care services through telehealth cannot be realized without the
assurance of payment for such services and the resolution of existing legal
and policy barriers to such payment.' ' 4u0 For online medicine, the key to
developing a robust lawful market, countering technophobia, encouraging
physician participation, and eventually, AMA and state board buy-in is
reimbursement. The current positives are as easy to identify as they are rare.
For example, the availability of Medicare payment for teleradiological
consults is clearly responsible for the robust state of teleradiology, 49' and in
January 2004, the AMA issued a new Current Procedural Terminology
(CPT) 492 for billing online care.49 3 Overall, development of federal
government reimbursement for telehealth has been woefully slow. The
Balanced Budget Act of 1997 contained some breakthrough provisions,
such as adding codes for reimbursement, but it was too limited because it
conditioned reimbursement on certain geographical requirements, shared
a single fee between the providers involved, and was not responsive in its
listing of eligible presenters to the practicalities of telemedicine. The
Medicare, Medicaid, and SCHIP Benefits Improvement and Protection Act
2000494 increased the number of codes, removed the fee sharing
requirement,495 and increased the population of eligible presenters.
496
Buy. com Founder Launches Music Service, CNET News.Com,July 22, 2003, at
http://news.com.com/2100-1027-5051609.html?tag=nl (last visited Apr. 17, 2004); see also
Amy Harmon, What Price Music?, N.Y. TIMES, Oct. 12, 2003, at 2-1; cf Press Release,Jupiter
Research, Jupiter Research Cuts Online Music Forecast, but Market Will Still Quadruple to
$3.3 Billion in 2008 (July 28, 2003), http://www.internet.com/corporate/releases/03.07.28-
newjupresearch.html (last visited Apr. 17, 2004).
490. NEB. REv. STAT. § 71-8502(4) (2003).
491. GUIDE TO ASSESSING TELECOMMUNICATIONS FOR HEALTH CARE, supra note 8, at 42.
492. Physicians' Current Procedural Terminology. See generally Am. Med. Ass'n, CPT
Process - How a Code Becomes a Code, at http://www.ama-
assn.org/ama/pub/category/3882.html (last updated Nov. 3, 2003).
493. CPT codes were released on January 1, 2004 and will be implemented byJuly 1,
2004. Am. Med. Ass'n, Category III CPT Codes, at http://www.ama-
assn.org/ama/pub/article/3885-4897.html (last visited Apr. 17, 2004).
494. 42 U.S.C. § 1395m (2000).
495. See, e.g., 42 U.S.C. § 1395m(A) (B) (2000).
496. The U.S. Code provides that:
Nothing in this subsection shall be construed as requiring an eligible telehealth
individual to be presented by a physician or practitioner at the originating site for
the furnishing of a service via a telecommunications system, unless it is medically
necessary (as determined by the physician or practitioner at the distant site).
See, e.g., 42 U.S.C. § 1395m(C) (2000).
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Whether such a funding mandate translates into services depends,
however, on the states,47 and their programs remain quite modest.49 As a
result, telemedicine programs, in particular, tend to be short-lived.4"' ' Most
years, congressional bills seek to nudge the system along,00 but public
sector financing of online care remains modest at best.
Investing public funds in technologically-mediated care is
economically and politically difficult. The shift of some services from
traditional to more efficient e-health models will not take place overnight,
and it will not feature direct or immediate cost substitution.50 As a result,
there are likely to be overlaps and, potentially, increases in costs during the
transition, or even long-term as patients respond positively to new
services. 5°2 As with HIPAA's Electronic Data Interchange (EDI) model we
must invest now and look for cost-savings later. And, while the public purse
is strained, we need to remove regulatory hurdles that discourage private
services from entering the telehealth market.
497. See Ctrs. for Medicare & Medicaid Srvs., Medicaid and Telemedicine, at
http://cms.hhs.gov/states/telemed.asp (last visited Apr. 17, 2004).
498. See Legislative, Legal and Policy Issues in Telemedicine & Telehealth, TIE, at
http://tie.telemed.org/legal/state/#bills (last visited Apr. 17, 2004); cf. CAL. HEALTH &
SAFETY CODE § 1374.13 (West 2003); CAL. WELF. & INST. CODE § 14132.72 (West 2003); CAL.
WEFL. & INST. CODE § 14132.73 (West 2003); see also COLO. REV. STAT. ANN. § 10-16-123
(West 1999); O.C.G.A. § 50-5-191 to -199 (2002). See generally Ctrs. for Medicare & Medicaid
Servs., States Where Medicaid Reimbursement of Services Utilizing Telemedicine is Available, at
http://cms.hhs.gov/states/telelist.asp (last visited Apr. 17, 2004).
499. Claudio Cipolat & Michael Geiges, The History of Telemedicine, in CURRENT PROBLEMS
IN DERMATOLOGY 7 (G. Burg Karger ed., 2003).
500. See, e.g., Medicare Telehealth Validation Act of 2003, H.R. 1940, 108th Cong.
(2003).
501. See, e.g., P. B. Jacklin et al., Virtual Outreach: Economic Evaluation ofJoint
Teleconsultations for Patients Referred by Their General Practitioner for a Specialist Opinion, 327
BRIT. MED.J. 84 (2003).
502. Alan Greenspan, Chairman of the Federal Reserve, has said:
[W]e know very little about how rapidly medical technology will continue to
advance and how those innovations will translate into future spending. To be
sure, technological innovations can greatly improve the quality of medical care
and can, in theory, reduce the costs of existing treatments. But because medical
technology expands the range of treatment options, it also has the potential of
adding to overall spending-in some cases, significantly.
Hearing Before the House Comm. on the Budget, 108th Cong. 6-7 (2004) (statement of Alan
Greenspan, Chairman, Board of Governors of the Federal Reserve System).
503. See supra note 387.
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VII. CONCLUSION
The transformation of U.S. healthcare delivery into a more
technologically adept model is an immensely complex undertaking. It is
also a fragile process. There are powerful stakeholders whose dominance is
threatened by disruptive new technologies. These stakeholders' reactions
to the cram-down style of regulation used in the HIPAA privacy rules and
the way technical compliance rules were substituted for general principles
that could have found broader acceptance should suggest to regulators
that they may want to adopt alternative approaches in the future.
The introduction of the HIPAA's Electronic Data Interchange, the
work of the Institute of Medicine and the Agency for Healthcare Research
and Quality, and a growing patient demand for online medical
information suggest that e-health has passed its tipping point. Contrary to
the fears of many and the exaggerations of some, e-health is not a
replacement for traditional healthcare delivery. It will impact primary,
secondary, and tertiary care differently, and will be more effective with
regard to some types of diagnosis, treatment, and care than with others.
Only through controlled experimentation in an innovative environment
will the correct mix of traditional and technological services and
regulations be discovered.
Much of today's prescribing and dispensing activity on the Internet is
not just unlawful, it is bad medicine. Clumsy regulation, however well
intended, seriously impedes innovation and experimentation, while the
parochial and technophobic attitudes that drive some of the regulatory
activity in this area are also unhealthy. As a result, overbroad medical and
pharmacy board statutes, regulations, and policies are chilling traditional
telemedicine and slowing innovation in safer online models.
Following the dot.corn implosion, investments in consumer e-health
businesses became relatively dormant. In the interim, consumer
expectations and familiarity with the Internet as a source of medical
information and services have grown exponentially. When the investments
return-and they are expected to return 5 04-- our regulatory systems will
need to embrace this new consumer-generated enthusiasm and improve
their tools for distinguishing the online wheat from the chaff.
504. See Gautum Naik, England Plans Major Revamp of Health Care, WALL ST.J., Dec. 3,
2003, at BI (noting that 2002 U.S. health-care computer spending increased 9.3% to $23.6
billion); see also Steve Lohr, Investment in Technology Is Roaring Softly Back, N.Y. TIMES, Nov. 1,
2003, at Cl; Michelle Kessler, Health Data Mandate Gives Tech a Boost, USA TODAY, June 8,
2003, at BI.
IV:2 (2004)
273
274
